<SEC-DOCUMENT>0000950103-25-012054.txt : 20250923
<SEC-HEADER>0000950103-25-012054.hdr.sgml : 20250923
<ACCEPTANCE-DATETIME>20250923170306
ACCESSION NUMBER:		0000950103-25-012054
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		19
FILED AS OF DATE:		20250923
DATE AS OF CHANGE:		20250923

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BARCLAYS BANK PLC
		CENTRAL INDEX KEY:			0000312070
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMERCIAL BANKS, NEC [6029]
		ORGANIZATION NAME:           	02 Finance
		EIN:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-287303
		FILM NUMBER:		251334432

	BUSINESS ADDRESS:	
		STREET 1:		1 CHURCHILL PLACE
		STREET 2:		CANARY WHARF
		CITY:			LONDON
		STATE:			X0
		ZIP:			E14 5HP
		BUSINESS PHONE:		0044-20-3555-4619

	MAIL ADDRESS:	
		STREET 1:		1 CHURCHILL PLACE
		STREET 2:		CANARY WHARF
		CITY:			LONDON
		STATE:			X0
		ZIP:			E14 5HP

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BARCLAYS BANK PLC /ENG/
		DATE OF NAME CHANGE:	19990402

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BARCLAYS BANK INTERNATIONAL LTD
		DATE OF NAME CHANGE:	19850313
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp234695_424b2-7823wfps.htm
<DESCRIPTION>FORM 424B2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="width: 49%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">PRICING SUPPLEMENT dated September 19, 2025</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">(To the Prospectus dated May 15, 2025,</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">the Prospectus Supplement dated May 15, 2025,</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">the Product Supplement No. WF-1 dated May 20, 2025 and</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">the Underlying Supplement dated May 15, 2025)</P></TD>
    <TD STYLE="width: 51%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Filed Pursuant to Rule 424(b)(2)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Registration Statement No. 333-287303</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"></P></TD></TR>
  <TR>
    <TD STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-size: 10pt"><IMG SRC="image_001.jpg" ALT="barclays PLC logo" STYLE="height: 29px; width: 121px"></FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EDEFEE">
    <TD STYLE="width: 100%">
    <P STYLE="color: #BB0826; font: bold 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Barclays Bank PLC</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left; color: #BB0826">Global Medium-Term Notes, Series
A</P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #D5D9D8">
    <TD>
    <P STYLE="color: #BB0826; font: bold 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">$5,598,000 Market Linked Securities&mdash;Callable
with Contingent Coupon with Daily Observation and Contingent Downside</P>
    <P STYLE="color: #BB0826; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Principal at Risk Securities Linked to the
Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the EURO STOXX 50<SUP>&reg;</SUP>
Index due March 22, 2030</P></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #5E8AB4">
    <TD STYLE="width: 100%">
    <P STYLE="color: white; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.7pt"><FONT STYLE="font-family: Wingdings">n</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: -11pt 4.3pt 0pt 0.25in; color: white; text-align: justify"><FONT STYLE="font-size: 10pt">Linked
to the lowest performing of the Nasdaq-100 Index<SUP>&#174;</SUP>, the Russell 2000<SUP>&#174;</SUP> Index and the EURO STOXX 50<SUP>&#174;</SUP>
Index (each referred to as an &#8220;<U>Index</U>&#8221;)</FONT></P>
    <P STYLE="color: white; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.7pt"><FONT STYLE="font-family: Wingdings">n</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: -11pt 4.3pt 0pt 0.25in; color: white; text-align: justify"><FONT STYLE="font-size: 10pt">The
securities are redeemable debt securities of Barclays Bank PLC that, unlike ordinary debt securities, do not provide for fixed payments
of interest and do not repay a fixed amount of principal at stated maturity. Whether the securities pay a contingent coupon and, if the
securities are not redeemed prior to stated maturity, whether you receive the principal amount of your securities at stated maturity
will depend in each case on the performance of the lowest performing Index as described below. The lowest performing Index on any eligible
trading day during an observation period (including on the final calculation day) is the Index that has the lowest performance factor
on that day, calculated for each Index as the closing level of that Index on that day <I>divided by</I> its starting level.</FONT></P>
    <P STYLE="color: white; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.7pt"><FONT STYLE="font-family: Wingdings">n</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: -11pt 4.3pt 0pt 0.25in; color: white; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Contingent
Coupon.</B> The securities will pay a contingent coupon with respect to each quarterly observation period until the earlier of stated
maturity or early redemption if the closing level of the lowest performing Index on <B>each eligible trading day during such observation
period</B> is greater than or equal to its coupon threshold level. However, if the closing level of the lowest performing Index on <B>any
eligible trading day during an observation period </B>is less than its coupon threshold level, you will not receive any contingent coupon
with respect to that observation period. <B>This will be the case even if the closing level of the lowest performing Index is greater
than or equal to its coupon threshold level on one or more other eligible trading days during that observation period, and even if the
better performing Indices perform favorably</B>. If the closing level of at least one Index is less than its coupon threshold level on
one or more eligible trading days during each observation period, you will not receive any contingent coupons throughout the entire term
of the securities. The contingent coupon rate is 10.20% per annum.</FONT></P>
    <P STYLE="color: white; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.7pt"><FONT STYLE="font-family: Wingdings">n</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: -11pt 4.3pt 0pt 0.25in; color: white; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Optional
Redemption.</B> The issuer may, at its option, redeem the securities on any contingent coupon payment date beginning approximately three
months after their issue date. If the issuer elects to redeem the securities prior to maturity, you will receive the principal amount
plus any contingent coupon payment otherwise due.</FONT></P>
    <P STYLE="color: white; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.7pt"><FONT STYLE="font-family: Wingdings">n</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: -11pt 4.3pt 0pt 0.25in; color: white; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Potential
Loss of Principal. </B>If the issuer does not redeem the securities prior to stated maturity, you will receive the principal amount at
stated maturity if the closing level of the lowest performing Index on the final calculation day is greater than or equal to its downside
threshold level. If the closing level of the lowest performing Index on the final calculation day is less than its downside threshold
level, you will lose more than 40%, and possibly all, of the principal amount of your securities.</FONT></P>
    <P STYLE="color: white; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.7pt"><FONT STYLE="font-family: Wingdings">n</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: -11pt 4.3pt 0pt 0.25in; color: white; text-align: justify"><FONT STYLE="font-size: 10pt">The
coupon threshold level of each Index is equal to 70% of its starting level, and the downside threshold level of each Index is equal to
60% of its starting level.</FONT></P>
    <P STYLE="color: white; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.7pt"><FONT STYLE="font-family: Wingdings">n</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: -11pt 4.3pt 0pt 0.25in; color: white; text-align: justify"><FONT STYLE="font-size: 10pt">You
will not participate in any appreciation of any Index.</FONT></P>
    <P STYLE="color: white; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.7pt"><FONT STYLE="font-family: Wingdings">n</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: -11pt 4.3pt 0pt 0.25in; color: white; text-align: justify"><FONT STYLE="font-size: 10pt">Your
return on the securities will depend <B>solely</B> on the performance of the Index that is the lowest performing Index on each eligible
trading day during the observation periods, including on the final calculation day. You will not benefit in any way from the performance
of the better performing Indices. Therefore, you will be adversely affected if <B>any Index</B> performs poorly, even if the other Indices
perform favorably.</FONT></P>
    <P STYLE="color: white; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.7pt"><FONT STYLE="font-family: Wingdings">n</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: -11pt 4.3pt 0pt 0.25in; color: white; text-align: justify"><FONT STYLE="font-size: 10pt">Any
payment on the securities, including any repayment of principal, is subject to the creditworthiness of Barclays Bank PLC and is not guaranteed
by any third party. If Barclays Bank PLC were to default on its payment obligations or become subject to the exercise of any U.K. Bail-in
Power (as described on page PS-7 of this pricing supplement) by the relevant U.K. resolution authority, you might not receive any amounts
owed to you under the securities. See &#8220;Selected Risk Considerations&#8221; and &#8220;Consent to U.K. Bail-in Power&#8221; in this
pricing supplement and &#8220;Risk Factors&#8221; in the accompanying prospectus supplement.</FONT></P>
    <P STYLE="color: white; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.7pt"><FONT STYLE="font-family: Wingdings">n</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: -11pt 4.3pt 0pt 0.25in; color: white; text-align: justify"><FONT STYLE="font-size: 10pt">No
fixed periodic interest payments or dividends</FONT></P>
    <P STYLE="color: white; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.7pt"><FONT STYLE="font-family: Wingdings">n</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: -11pt 4.3pt 0pt 0.25in; color: white; text-align: justify"><FONT STYLE="font-family: Wingdings"></FONT><FONT STYLE="font-size: 10pt">No
exchange listing; designed to be held to maturity</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">See &ldquo;Additional Information about the
Issuer and the Securities&rdquo; on page PS-5 of this pricing supplement. The securities will have the terms specified in the prospectus
dated May 15, 2025, the prospectus supplement dated May 15, 2025, the product supplement no. WF-1 dated May 20, 2025 and the underlying
supplement dated May 15, 2025, as supplemented or superseded by this pricing supplement.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The securities have complex features and
investing in the securities involves risks not associated with an investment in conventional debt securities. See &ldquo;Selected Risk
Considerations&rdquo; on page PS-12 herein, &ldquo;Risk Factors&rdquo; beginning on page PS-3 of the product supplement and &ldquo;Risk
Factors&rdquo; beginning on page S-9 of the prospectus supplement.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The securities constitute our unsecured and
unsubordinated obligations. The securities are not deposit liabilities of Barclays Bank PLC and are not covered by the U.K. Financial
Services Compensation Scheme or insured by the U.S. Federal Deposit Insurance Corporation or any other governmental agency or deposit
insurance agency of the United States, the United Kingdom or any other jurisdiction.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Neither the U.S. Securities and Exchange
Commission (the &ldquo;<U>SEC</U>&rdquo;) nor any state securities commission has approved or disapproved of these securities or determined
that this pricing supplement is truthful or complete. Any representation to the contrary is a criminal offense.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">We may use this pricing supplement in the
initial sale of the securities. In addition, Barclays Capital Inc. or any other of our affiliates may use this pricing supplement in
market resale transactions in any of the securities after their initial sale. Unless we or our agent informs you otherwise in the confirmation
of sale, this pricing supplement is being used in a market resale transaction.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Notwithstanding and to the exclusion of any
other term of the securities or any other agreements, arrangements or understandings between Barclays Bank PLC and any holder or beneficial
owner of the securities (or the trustee on behalf of the holders of the securities), by acquiring the securities, each holder or beneficial
owner of the securities acknowledges, accepts, agrees to be bound by, and consents to the exercise of, any U.K. Bail-in Power by the
relevant U.K. resolution authority. See &ldquo;Consent to U.K. Bail-in Power&rdquo; on page PS-7 of this pricing supplement.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 17%; font: bold 10pt Arial, Helvetica, Sans-Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 29%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt"><B>Original Offering Price<SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="width: 27%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt"><B>Agent Discount<SUP>(2), (3)</SUP></B></FONT></TD>
    <TD STYLE="width: 27%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt"><B>Proceeds to Barclays Bank PLC</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt"><B>Per Security</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">$15.25</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">$984.75</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt"><B>Total</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">$5,598,000.00</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">$85,369.50</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">$5,512,630.50</FONT></TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="background-color: white"><SUP>(1)</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">Our estimated value of the securities on the pricing date, based
on our internal pricing models, is $978.30 per security. The estimated value is less than the original offering price of the securities.
See &ldquo;Additional Information Regarding Our Estimated Value of the Securities&rdquo; on page PS-6 of this pricing supplement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="background-color: white"><SUP>(2)</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">Wells Fargo Securities, LLC (&ldquo;WFS&rdquo;) and Barclays Capital
Inc. are the agents for the distribution of the securities and are acting as principal. The agent will receive an underwriting discount
of $15.25 per security. Barclays Capital Inc. will sell the securities to WFS at the original offering price of the securities less a
concession of $15.25 per security. WFS may provide dealers, which may include Wells Fargo Advisors (&ldquo;WFA&rdquo;) (the trade name
of the retail brokerage business of WFS&rsquo;s affiliates, Wells Fargo Clearing Services, LLC and Wells Fargo Advisors Financial Network,
LLC), with a selling concession of $12.50 per security. In addition to the concession allowed to WFA, WFS may pay $0.75 per security of
the agent&rsquo;s discount to WFA as a distribution expense fee for each security sold by WFA. See &ldquo;Terms of the Securities&mdash;Supplemental
Plan of Distribution&rdquo; in this pricing supplement for further information.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="background-color: white"><SUP>(3)</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">In respect of certain securities sold in this offering, Barclays
Capital Inc. may pay a fee of up to $1.00 per security to selected securities dealers in consideration for marketing and other services
in connection with the distribution of the securities to other securities dealers.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font: bold 12pt Arial, Helvetica, Sans-Serif; text-align: justify"><FONT STYLE="font-size: 10pt">Wells Fargo Securities</FONT></TD>
    <TD STYLE="width: 50%; font: bold 12pt Arial, Helvetica, Sans-Serif; text-align: right"><FONT STYLE="font-size: 10pt">Barclays Capital Inc</FONT>.</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the EURO STOXX 50<SUP>&reg;</SUP> Index due March 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Terms
of the Securities</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
  <TR>
    <TD STYLE="padding-top: 2pt; width: 25%; border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #D9D9D6; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt; color: black"><B>Issuer:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; vertical-align: top; width: 75%; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Barclays Bank PLC</FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR>
    <TD ROWSPAN="6" STYLE="padding-top: 2pt; border-left: White 1pt solid; width: 25%; background-color: #D9D9D6; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Market Measures<SUP>1</SUP>:</B></FONT></TD>
    <TD COLSPAN="5" STYLE="padding-top: 2pt; vertical-align: top; text-align: justify; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">The Nasdaq-100 Index<SUP>&reg;</SUP> (the &ldquo;<U>NDX Index</U>&rdquo;), the Russell 2000<SUP>&reg;</SUP> Index (the &ldquo;<U>RTY Index</U>&rdquo;) and the EURO STOXX 50<SUP>&reg;</SUP> Index (the &ldquo;<U>SX5E Index</U>&rdquo;) (each referred to as an &ldquo;<U>Index</U>,&rdquo; and collectively as the &ldquo;<U>Indices</U>&rdquo;)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; border: Black 1pt solid; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Market Measure</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Bloomberg Ticker Symbol</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Starting Level<SUP>(a)</SUP></B></FONT></TD>
    <TD STYLE="padding-top: 2pt; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Coupon Threshold Level<SUP>(b)</SUP></B></FONT></TD>
    <TD STYLE="padding-top: 2pt; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Downside Threshold Level<SUP>(c)</SUP></B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; border-left: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">NDX Index</FONT></TD>
    <TD STYLE="padding-top: 2pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">NDX&lt;Index&gt;</FONT></TD>
    <TD STYLE="padding-top: 2pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">24,626.25</FONT></TD>
    <TD STYLE="padding-top: 2pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">17,238.375</FONT></TD>
    <TD STYLE="padding-top: 2pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">14,775.75</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; border-left: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">RTY Index</FONT></TD>
    <TD STYLE="padding-top: 2pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">RTY&lt;Index&gt;</FONT></TD>
    <TD STYLE="padding-top: 2pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">2,448.769</FONT></TD>
    <TD STYLE="padding-top: 2pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">1,714.1383</FONT></TD>
    <TD STYLE="padding-top: 2pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">1,469.2614</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; border-left: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">SX5E Index</FONT></TD>
    <TD STYLE="padding-top: 2pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">SX5E&lt;Index&gt;</FONT></TD>
    <TD STYLE="padding-top: 2pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">5,458.42</FONT></TD>
    <TD STYLE="padding-top: 2pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">3,820.894</FONT></TD>
    <TD STYLE="padding-top: 2pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">3,275.052</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="5" STYLE="padding-top: 2pt; padding-bottom: 2pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>(a)</SUP> With respect to each Index,
the closing level of that Index on the pricing date</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>(b)</SUP> With respect to each Index,
70% of its starting level</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>(c)</SUP> With respect to each Index,
60% of its starting level</P></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR>
    <TD STYLE="padding-top: 2pt; width: 25%; border: white 1pt solid; background-color: #D9D9D6; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Pricing Date:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; vertical-align: top; width: 75%; text-align: justify; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">September 19, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 2pt; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; background-color: #D9D9D6; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Issue Date:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; vertical-align: top; text-align: justify; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">September 24, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 2pt; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; background-color: #D9D9D6; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Final Calculation Day<SUP>2</SUP>:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: justify; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">March 19, 2030</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 2pt; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; background-color: #D9D9D6; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Stated Maturity Date<SUP>2</SUP>:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; vertical-align: top; text-align: justify; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">March 22, 2030</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 2pt; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; background-color: #D9D9D6; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Principal Amount:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; vertical-align: top; text-align: justify; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">$1,000 per security. References in this pricing supplement to a &ldquo;<U>security</U>&rdquo; are to a security with a principal amount of $1,000.</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 2pt; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; background-color: #D9D9D6; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Contingent Coupon Payment:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With respect to each observation period,
you will receive on the related contingent coupon payment date a contingent coupon payment at a per annum rate equal to the contingent
coupon rate if the closing level of the lowest performing Index on each eligible trading day during such observation period is greater
than or equal to its coupon threshold level.</P>
    <P STYLE="padding-top: 2pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Each &ldquo;<U>contingent coupon payment</U>,&rdquo;
if any, will be calculated per security as follows:</P>
    <P STYLE="padding-top: 2pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">($1,000 &times; contingent coupon rate) /
4</P>
    <P STYLE="padding-top: 2pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Any contingent coupon payments will be rounded
to the nearest cent, with one-half cent rounded upward.</P>
    <P STYLE="padding-top: 2pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B>If the closing level of the lowest performing
Index on any eligible trading day during an observation period is less than its coupon threshold level, you will not receive any contingent
coupon payment on the related contingent coupon payment date. If the closing level of at least one Index is less than its coupon threshold
level on one or more eligible trading days during each observation period, you will not receive any contingent coupon payments over the
term of the securities.</B></P>
    <P STYLE="padding-top: 2pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B>Any return on the securities will be limited
to the sum of your contingent coupon payments, if any, even if the closing level of the lowest performing Index on any observation period
end-date significantly exceeds its starting level. You will not participate in any appreciation of any Index.</B></P></TD></TR>
  <TR>
    <TD STYLE="padding-top: 2pt; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; background-color: #D9D9D6; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Contingent Coupon Payment Dates<SUP>2</SUP>:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: justify; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Quarterly, on the third business day following each observation period end-date, <I>provided</I> that the contingent coupon payment date with respect to the final observation period will be the stated maturity date. If an observation period end-date is postponed with respect to one or more Indices, the related contingent coupon payment date will be three business days after the latest observation period end-date as postponed.</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 2pt; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; background-color: #D9D9D6; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Contingent Coupon Rate:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: justify; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">The &ldquo;<U>contingent coupon rate</U>&rdquo; is 10.20% per annum. </FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the EURO STOXX 50<SUP>&reg;</SUP> Index due March 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR>
    <TD STYLE="padding-top: 2pt; width: 25%; border: white 1pt solid; background-color: #D9D9D6; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Optional Redemption:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; width: 75%; padding-bottom: 2pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may, at our option, redeem the securities,
in whole but not in part, on any optional redemption date. If we elect to redeem the securities prior to stated maturity, you will be
entitled to receive on the applicable optional redemption date a cash payment per security in U.S. dollars equal to the principal amount
plus any contingent coupon payment otherwise due.</P>
    <P STYLE="padding-top: 2pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">If we elect to redeem the securities on an
optional redemption date, we will give notice to the trustee on or before the observation period end-date immediately preceding that
optional redemption date. Any redemption of the securities will be at our option and will not automatically occur based on the performance
of any Index.</P>
    <P STYLE="padding-top: 2pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">If the securities are redeemed, they will
cease to be outstanding on the applicable optional redemption date and you will have no further rights under the securities after that
date.</P></TD></TR>
  <TR>
    <TD STYLE="padding-top: 2pt; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; background-color: #D9D9D6; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Observation Periods: </B></FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each observation period will consist of each
day that is a trading day for at least one Index (each such day, an &ldquo;<U>eligible trading day</U>&rdquo;) from but excluding an
observation period end-date to and including the following observation period end-date, <I>provided</I> that the first observation period
will consist of each eligible trading day from but excluding the pricing date to and including the first observation period end-date.</P>
    <P STYLE="padding-top: 2pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">If a market disruption event or non-trading
day occurs with respect to an Index on any eligible trading day during an observation period (other than an observation period end-date),
that Index will be disregarded on that eligible trading day for purposes of determining whether a contingent coupon payment is payable
with respect to such observation period. For the avoidance of doubt, any such eligible trading day for any Index not affected by a market
disruption event or non-trading day on that eligible trading day will remain a valid day for purposes of determining whether a contingent
coupon payment is payable with respect to such observation period, even if that day is not a trading day for any other Index or a market
disruption event has occurred with respect to any other Index on that day.</P></TD></TR>
  <TR>
    <TD STYLE="padding-top: 2pt; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; background-color: #D9D9D6; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Observation Period End-Dates<SUP>2</SUP>:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: justify; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Quarterly, on the 19th day of each March, June, September and December, commencing December 2025 and ending March 2030, <I>provided</I> that the March 2030 observation period end-date will be the final calculation day</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 2pt; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; background-color: #D9D9D6; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Optional Redemption Dates<SUP>2</SUP>:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: justify; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Quarterly, beginning approximately three months after the issue date, on the contingent coupon payment dates following each observation period end-date scheduled to occur from December 2025 to December 2029, inclusive</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 2pt; border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #D9D9D6; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Maturity Payment Amount:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; vertical-align: bottom; padding-bottom: 2pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we do not redeem the securities prior
to the stated maturity date, you will be entitled to receive on the stated maturity date a cash payment per security in U.S. dollars
equal to the maturity payment amount (in addition to any contingent coupon payment otherwise due). The &ldquo;<U>maturity payment amount</U>&rdquo;
per security will equal:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.75pt; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Symbol">&#183;&#9;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0pt 0pt 18.75pt; text-align: justify">if
the ending level of the lowest performing Index on the final calculation day is greater than or equal to its downside threshold level:
$1,000; or</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.75pt; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Symbol">&#183;&#9;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0pt 0pt 18.75pt; text-align: justify">if
the ending level of the lowest performing Index on the final calculation day is less than its downside threshold level:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 2pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center">$1,000
&times; performance factor of the lowest performing Index on the final calculation day</P>
    <P STYLE="padding-top: 2pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B>If we do not redeem the securities prior
to stated maturity and the ending level of the lowest performing Index on the final calculation day is less than its downside threshold
level, you will lose more than 40%, and possibly all, of the principal amount of your securities at stated maturity.</B></P>
    <P STYLE="padding-top: 2pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B>Any payment on the securities, including
any repayment of principal, is subject to the creditworthiness of Barclays Bank PLC and is not guaranteed by any third party. If Barclays
Bank PLC were to default on its payment obligations or become subject to the exercise of any U.K. Bail-in Power by the relevant U.K.
resolution authority, you might not receive any amounts owed to you under the securities.</B></P></TD></TR>
  <TR>
    <TD STYLE="padding-top: 2pt; border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #D9D9D6; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Lowest Performing Index:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: justify; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">For any eligible trading day during an observation period (including the final calculation day), the &ldquo;<U>lowest performing Index</U>&rdquo; will be the Index with the lowest performance factor on that eligible trading day and that has not been disregarded due to a market disruption event or non-trading day in accordance with &ldquo;&mdash;Observation Periods&rdquo; above. For the avoidance of doubt, if any eligible trading day is a valid day for only one Index, then that Index will be the lowest performing Index on that eligible trading day.</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the EURO STOXX 50<SUP>&reg;</SUP> Index due March 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR>
    <TD STYLE="padding-top: 2pt; width: 25%; border: white 1.5pt solid; background-color: #D9D9D6; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Performance Factor:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; width: 75%; text-align: justify; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">With respect to an Index on any eligible trading day during an observation period, its closing level on such day <I>divided by</I> its starting level.</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 2pt; border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #D9D9D6; text-align: justify; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Closing Level<SUP>1</SUP>:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: justify; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">With respect to each Index, &ldquo;<U>closing level</U>&rdquo; has the meaning set forth under &ldquo;General Terms of the Securities&mdash;Certain Terms for Securities Linked to an Index&mdash;Certain Definitions&rdquo; in the product supplement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #D9D9D6; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Ending Level:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: justify; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">The &ldquo;<U>ending level</U>&rdquo; of an Index will be its closing level on the final calculation day.</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 2pt; border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #D9D9D6; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Additional Terms:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; vertical-align: top; text-align: justify; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Terms used in this pricing supplement, but not defined herein, will have the meanings ascribed to them in the product supplement, <I>provided</I> that terms used in this pricing supplement, but not defined herein or in the product supplement, will have the meanings ascribed to them in the prospectus supplement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #D9D9D6; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Calculation Agent:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: justify; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Barclays Bank PLC</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #D9D9D6; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Tax Considerations:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: justify; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">For a discussion of the tax considerations relating to ownership and disposition of the securities, see &ldquo;Tax Considerations.&rdquo;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #D9D9D6; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Denominations:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: justify; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">$1,000 and any integral multiple of $1,000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #D9D9D6; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>CUSIP / ISIN:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: justify; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">06746EAD7 / US06746EAD76</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #D9D9D6; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Supplemental Plan of Distribution:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Wells Fargo Securities, LLC (&ldquo;WFS&rdquo;)
and Barclays Capital Inc. will act as agents for the securities. The agent will receive an underwriting discount of $15.25 per security.
Barclays Capital Inc. will sell the securities to WFS at the original offering price of the securities less a concession of $15.25 per
security. WFS may provide dealers, which may include Wells Fargo Advisors (&ldquo;WFA&rdquo;) (the trade name of the retail brokerage
business of WFS&rsquo;s affiliates, Wells Fargo Clearing Services, LLC and Wells Fargo Advisors Financial Network, LLC), with a selling
concession of $12.50 per security. In addition to the concession allowed to WFA, WFS may pay $0.75 per security of the agent&rsquo;s
discount to WFA as a distribution expense fee for each security sold by WFA.</P>
    <P STYLE="padding-top: 2pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">In addition, in respect of certain securities
sold in this offering, Barclays may pay a fee of up to $1.00 per security to selected securities dealers in consideration for marketing
and other services in connection with the distribution of the securities to other securities dealers.</P>
    <P STYLE="padding-top: 2pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Barclays Bank PLC or its affiliate will enter
into swap agreements or related hedge transactions with one of its other affiliates or unaffiliated counterparties in connection with
the sale of the securities. If WFS, Barclays Capital Inc. or an affiliate of either agent participating as a dealer in the distribution
of the securities conducts hedging activities for Barclays Bank PLC in connection with the securities, such agent or participating dealer
will expect to realize a projected profit from such hedging activities, and this projected profit will be in addition to any discount,
concession or fee received in connection with the sale of the securities to you. This additional projected profit may create a further
incentive for the agents or participating dealers to sell the securities to you.</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>&nbsp;</SUP></P>


<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>1</SUP> If an Index is discontinued or if
the sponsor of an Index fails to publish that Index, the calculation agent may select a successor index or, if no successor index is
available, will calculate the value to be used as the closing level of that Index. In addition, the calculation agent will calculate
the value to be used as the closing level of an Index in the event of certain changes in or modifications to that Index. For more information,
see &ldquo;General Terms of the Securities&mdash;Certain Terms for Securities Linked to an Index&mdash;Adjustments to an Index&rdquo;
and &ldquo;&mdash;Discontinuance of an Index&rdquo; in the accompanying product supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>2</SUP> If any observation period end-date
is not a trading day with respect to any Index, that observation period end-date for each Index will be postponed to the next succeeding
day that is a trading day with respect to each Index. An observation period end-date will also be postponed for any Index if a market
disruption event occurs with respect to that Index on that observation period end-date as described under &ldquo;General Terms of the
Securities&mdash;Consequences of a Market Disruption Event; Postponement of a Calculation Day&mdash;Securities Linked to Multiple Market
Measures&rdquo; in the accompanying product supplement. In addition, the stated maturity date will be postponed if that day is not a business
day or if the final calculation day is postponed as described under &ldquo;General Terms of the Securities&mdash;Payment Dates&rdquo;
in the accompanying product supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the EURO STOXX 50<SUP>&reg;</SUP> Index due March 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Additional
Information about the Issuer and the Securities</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should read this pricing supplement together
with the prospectus dated May 15, 2025, as supplemented by the prospectus supplement dated May 15, 2025 relating to our Global Medium-Term
Notes, Series A, of which these securities are a part, the product supplement no. WF-1 dated May 20, 2025 and the underlying supplement
dated May 15, 2025. This pricing supplement, together with the documents listed below, contains the terms of the securities and supersedes
all prior or contemporaneous oral statements as well as any other written materials including preliminary or indicative pricing terms,
correspondence, trade ideas, structures for implementation, sample structures, brochures or other educational materials of ours. You should
carefully consider, among other things, the matters set forth under &ldquo;Risk Factors&rdquo; in the prospectus supplement and &ldquo;Selected
Risk Considerations&rdquo; in this pricing supplement, as the securities involve risks not associated with conventional debt securities.
We urge you to consult your investment, legal, tax, accounting and other advisors before you invest in the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent the information or terms in this
pricing supplement are different from or inconsistent with the information or terms in the prospectus, prospectus supplement, product
supplement or underlying supplement, the information and terms in this pricing supplement will control. To the extent the information
or terms in the product supplement are different from or inconsistent with the information or terms in the prospectus or prospectus supplement,
the information and terms in the product supplement will control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You may access these documents on the SEC website
at www.sec.gov as follows (or if such address has changed, by reviewing our filings for the relevant date on the SEC website):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Prospectus dated May 15, 2025:<BR>
<A HREF="http://www.sec.gov/Archives/edgar/data/312070/000119312525120720/d925982d424b2.htm">http://www.sec.gov/Archives/edgar/data/312070/000119312525120720/d925982d424b2.htm</A></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Prospectus Supplement dated May 15, 2025:<BR>
<A HREF="http://www.sec.gov/Archives/edgar/data/312070/000095010325006051/dp228678_424b2-prosupp.htm">http://www.sec.gov/Archives/edgar/data/312070/000095010325006051/dp228678_424b2-prosupp.htm</A></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Product Supplement No. WF-1 dated May 20, 2025:<BR>
<A HREF="http://www.sec.gov/Archives/edgar/data/312070/000095010325006260/dp229046_424b2-wf1.htm">http://www.sec.gov/Archives/edgar/data/312070/000095010325006260/dp229046_424b2-wf1.htm</A></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>Underlying <FONT STYLE="font-size: 10pt">Supplement</FONT> dated May 15, 2025:<BR>
<FONT STYLE="font-family: Georgia, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/312070/000095010325006053/dp228705_424b2-underl.htm"></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">http://www.sec.gov/Archives/edgar/data/312070/000095010325006053/dp228705_424b2-underl.htm</FONT><FONT STYLE="font-family: Georgia, Times, Serif; font-size: 10pt"></A></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our SEC file number is 1-10257. As used in this
pricing supplement, &ldquo;we,&rdquo; &ldquo;us&rdquo; and &ldquo;our&rdquo; refer to Barclays Bank PLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the EURO STOXX 50<SUP>&reg;</SUP> Index due March 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Additional
Information Regarding Our Estimated Value of the Securities</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our internal pricing models take into account
a number of variables and are based on a number of subjective assumptions, which may or may not materialize, typically including volatility,
interest rates and our internal funding rates. Our internal funding rates (which are our internally published borrowing rates based on
variables, such as market benchmarks, our appetite for borrowing and our existing obligations coming to maturity) may vary from the levels
at which our benchmark debt securities trade in the secondary market. Our estimated value on the pricing date is based on our internal
funding rates. Our estimated value of the securities might be lower if such valuation were based on the levels at which our benchmark
debt securities trade in the secondary market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our estimated value of the securities on the pricing
date is less than the original offering price of the securities. The difference between the original offering price of the securities
and our estimated value of the securities results from several factors, including any sales commissions to be paid to Barclays Capital
Inc. or another affiliate of ours, any selling concessions, discounts, commissions or fees to be allowed or paid to non-affiliated intermediaries,
the estimated profit that we or any of our affiliates expect to earn in connection with structuring the securities, the estimated cost
that we may incur in hedging our obligations under the securities, and estimated development and other costs that we may incur in connection
with the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our estimated value on the pricing date is not
a prediction of the price at which the securities may trade in the secondary market, nor will it be the price at which Barclays Capital
Inc. may buy or sell the securities in the secondary market. Subject to normal market and funding conditions, Barclays Capital Inc. or
another affiliate of ours intends to offer to purchase the securities in the secondary market but it is not obligated to do so.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Assuming that all relevant factors remain constant
after the pricing date, the price at which Barclays Capital Inc. may initially buy or sell the securities in the secondary market, if
any, and the value that we may initially use for customer account statements, if we provide any customer account statements at all, may
exceed our estimated value on the pricing date for a temporary period expected to be approximately five months after the initial issue
date of the securities because, in our discretion, we may elect to effectively reimburse to investors a portion of the estimated cost
of hedging our obligations under the securities and other costs in connection with the securities that we will no longer expect to incur
over the term of the securities. We made such discretionary election and determined this temporary reimbursement period on the basis of
a number of factors, which may include the tenor of the securities and/or any agreement we may have with the distributors of the securities.
The amount of our estimated costs that we effectively reimburse to investors in this way may not be allocated ratably throughout the reimbursement
period, and we may discontinue such reimbursement at any time or revise the duration of the reimbursement period after the initial issue
date of the securities based on changes in market conditions and other factors that cannot be predicted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We urge you to read the &ldquo;Selected Risk
Considerations&rdquo; beginning on page PS-12 of this pricing supplement.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the EURO STOXX 50<SUP>&reg;</SUP> Index due March 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Consent
to U.K. Bail-in Power</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Notwithstanding and to the exclusion of any
other term of the securities or any other agreements, arrangements or understandings between us and any holder or beneficial owner of
the securities (or the trustee on behalf of the holders of the securities), by acquiring the securities, each holder or beneficial owner
of the securities acknowledges, accepts, agrees to be bound by and consents to the exercise of, any U.K. Bail-in Power by the relevant
U.K. resolution authority.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the U.K. Banking Act 2009, as amended, the
relevant U.K. resolution authority may exercise a U.K. Bail-in Power in circumstances in which the relevant U.K. resolution authority
is satisfied that the resolution conditions are met. These conditions include that a U.K. bank or investment firm is failing or is likely
to fail to satisfy the Financial Services and Markets Act 2000 (the &ldquo;<U>FSMA</U>&rdquo;) threshold conditions for authorization
to carry on certain regulated activities (within the meaning of section 55B FSMA) or, in the case of a U.K. banking group company that
is a European Economic Area (&ldquo;<U>EEA</U>&rdquo;) or third country institution or investment firm, that the relevant EEA or third
country relevant authority is satisfied that the resolution conditions are met in respect of that entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The U.K. Bail-in Power includes any write-down,
conversion, transfer, modification and/or suspension power, which allows for (i) the reduction or cancellation of all, or a portion, of
the principal amount of, or interest on, or any other amounts payable on, the securities; (ii) the conversion of all, or a portion, of
the principal amount of, or interest on, or any other amounts payable on, the securities into shares or other securities or other obligations
of Barclays Bank PLC or another person (and the issue to, or conferral on, the holder or beneficial owner of the securities of such shares,
securities or obligations); (iii) the cancellation of the securities and/or (iv) the amendment or alteration of the maturity of the securities,
or the amendment of the amount of interest or any other amounts due on the securities, or the dates on which interest or any other amounts
become payable, including by suspending payment for a temporary period; which U.K. Bail-in Power may be exercised by means of a variation
of the terms of the securities solely to give effect to the exercise by the relevant U.K. resolution authority of such U.K. Bail-in Power.
Each holder and beneficial owner of the securities further acknowledges and agrees that the rights of the holders or beneficial owners
of the securities are subject to, and will be varied, if necessary, solely to give effect to, the exercise of any U.K. Bail-in Power by
the relevant U.K. resolution authority. For the avoidance of doubt, this consent and acknowledgment is not a waiver of any rights holders
or beneficial owners of the securities may have at law if and to the extent that any U.K. Bail-in Power is exercised by the relevant U.K.
resolution authority in breach of laws applicable in England.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For more information, please see &ldquo;Selected
Risk Considerations&mdash;Risks Relating to the Issuer&mdash;You May Lose Some or All of Your Investment If Any U.K. Bail-in Power Is
Exercised by the Relevant U.K. Resolution Authority&rdquo; in this pricing supplement as well as &ldquo;U.K. Bail-in Power,&rdquo; &ldquo;Risk
Factors&mdash;Risks Relating to the Securities Generally&mdash;Regulatory action in the event a bank or investment firm in the Group is
failing or likely to fail, including the exercise by the relevant U.K. resolution authority of a variety of statutory resolution powers,
could materially adversely affect the value of any securities&rdquo; and &ldquo;Risk Factors&mdash;Risks Relating to the Securities Generally&mdash;Under
the terms of the securities, you have agreed to be bound by the exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority&rdquo;
in the accompanying prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the EURO STOXX 50<SUP>&reg;</SUP> Index due March 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Investor
Considerations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The securities are not appropriate for all
investors. The securities <I>may</I> be an appropriate investment for you if all of the following statements are true:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">You do not seek an investment that produces fixed periodic interest or coupon
payments or other non-contingent sources of current income.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">You do not anticipate that the ending level of the lowest performing Index
on the final calculation day will be less than its downside threshold level, and you are willing and able to accept the risk that, if
it is, you will lose more than 40%, and possibly all, of the principal amount of your securities at stated maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">You are willing and able to accept that you will not receive a contingent
coupon payment with respect to an observation period if the closing level of the lowest performing Index on any eligible trading day during
that observation period is less than its coupon threshold level, even if the closing level of the lowest performing Index is greater than
or equal to its coupon threshold level on one or more other eligible trading days during that observation period.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">You do not anticipate that the closing level of the lowest performing Index
will be less than its coupon threshold level on any eligible trading day during the observation periods, and you are willing and able
to accept the risk that, if it is, you may receive few or no contingent coupon payments over the term of the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">You are willing and able to accept the individual market risk of each Index
and you understand that poor performance by any Index over the term of the securities may negatively affect your return and will not be
offset or mitigated by any positive performance by the other Indices.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">You are willing and able to forgo participation in any appreciation of any
Index, and you understand that any return on your investment will be limited to the contingent coupon payments that may be payable on
the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">You are willing and able to accept the risks associated with an investment
linked to the performance of the lowest performing Index, as explained in more detail in the &#8220;Selected Risk Considerations&#8221;
section of this pricing supplement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">You understand and accept that you will not be entitled to receive dividends
or distributions that may be paid to holders of the securities composing the Indices, nor will you have any voting rights with respect
to the securities composing the Indices.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">You are willing and able to accept the risk that we may redeem the securities
prior to stated maturity at our option beginning approximately three months after their issue date, that it is more likely that we will
redeem the securities when it would otherwise be advantageous for you to continue to hold the securities and that you may not be able
to reinvest your money in an alternative investment with comparable risk and yield.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">You do not seek an investment for which there will be an active secondary
market and you are willing and able to hold the securities to stated maturity if we do not redeem the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">You are willing and able to assume our credit risk for all payments on the
securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">You are willing and able to consent to the exercise of any U.K. Bail-in
Power by any relevant U.K. resolution authority.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The securities may <I>not</I> be an appropriate
investment for you if <I>any</I> of the following statements are true:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">You seek an investment that produces fixed periodic interest or coupon payments or other non-contingent
sources of current income.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">You seek an investment that provides for the full repayment of principal at stated maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">You anticipate that the ending level of the lowest performing Index on the final calculation day will
be less than its downside threshold level, or you are unwilling or unable to accept the risk that, if it is, you will lose more than 40%,
and possibly all, of the principal amount of your securities at stated maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">You anticipate that the closing level of the lowest performing Index will be less than its coupon threshold
level on one or more eligible trading days during the observation periods, or you are unwilling or unable to accept the risk that, if
it is, you may receive few or no contingent coupon payments over the term of the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the EURO STOXX 50<SUP>&reg;</SUP> Index due March 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">You are unwilling or unable to accept the individual market risk of each Index or the risk that poor performance
by any Index over the term of the securities may negatively affect your return and will not be offset or mitigated by any positive performance
by the other Indices.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">You seek exposure to any upside performance of the Indices or you seek an investment with a return that
is not limited to the contingent coupon payments that may be payable on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">You are unwilling or unable to accept the risks associated with an investment linked to the performance
of the lowest performing Index, as explained in more detail in the &#8220;Selected Risk Considerations&#8221; section of this pricing
supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">You seek an investment that entitles you to dividends or distributions on, or voting rights related to,
the securities composing the Indices.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">You are unwilling or unable to accept the risk that we may redeem the securities prior to stated maturity
at our option.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">You seek an investment for which there will be an active secondary market and/or you are unwilling or
unable to hold the securities to stated maturity if they are not redeemed.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">You are unwilling or unable to assume our credit risk for all payments on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">You are unwilling or unable to consent to the exercise of any U.K. Bail-in Power by any relevant U.K.
resolution authority.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The considerations identified above are not
exhaustive. Whether or not the securities are an appropriate investment for you will depend on your individual circumstances, and you
should reach an investment decision only after you and your investment, legal, tax, accounting and other advisors have carefully considered
the appropriateness of an investment in the securities in light of your particular circumstances. You should also review carefully the
&ldquo;Selected Risk Considerations&rdquo; beginning on page PS-12 of this pricing supplement and the &ldquo;Risk Factors&rdquo; beginning
on page PS-3 of the accompanying product supplement and the &ldquo;Risk Factors&rdquo; beginning on page S-9 of the accompanying prospectus
supplement for risks related to an investment in the securities. For more information about the Indices, please see the sections titled
&ldquo;The Nasdaq-100 Index<SUP>&reg;</SUP>,&rdquo; &ldquo;The Russell 2000<SUP>&reg;</SUP> Index&rdquo; and &ldquo;The EURO STOXX 50<SUP>&reg;</SUP>
Index&rdquo; below.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the EURO STOXX 50<SUP>&reg;</SUP> Index due March 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Determining
Payment on a Contingent Coupon Payment Date and at Maturity</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless we have previously redeemed the securities
at our option, on each contingent coupon payment date prior to the stated maturity date, whether you receive a contingent coupon payment
will be determined based on the closing level of the lowest performing Index on each eligible trading day during the related observation
period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Step 1</B>: Determine which Index is the lowest
performing Index on each eligible trading day during the related observation period. The lowest performing Index on any eligible trading
day during an observation period is the Index that has the lowest performance factor on that date, calculated for each Index as the closing
level of that Index on that date divided by its starting level.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Step 2</B>: Determine whether a contingent
coupon payment is paid on the applicable contingent coupon payment date prior to the stated maturity date, based on the closing level
of the lowest performing Index on each eligible trading day during the relevant observation period, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<IMG SRC="image_006.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, if we have not previously
redeemed the securities at our option, you will receive a cash payment per security (the maturity payment amount) calculated as described
below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Step 1</B>: Determine which Index is the lowest
performing Index on the final calculation day. The lowest performing Index on the final calculation day is the Index that has the lowest
performance factor on the final calculation day, calculated for each Index as its ending level divided by its starting level.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Step 2</B>: Calculate the maturity payment
amount based on the ending level of the lowest performing Index on the final calculation day, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_007.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the EURO STOXX 50<SUP>&reg;</SUP> Index due March 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Hypothetical
Payout Profile</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following profile illustrates the potential
maturity payment amount on the securities (excluding any contingent coupon payment otherwise due) for a range of hypothetical performances
of the lowest performing Index on the final calculation day from its starting level to its ending level, assuming the securities have
not been redeemed prior to the stated maturity date. As this profile illustrates, in no event will you have a positive rate of return
based solely on the maturity payment amount received at maturity; any positive return will be based solely on the contingent coupon payments,
if any, received during the term of the securities. This graph has been prepared for purposes of illustration only. Your actual return
will depend on the actual ending level of the lowest performing Index on the final calculation day and whether you hold your securities
to stated maturity. The performance of the better performing Indices is not relevant to your return on the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="image_002.jpg" ALT="" STYLE="height: 356px; width: 557px"></B></FONT></P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the EURO STOXX 50<SUP>&reg;</SUP> Index due March 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Selected
Risk Considerations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An investment in the securities involves significant
risks. Investing in the securities is not equivalent to investing directly in any or all of the Indices or their components. Some of the
risks that apply to an investment in the securities are summarized below, but we urge you to read the more detailed explanation of risks
relating to the securities generally in the &ldquo;Risk Factors&rdquo; sections of the product supplement and prospectus supplement. You
should not purchase the securities unless you understand and can bear the risks of investing in the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Relating to the Securities Generally</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>If We Do Not Redeem The Securities Prior To Stated Maturity, You May Lose Some Or All Of The Principal
Amount Of Your Securities At Stated Maturity</B> &#8212; We will not repay you a fixed amount on your securities at stated maturity. If
we do not exercise our right to redeem the securities prior to stated maturity, you will receive a maturity payment amount that will be
equal to or less than the principal amount, depending on the ending level of the lowest performing Index on the final calculation day.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">If the ending level
of the lowest performing Index on the final calculation day is less than its downside threshold level, the maturity payment amount will
be less than the principal amount and you will have full downside exposure to the decrease in the level of the lowest performing Index
from its starting level. The downside threshold level for each Index is 60% of its starting level. For example, if we do not redeem the
securities prior to stated maturity and the lowest performing Index on the final calculation day has declined by 40.1% from its starting
level to its ending level, you will not receive any benefit of the contingent downside protection feature and you will lose 40.1% of the
principal amount. As a result, you will not receive any protection if the level of the lowest performing Index on the final calculation
day declines significantly and you may lose some, and possibly all, of the principal amount of your securities at stated maturity, even
if the level of the lowest performing Index is greater than or equal to its starting level or its downside threshold level at certain
times during the term of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">Even if the ending
level of the lowest performing Index on the final calculation day is greater than its downside threshold level, the maturity payment amount
will not exceed the principal amount, and your yield on the securities, taking into account any contingent coupon payments you may have
received during the term of the securities, may be less than the yield you would earn if you bought a traditional interest-bearing debt
security of Barclays Bank PLC or another issuer with a similar credit rating.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>The Securities Do Not Provide For Fixed Payments Of Interest And You May Receive No Coupon Payments
On One Or More Contingent Coupon Payment Dates, Or Even Throughout The Entire Term Of The Securities</B> &#8212; On each contingent coupon
payment date you will receive a contingent coupon payment if the closing level of the lowest performing Index on each eligible trading
day during the related observation period is greater than or equal to its coupon threshold level. If the closing level of the lowest performing
Index on any eligible trading day during the related observation period is less than its coupon threshold level, you will not receive
any contingent coupon payment on the related contingent coupon payment date, and if the closing level of at least one Index is less than
its coupon threshold level on one or more eligible trading days during each observation period over the term of the securities, you will
not receive any contingent coupon payments over the entire term of the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>Whether You Receive A Contingent Coupon Payment On A Contingent Coupon Payment Date Will Depend On
The Closing Level Of The Lowest Performing Index On Each Eligible Trading Day During The Related Observation Period </B>&#8212; Whether
you receive a contingent coupon payment on any contingent coupon payment date will be determined at the end of the related observation
period, based on the closing level of the lowest performing Index on each eligible trading day during that observation period. If any
eligible trading day during an observation period is a valid day for only one Index due to a market disruption event or non-trading day
for the other Indices, then that Index will be the lowest performing Index on that eligible trading day. Therefore, if the closing level
of any one of the Indices is less than its coupon threshold level on any eligible trading day during an observation period, you will not
receive a contingent coupon payment with respect to that observation period. This will be the case even if the closing level of the lowest
performing Index is greater than or equal to its coupon threshold level on one or more other eligible trading days during that observation
period, and even if the better performing Indices perform favorably.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>The Securities Are Subject To The Full Risks Of Each Index And Will Be Negatively Affected If Any Index
Performs Poorly, Even If The Other Indices Perform Favorably </B>&#8212; You are subject to the full risks of each Index. If any Index
performs poorly, you will be negatively affected, even if the other Indices perform favorably. The securities are not linked to a basket
composed of the Indices, where the better performance of some Indices could offset the poor performance of others. Instead, you are subject
to the full risks of whichever Index is the lowest performing Index on each eligible trading day during each observation period. As a
result, the securities are riskier than an alternative investment linked to only one of the Indices or linked to a basket composed of
each Index. You should not invest in the securities unless you understand and are willing to accept the full downside risks of each Index.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>You May Be Fully Exposed To The Decline In The Lowest Performing Index On The Final Calculation Day
From Its Starting Level, But Will Not Participate In Any Positive Performance Of Any Index</B> &#8212; Even though you will be fully</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the EURO STOXX 50<SUP>&reg;</SUP> Index due March 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">exposed to a decline in the level of
the lowest performing Index on the final calculation day if its ending level is below its downside threshold level, you will not participate
in any increase in the level of any Index over the term of the securities. Your maximum possible return on the securities will be limited
to the sum of the contingent coupon payments you receive, if any. Consequently, your return on the securities may be significantly less
than the return you could achieve on an alternative investment that provides for participation in an increase in the level of any or each
Index.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>Your Return On The Securities Will Depend Solely On The Performance Of The Index That Is The Lowest
Performing Index On Each Eligible Trading Day During The Observation Periods, Including The Final Calculation Day, And You Will Not Benefit
In Any Way From The Performance Of The Better Performing Indices</B> &#8212; Your return on the securities will depend solely on the performance
of the Index that is the lowest performing Index on each eligible trading day during the observation periods, including on the final calculation
day. Although it is necessary for each Index to close at or above its coupon threshold level on each eligible trading during the relevant
observation period in order for you to receive a contingent coupon payment and at or above its downside threshold level on the final calculation
day for you to be repaid the principal amount of your securities at maturity, you will not benefit in any way from the performance of
the better performing Indices. The securities may underperform an alternative investment linked to a basket composed of the Indices, since
in such case the performance of the better performing Indices would be blended with the performance of the lowest performing Index, resulting
in a better return than the return of the lowest performing Index alone.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>Higher Contingent Coupon Rates Are Associated With Greater Risk</B> &#8212; The securities offer contingent
coupon payments at a higher rate, if paid, than the fixed rate we would pay on conventional debt securities of the same maturity. These
higher potential contingent coupon payments are associated with greater levels of expected risk as of the pricing date as compared to
conventional debt securities, including the risk that you may not receive a contingent coupon payment on one or more, or any, contingent
coupon payment dates and the risk that you may lose a substantial portion, and possibly all, of the principal amount at maturity. The
volatility of the Indices and the correlation among the Indices are important factors affecting this risk. Volatility is a measure of
the degree of variation in the levels of the Indices over a period of time. Volatility can be measured in a variety of ways, including
on a historical basis or on an expected basis as implied by option prices in the market. The correlation of a pair of Indices represents
a statistical measurement of the degree to which the returns of those Indices are similar to each other over a given period in terms of
timing and direction. Greater expected volatility of the Indices or lower expected correlation among the Indices as of the pricing date
may result in a higher contingent coupon rate, but it also represents a greater expected likelihood as of the pricing date that the closing
level of at least one Index will be less than its coupon threshold level on one or more eligible trading days during one or more observation
periods, such that you will not receive one or more, or any, contingent coupon payments during the term of the securities, and that the
closing level of at least one Index will be less than its downside threshold level on the final calculation day such that you will lose
a substantial portion, and possibly all, of the principal amount at maturity. In general, the higher the contingent coupon rate is relative
to the fixed rate we would pay on conventional debt securities, the greater the expected risk that you will not receive one or more, or
any, contingent coupon payments during the term of the securities and that you will lose a substantial portion, and possibly all, of the
principal amount at maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>Our Redemption Right May Limit Your Potential To Receive Contingent Coupon Payments</B> &#8212; We
may, at our option, redeem the securities on any optional redemption date. Although exercise of the redemption right will be within our
sole discretion, we will be more likely to redeem the securities at a time when the lowest performing Index is performing favorably from
your perspective&#8212;in other words, at a time when, if the securities were to remain outstanding, it is more likely that you would
have continued to receive contingent coupon payments and been repaid the principal amount at maturity. Therefore, our redemption right
is likely to limit your potential to receive contingent coupon payments if the lowest performing Index is performing favorably from your
perspective. On the other hand, we will be less likely to redeem the securities at a time when the lowest performing Index is performing
unfavorably from your perspective&#8212;in other words, you are more likely to continue to hold the securities at a time when it is less
likely that you will continue to receive contingent coupon payments and it is less likely that you will be repaid the principal amount
at maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">If we exercise our
redemption right, the term of the securities may be reduced to as short as approximately three months. There is no guarantee that you
would be able to reinvest the proceeds from an investment in the securities at a comparable return for a similar level of risk in the
event we redeem the securities prior to maturity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>You Will Be Subject To Risks Resulting From The Relationship Between The Indices</B> &#8212; The correlation
of a pair of Indices represents a statistical measurement of the degree to which the returns of those Indices are similar to each other
over a given period in terms of timing and direction. By investing in the securities, you assume the risk that the returns of the Indices
will not be correlated. The less correlated the Indices, the more likely it is that any one of the Indices will be performing poorly at
any time over the term of the securities. All that is necessary for the securities to perform poorly is for one of the Indices to perform
poorly; the performance of the better performing Indices is not relevant to your return on the securities. It is impossible to predict
what the relationship between the Indices will be over the term of the securities. The Indices may represent different equity markets,
and those equity markets may not perform similarly over the term of the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the EURO STOXX 50<SUP>&reg;</SUP> Index due March 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>Any Payment On The Securities Will Be Determined Based On The Closing Levels Of The Indices On The
Dates Specified</B> &#8212; Any payment on the securities will be determined based on the closing levels of the Indices on the dates specified.
You will not benefit from any more favorable values of the Indices determined at any other time.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>Owning The Securities Is Not The Same As Owning The Securities Composing Any Or All Of The Indices</B>
&#8212; The return on your securities may not reflect the return you would realize if you actually owned the securities composing any
or all of the Indices. For instance, as a holder of the securities, you will not have voting rights or rights to receive cash dividends
or other distributions or any other rights that holders of the securities composing any Index would have.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>No Assurance That The Investment View Implicit In The Securities Will Be Successful</B> &#8212; It
is impossible to predict whether and the extent to which the level of any Index will rise or fall. There can be no assurance that the
level of any Index will not close below its coupon threshold level on any eligible trading day during an observation period or below its
downside threshold level on the final calculation day. The level of each Index will be influenced by complex and interrelated political,
economic, financial and other factors that affect that Index and the securities composing that Index. You should be willing to accept
the downside risks associated with equities in general and each Index in particular, and the risk of losing a significant portion or all
of the principal amount.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>Tax Treatment &#8212; </B>Significant aspects of the tax treatment of the securities are uncertain.
You should consult your tax advisor about your tax situation. See &#8220;Tax Considerations&#8221; below.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Relating to the Issuer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>The Securities Are Subject To The Credit Risk Of Barclays Bank PLC</B> &#8212; The securities are unsecured
and unsubordinated debt obligations of the issuer, Barclays Bank PLC, and are not, either directly or indirectly, an obligation of any
third party. Any payment to be made on the securities, including any repayment of principal, is subject to the ability of Barclays Bank
PLC to satisfy its obligations as they come due and is not guaranteed by any third party. As a result, the actual and perceived creditworthiness
of Barclays Bank PLC may affect the market value of the securities and, in the event Barclays Bank PLC were to default on its obligations,
you might not receive any amount owed to you under the terms of the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>You May Lose Some Or All Of Your Investment If Any U.K. Bail-In Power Is Exercised By The Relevant
U.K. Resolution Authority &#8212; </B>Notwithstanding and to the exclusion of any other term of the securities or any other agreements,
arrangements or understandings between Barclays Bank PLC and any holder or beneficial owner of the securities (or the trustee on behalf
of the holders of the securities), by acquiring the securities, each holder or beneficial owner of the securities acknowledges, accepts,
agrees to be bound by, and consents to the exercise of, any U.K. Bail-in Power by the relevant U.K. resolution authority as set forth
under &#8220;Consent to U.K. Bail-in Power&#8221; in this pricing supplement. Accordingly, any U.K. Bail-in Power may be exercised in
such a manner as to result in you and other holders and beneficial owners of the securities losing all or a part of the value of your
investment in the securities or receiving a different security from the securities, which may be worth significantly less than the securities
and which may have significantly fewer protections than those typically afforded to debt securities. Moreover, the relevant U.K. resolution
authority may exercise the U.K. Bail-in Power without providing any advance notice to, or requiring the consent of, the holders and beneficial
owners of the securities. The exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority with respect to the securities
will not be a default or an Event of Default (as each term is defined in the senior debt securities indenture) and the trustee will not
be liable for any action that the trustee takes, or abstains from taking, in either case, in accordance with the exercise of the U.K.
Bail-in Power by the relevant U.K. resolution authority with respect to the securities. See &#8220;Consent to U.K. Bail-in Power&#8221;
in this pricing supplement as well as &#8220;U.K. Bail-in Power,&#8221; &#8220;Risk Factors&#8212;Risks Relating to the Securities Generally&#8212;Regulatory
action in the event a bank or investment firm in the Group is failing or likely to fail, including the exercise by the relevant U.K. resolution
authority of a variety of statutory resolution powers, could materially adversely affect the value of any securities&#8221; and &#8220;Risk
Factors&#8212;Risks Relating to the Securities Generally&#8212;Under the terms of the securities, you have agreed to be bound by the exercise
of any U.K. Bail-in Power by the relevant U.K. resolution authority&#8221; in the accompanying prospectus supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Relating to the Indices</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>There Are Risks Associated With Investments In Securities Linked To The Value Of Non-U.S. Equity Securities
With Respect To The NDX Index</B> &#8212; Some of the equity securities composing the NDX Index are issued by non-U.S. companies. Investments
in securities linked to the value of such non-U.S. equity securities involve risks associated with the home countries of the issuers of
those non-U.S. equity securities. The prices of securities in non-U.S. markets may be affected by political, economic, financial and social
factors in those countries, or global regions, including changes in government, economic and fiscal policies and currency exchange laws.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>The Securities Are Subject To Small-Capitalization Companies Risk With Respect To The RTY Index</B>
&#8212; The RTY Index tracks companies that are considered small-capitalization companies. These companies often have greater stock price
volatility, lower trading volume and less liquidity than large-capitalization companies, and therefore securities linked to the RTY Index
may be more</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the EURO STOXX 50<SUP>&reg;</SUP> Index due March 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">volatile than an
investment linked to an index with component stocks issued by large-capitalization companies. Stock prices of small-capitalization companies
are also more vulnerable than those of large-capitalization companies to adverse business and economic developments. In addition, small-capitalization
companies are typically less stable financially than large-capitalization companies and may depend on a small number of key personnel,
making them more vulnerable to loss of personnel. Small-capitalization companies are often subject to less analyst coverage and may be
in early, and less predictable, periods of their corporate existences. Such companies tend to have smaller revenues, less diverse product
lines, smaller shares of their product or service markets, fewer financial resources and less competitive strengths than large-capitalization
companies and are more susceptible to adverse developments related to their products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>There Are Risks Associated With Investments In Securities Linked To The Value Of Non-U.S. Equity Securities
In Non-U.S. Securities Markets With Respect To The SX5E Index</B> &#8212; The equity securities composing the SX5E Index are issued by
non-U.S. companies in non-U.S. securities markets. Investments in securities linked to the value of such non-U.S. equity securities involve
risks associated with the securities markets in the home countries of the issuers of those non-U.S. equity securities, including risks
of volatility in those markets, governmental intervention in those markets and cross shareholdings in companies in certain countries.
Also, there is generally less publicly available information about companies in some of these jurisdictions than there is about U.S. companies
that are subject to the reporting requirements of the SEC, and generally non-U.S. companies are subject to accounting, auditing and financial
reporting standards and requirements and securities trading rules different from those applicable to U.S. reporting companies. The prices
of securities in non-U.S. markets may be affected by political, economic, financial and social factors in those countries, or global regions,
including changes in government, economic and fiscal policies and currency exchange laws.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>The Securities Do Not Provide Direct Exposure To Fluctuations In Exchange Rates Between The U.S. Dollar
And The Euro With Respect To The SX5E Index</B> &#8212; The SX5E Index is composed of non-U.S. securities denominated in euros. Because
the value of the SX5E Index is also calculated in euros (and not in U.S. dollars), the performance of the SX5E Index will not be adjusted
for exchange rate fluctuations between the U.S. dollar and the euro. In addition, any payments on the securities determined based in part
on the performance of the SX5E Index will not be adjusted for exchange rate fluctuations between the U.S. dollar and the euro. Therefore,
holders of the securities will not benefit from any appreciation of the euro relative to the U.S. dollar.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>Each Index Reflects The Price Return Of The Securities Composing That Index, Not The Total Return</B>
&#8212; The return on the securities is based on the performance of the Indices, which reflects changes in the market prices of the securities
composing each Index. Each Index is not a &#8220;total <FONT STYLE="background-color: white">return</FONT>&#8221; index that, in addition
to reflecting those price returns, would also reflect dividends paid on the securities composing the applicable Index. Accordingly, the
return on the securities will not include such a total return feature.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>We Cannot Control Actions Of Any Of The Unaffiliated Companies Whose Securities Are Included As Components
Of The Indices </B>&#8212; Actions by any company whose securities are components of an Index may have an adverse effect on the price
of its security, the closing level of such Index on any eligible trading day during the observation periods, the ending level of such
Index and the value of the securities. These unaffiliated companies will not be involved in the offering of the securities and will have
no obligations with respect to the <FONT STYLE="background-color: white">securities</FONT>, including any obligation to take <FONT STYLE="background-color: white">our</FONT>
or your interests into consideration for any reason. These companies will not <FONT STYLE="background-color: white">receive</FONT> any
of the proceeds of the offering of the securities and will not be responsible for, and will not have participated in, the determination
of the timing of, prices for, or quantities of, the securities to be issued. These companies will not be involved with the administration,
marketing or trading of the securities and will have no obligations with respect to any amounts to be paid to you on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>We And Our Affiliates Have No Affiliation With Any Index Sponsor And Have Not Independently Verified
Their Public Disclosure Of Information </B>&#8212; We, our affiliates and WFS and its affiliates are not affiliated in any way with any
index sponsor and have no ability to control or predict their actions, including any errors in or discontinuation of disclosure regarding
the methods or policies relating to the calculation of <FONT STYLE="background-color: white">the</FONT> applicable Index. We have derived
the information about each Index contained in this pricing <FONT STYLE="background-color: white">supplement</FONT> and the accompanying
underlying supplement from publicly available information, without independent verification. You, as an investor in the securities, should
make your own investigation into each Index and the index sponsors. The index sponsors will not be involved in the offering of the securities
made hereby in any way, and the index sponsors do not have any obligation to consider your interests as an owner of the securities in
taking any actions that might affect the value of the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>Adjustments To The Indices Could Adversely Affect The Value Of The Securities And The Amount You Will
Receive At Maturity</B> &#8212; The sponsor of an Index (an &#8220;<U>index sponso</U>r&#8221;) may add, delete, substitute or adjust
the securities composing that Index or make other methodological <FONT STYLE="background-color: white">changes</FONT> to that Index that
could affect its performance. The calculation agent will calculate the value to be used as the closing level of an Index in the event
of certain material changes in or modifications to that Index. In addition, an index sponsor may also discontinue or suspend calculation
or publication of that Index at any time. Under these circumstances, the calculation agent may select a successor index that the calculation
agent determines to be comparable to the discontinued index or, if no successor index is available, the calculation agent will determine
the value to be used as the closing level of that Index. Any of these actions could adversely affect the level of the relevant Index and,
consequently, the value of the securities. See &#8220;General</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the EURO STOXX 50<SUP>&reg;</SUP> Index due March 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">Terms of the Securities&mdash;Certain
Terms for Securities Linked to an Index&mdash;Adjustments to an Index&rdquo; and &ldquo;&mdash;Discontinuance of an Index&rdquo; in the
accompanying product supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>The Historical Performance Of The Indices Is Not An Indication Of Their Future Performance &#8212;</B>
The historical performance of the Indices should not be taken as an indication of the future performance of the Indices. It is impossible
to predict whether the closing levels of the Indices will fall or rise during the term of the securities, in particular in the environment
in the last several years, which has been characterized by volatility across a wide range of asset classes. Past fluctuations and trends
in the levels of the Indices are not necessarily indicative of fluctuations or trends that may occur in the future.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Relating to Conflicts of Interest</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>Potentially Inconsistent Research, Opinions Or Recommendations By Barclays Capital Inc., WFS Or Their
Respective Affiliates</B> &#8212; Barclays Capital Inc., WFS or their respective affiliates may publish research from time to time on
financial markets and other matters that may influence the value of the securities or express opinions or provide recommendations that
are inconsistent with purchasing or holding the securities. Any research, opinions or recommendations expressed by Barclays Capital Inc.,
WFA or their respective affiliates may not be consistent with each other and may be modified from time to time without notice. You should
make your own independent investigation of each Index and the merits of investing in the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>We, Our Affiliates And Any Other Agent And/Or Participating Dealer May Engage In Various Activities
Or Make Determinations That Could Materially Affect Your Securities In Various Ways And Create Conflicts Of Interest </B>&#8212; We, our
affiliates, WFS and any dealer participating in the distribution of the securities (a &#8220;<U>participating dealer</U>&#8221;) may play
a variety of roles in connection with the issuance of the securities, as described below. In performing these roles, our economic interests
and the economic interests of our affiliates, WFS and any participating dealer are potentially adverse to your interests as an investor
in the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">In connection with
our normal business activities and in connection with hedging our obligations under the securities, we and our affiliates make markets
in and trade various financial instruments or products for our accounts and for the account of our clients and otherwise provide investment
banking and other financial services with respect to these financial instruments and products. These financial instruments and products
may include securities, derivative instruments or assets that may relate to the Indices or their components. In any such market making,
trading and hedging activity, investment banking and other financial services, we or our affiliates may take positions or take actions
that are inconsistent with, or adverse to, the investment objectives of the holders of the securities. We and our affiliates have no obligation
to take the needs of any buyer, seller or holder of the securities into account in conducting these activities. Such market making, trading
and hedging activity, investment banking and other financial services may negatively impact the value of the securities. Participating
dealers may also engage in such activities that may negatively impact the value of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">In addition, the
role played by Barclays Capital Inc., as the agent for the securities, could present significant conflicts of interest with the role of
Barclays Bank PLC, as issuer of the securities. For example, Barclays Capital Inc. or its representatives may derive compensation or financial
benefit from the distribution of the securities and such compensation or financial benefit may serve as an incentive to sell the securities
instead of other investments. Furthermore, we and our affiliates establish the offering price of the securities for initial sale to the
public, and the offering price is not based upon any independent verification or valuation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">Furthermore, if any
dealer participating in the distribution of the securities or any of its affiliates conducts hedging activities for us in connection with
the securities, that participating dealer or its affiliates will expect to realize a projected profit from such hedging activities, and
this projected profit will be in addition to any selling concession and/or any fee that the participating dealer realizes for the sale
of the securities to you. This additional projected profit may create a further incentive for the participating dealer to sell the securities
to you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">In addition to the
activities described above, Barclays Bank PLC will also act as the calculation agent for the securities. As calculation agent, we will
determine any levels of the Indices and make any other determinations necessary to calculate any payments on the securities. In making
these determinations, we may be required to make discretionary judgments, including those described in the accompanying product supplement
and under &ldquo;&mdash;Risks Relating to the Indices&rdquo; above. In making these discretionary judgments, our economic interests are
potentially adverse to your interests as an investor in the securities, and any of these determinations may adversely affect any payments
on the securities. Absent manifest error, all determinations of the calculation agent will be final and binding, without any liability
on the part of the calculation agent. You will not be entitled to any compensation from Barclays Bank PLC for any loss suffered as a result
of any determinations made by the calculation agent with respect to the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Risks Relating to the Estimated
Value of the Securities and the Secondary Market </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>The Securities Will Not Be Listed On Any Securities Exchange And We Do Not Expect A Trading Market
For The Securities To Develop</B> &#8212; The securities will not be listed on any securities exchange. Barclays Capital Inc. and other
affiliates of Barclays Bank PLC intend to make a secondary market for the securities but are not required to do so, and may discontinue
any such</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the EURO STOXX 50<SUP>&reg;</SUP> Index due March 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">secondary market
making at any time, without notice. Even if there is a secondary market, it may not provide enough liquidity to allow you to trade or
sell the securities easily. Because other dealers are not likely to make a secondary market for the securities, the price at which you
may be able to trade your securities is likely to depend on the price, if any, at which Barclays Capital Inc. and other affiliates of
Barclays Bank PLC are willing to buy the securities. The securities are not designed to be short-term trading instruments. Accordingly,
you should be willing and able to hold your securities to maturity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>The Value Of The Securities Prior To Maturity Will Be Affected By Numerous Factors, Some Of Which Are
Related In Complex Ways</B> &#8212; Structured notes, including the securities, can be thought of as securities that combine a debt instrument
with one or more options or other derivative instruments. As a result, the factors that influence the values of debt instruments and options
or other derivative instruments will also influence the terms and features of the securities at issuance and their value in the secondary
market. Accordingly, in addition to the levels of the Indices on any day, the value of the securities will be affected by a number of
economic and market factors that may either offset or magnify each other, including:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">the expected volatility of the Indices;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">correlation (or lack of correlation) of the Indices;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">the time to maturity of the securities;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">the market prices of, and dividend rates on, the securities composing the Indices;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">interest and yield rates in the market generally;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">supply and demand for the securities;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">the exchange rate of the U.S. dollar relative to the euro;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">a variety of economic, financial, political, regulatory and judicial events; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">our creditworthiness, including actual or anticipated downgrades in our credit ratings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>The Estimated Value Of Your Securities Is Lower Than The Original Offering Price Of Your Securities</B>
&#8212; The estimated value of your securities on the pricing date is lower than the original offering price of your securities. The difference
between the original offering price of your securities and the estimated value of the securities is a result of certain factors, such
as any sales commissions, selling concessions, discounts, commissions or fees to be allowed or paid to Barclays Capital Inc., another
affiliate of ours, WFS or its affiliates or other non-affiliated intermediaries, the estimated profit that we or any of our affiliates
expect to earn in connection with structuring the securities, the estimated cost that we may incur in hedging our obligations under the
securities, and estimated development and other costs that we may incur in connection with the securities.&#9;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>The Estimated Value Of Your Securities Might Be Lower If Such Estimated Value Were Based On The Levels
At Which Our Debt Securities Trade In The Secondary Market</B> &#8212; The estimated value of your securities on the pricing date is based
on a number of variables, including our internal funding rates. Our internal funding rates may vary from the levels at which our benchmark
debt securities trade in the secondary market. As a result of this difference, the estimated value referenced above might be lower if
such estimated value were based on the levels at which our benchmark debt securities trade in the secondary market.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>The Estimated Value Of The Securities Is Based On Our Internal Pricing Models, Which May Prove To Be
Inaccurate And May Be Different From The Pricing Models Of Other Financial Institutions</B> &#8212; The estimated value of your securities
on the pricing date is based on our internal pricing models, which take into account a number of variables and are based on a number of
subjective assumptions, which may or may not materialize. These variables and assumptions are not evaluated or verified on an independent
basis. Further, our pricing models may be different from other financial institutions&#8217; pricing models and the methodologies used
by us to estimate the value of the securities may not be consistent with those of other financial institutions that may be purchasers
or sellers of securities in the secondary market. As a result, the secondary market price of your securities may be materially different
from the estimated value of the securities determined by reference to our internal pricing models.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>The Estimated Value Of Your Securities Is Not A Prediction Of The Prices At Which You May Sell Your
Securities In The Secondary Market, If Any, And Such Secondary Market Prices, If Any, Will Likely Be Lower Than The Original Offering
Price Of Your Securities And May Be Lower Than The Estimated Value Of Your Securities</B> &#8212; The estimated value of the securities
will not be a prediction of the prices at which Barclays Capital Inc., other affiliates of ours or third parties may be willing to purchase
the securities from you in secondary market transactions (if they are willing to purchase, which they are not obligated to do). The price
at which you may be able to sell your securities in the secondary market at any time will be influenced by many factors that cannot be
predicted, such as market conditions, and any bid and ask spread for similar sized trades,</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the EURO STOXX 50<SUP>&reg;</SUP> Index due March 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">and may be substantially
less than our estimated value of the securities. Further, as secondary market prices of your securities take into account the levels at
which our debt securities trade in the secondary market, and do not take into account our various costs related to the securities such
as fees, commissions, discounts, and the costs of hedging our obligations under the securities, secondary market prices of your securities
will likely be lower than the original offering price of your securities. As a result, the price at which Barclays Capital Inc., other
affiliates of ours or third parties may be willing to purchase the securities from you in secondary market transactions, if any, will
likely be lower than the price you paid for your securities, and any sale prior to the stated maturity date could result in a substantial
loss to you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>The Temporary Price At Which We May Initially Buy The Securities In The Secondary Market And The Value
We May Initially Use For Customer Account Statements, If We Provide Any Customer Account Statements At All, May Not Be Indicative Of Future
Prices Of Your Securities</B> &#8212; Assuming that all relevant factors remain constant after the pricing date, the price at which Barclays
Capital Inc. may initially buy or sell the securities in the secondary market (if Barclays Capital Inc. makes a market in the securities,
which it is not obligated to do) and the value that we may initially use for customer account statements, if we provide any customer account
statements at all, may exceed our estimated value of the securities on the pricing date, as well as the secondary market value of the
securities, for a temporary period after the initial issue date of the securities. The price at which Barclays Capital Inc. may initially
buy or sell the securities in the secondary market and the value that we may initially use for customer account statements may not be
indicative of future prices of your securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the EURO STOXX 50<SUP>&reg;</SUP> Index due March 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Hypothetical
Returns</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If we redeem the securities prior to stated
maturity:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we redeem the securities prior to stated maturity,
you will receive the principal amount of your securities plus any contingent coupon payment otherwise due on the applicable optional redemption
date. In the event we redeem the securities prior to stated maturity, your total return on the securities will equal any contingent coupon
payments received prior to the optional redemption date and any contingent coupon payment received on the optional redemption date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If we do not redeem the securities prior to
stated maturity:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we do not redeem the securities prior to stated
maturity, the following table illustrates, for a range of hypothetical performance factors of the lowest performing Index on the final
calculation day, the hypothetical maturity payment amount payable at stated maturity per security (excluding any contingent coupon payment
otherwise due). The performance factor of the lowest performing Index on the final calculation day is calculated as its ending level divided
by its starting level.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 50%; border: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Hypothetical performance factor of lowest performing Index on final calculation day</B></FONT></TD>
    <TD STYLE="width: 50%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Hypothetical maturity payment amount per security</B></FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">175.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">150.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">140.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">130.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">120.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">110.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR STYLE="background-color: #CCCCCC">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">90.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">80.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR STYLE="background-color: #CCCCCC">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">60.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">59.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$590.00</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">50.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$500.00</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">40.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$400.00</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">25.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$250.00</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">0.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$0.00</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The above figures do not take into account contingent
coupon payments, if any, received during the term of the securities. As evidenced above, in no event will you have a positive rate of
return based solely on the maturity payment amount received at maturity (excluding any contingent coupon payment otherwise due); any positive
return will be based solely on the contingent coupon payments, if any, received during the term of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The above figures are for purposes of illustration
only and may have been rounded for ease of analysis. If we do not redeem the securities prior to stated maturity, the actual amount you
will receive at stated maturity will depend on the actual ending level of the lowest performing Index on the final calculation day. The
performance of the better performing Indices is not relevant to your return on the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the EURO STOXX 50<SUP>&reg;</SUP> Index due March 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Hypothetical
Contingent Coupon Payments</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Set forth below are examples that illustrate how
to determine whether a contingent coupon payment will be paid on a contingent coupon payment date. The examples do not reflect any specific
contingent coupon payment date. The following examples assume the hypothetical starting level, coupon threshold level and closing levels
for each Index indicated in the examples. The terms used for purposes of these hypothetical examples do not represent any actual starting
level or coupon threshold level. The hypothetical starting level of 100.00 for each Index has been chosen for illustrative purposes only
and does not represent the actual starting level for any Index. The actual starting level and coupon threshold level for each Index are
set forth under &ldquo;Terms of the Securities&rdquo; above. For historical closing levels of the Indices, see the historical information
set forth under the sections titled &ldquo;The Nasdaq-100 Index<SUP>&reg;</SUP>,&rdquo; &ldquo;The Russell 2000<SUP>&reg;</SUP> Index&rdquo;
and &ldquo;The EURO STOXX 50<SUP>&reg;</SUP> Index&rdquo; below. These examples are for purposes of illustration only and the values used
in the examples may have been rounded for ease of analysis. If we were to redeem the securities on the relevant contingent coupon payment
date in either of the examples below, you would receive the principal amount on the contingent coupon payment date in addition to the
contingent coupon payment, if any, and would not receive any further payments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 1.&nbsp;The closing level of the lowest
performing Index on each eligible trading day during the relevant observation period is greater than or equal to its coupon threshold
level. As a result, investors receive a contingent coupon payment on the applicable contingent coupon payment date.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; width: 55%; border: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="padding: 1pt 4pt; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>NDX Index</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>RTY Index</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>SX5E Index</B></FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical starting level:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.000</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical lowest closing level during observation period:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">95.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">115.000</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">90.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical coupon threshold level: </B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.000</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Lowest performance factor during observation period (lowest closing level during observation period <I>divided by</I> starting level):</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">95.00%</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">115.00%</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">90.00%</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify"><U>Step 1</U>: Determine whether the
closing level of the lowest performing Index on any eligible trading day during the relevant observation period was less than its hypothetical
coupon threshold level.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">In this example, the closing level of
each Index on each eligible trading day during the relevant observation period is greater than its hypothetical coupon threshold level.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify"><U>Step 2</U>: Determine whether a
contingent coupon payment will be paid on the applicable contingent coupon payment date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">Since the hypothetical closing level
of the lowest performing Index on each eligible trading day during the relevant observation period is greater than or equal to its hypothetical
coupon threshold level, you would receive a contingent coupon payment on the applicable contingent coupon payment date. The contingent
coupon payment would be equal to $25.50 per security, determined as follows: (i) $1,000 <I>multiplied by</I> 10.20% per annum <I>divided
by</I> (ii) 4, rounded to the nearest cent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 2. The closing level of the lowest
performing Index on at least one eligible trading day during the relevant observation period is less than its coupon threshold level.
As a result, investors do not receive a contingent coupon payment on the applicable contingent coupon payment date.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="background-color: white">
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; width: 55%; border: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="padding: 1pt 4pt; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>NDX Index</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>RTY Index</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>SX5E Index</B></FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical starting level:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.000</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical lowest closing level during observation period:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">125.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">55.000</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">105.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical coupon threshold level: </B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.000</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Lowest performance factor during observation period (lowest closing level during observation period <I>divided by</I> starting level):</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">125.00%</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">55.00%</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">105.00%</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify"><U>Step 1</U>: Determine whether the
closing level of the lowest performing Index on any eligible trading day during the relevant observation period was less than its hypothetical
coupon threshold level.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">In this example, the closing level of
the RTY Index on at least one eligible trading day during the relevant observation period was less than its hypothetical coupon threshold
level.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify"><U>Step 2</U>: Determine whether a
contingent coupon payment will be paid on the applicable contingent coupon payment date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">Since the hypothetical closing level
of the lowest performing Index on at least one eligible trading day during the relevant observation period is less than its hypothetical
coupon threshold level, you would not receive a contingent coupon payment on the applicable contingent coupon payment date. This is the
case even though the closing levels of the better performing Indices were</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the EURO STOXX 50<SUP>&reg;</SUP> Index due March 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">each greater than their respective hypothetical
coupon threshold levels on every eligible trading day during the relevant observation period, and would be the case even if the closing
level of the RTY Index was greater than or equal to its hypothetical coupon threshold level on every other eligible trading day during
the relevant observation period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">As this example illustrates, whether
you receive a contingent coupon payment on a contingent coupon payment date will depend solely on the closing level of the lowest performing
Index on each eligible trading day during the relevant observation period. Therefore, if the closing level of any one of the Indices is
less than its coupon threshold level on any eligible trading day during an observation period, you will not receive a contingent coupon
payment with respect to that observation period. This will be the case even if the closing level of the lowest performing Index is greater
than or equal to its coupon threshold level on every other eligible trading day during that observation period, and even if the better
performing Indices perform favorably. The performance of the better performing Indices is not relevant to your return on the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the EURO STOXX 50<SUP>&reg;</SUP> Index due March 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Hypothetical
Maturity Payment Amount</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Set forth below are examples of calculations of
the maturity payment amount payable at stated maturity, assuming that the securities are not redeemed at our option prior to stated maturity
and assuming the hypothetical starting level, coupon threshold level, downside threshold level, closing levels and ending levels for each
Index indicated in the examples. The terms used for purposes of these hypothetical examples do not represent any actual starting level,
coupon threshold level or downside threshold level. The hypothetical starting level of 100.00 for each Index has been chosen for illustrative
purposes only and does not represent the actual starting level for any Index. The actual starting level, coupon threshold level and downside
threshold level for each Index are set forth under &ldquo;Terms of the Securities&rdquo; above. For historical closing levels of the Indices,
see the historical information set forth under the sections titled &ldquo;The Nasdaq-100 Index<SUP>&reg;</SUP>,&rdquo; &ldquo;The Russell
2000<SUP>&reg;</SUP> Index&rdquo; and &ldquo;The EURO STOXX 50<SUP>&reg;</SUP> Index&rdquo; below. These examples are for purposes of
illustration only and the values used in the examples may have been rounded for ease of analysis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 1.&nbsp;The closing level of the lowest
performing Index on each eligible trading day during the final observation period is greater than or equal to its coupon threshold level,
and the ending level of the lowest performing Index on the final calculation day is greater than its starting level. As a result, the
maturity payment amount is equal to the principal amount of your securities at maturity and you receive a final contingent coupon payment.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; width: 55%; border: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="padding: 1pt 4pt; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>NDX Index</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>RTY Index</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>SX5E Index</B></FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical starting level:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.000</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.00</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical lowest closing level during final observation period:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">95.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">80.000</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">90.00</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical ending level:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">135.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">145.000</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">125.00</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical coupon threshold level:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.000</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.00</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical downside threshold level:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">60.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">60.000</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">60.00</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Lowest performance factor during final observation period (lowest closing level during final observation period <I>divided by</I> starting level):</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">95.00%</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">80.00%</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">90.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Performance factor on final calculation day (ending level <I>divided by</I> starting level): </B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">135.00%</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">145.00%</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">125.00%</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify"><U>Step 1</U>: Determine which Index
is the lowest performing Index on the final calculation day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">In this example, the SX5E Index has the
lowest performance factor on the final calculation day and is, therefore, the lowest performing Index on the final calculation day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify"><U>Step 2</U>: Determine the maturity
payment amount based on the ending level of the lowest performing Index on the final calculation day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">Since the hypothetical ending level of
the lowest performing Index on the final calculation day is greater than its hypothetical downside threshold level, the maturity payment
amount would equal the principal amount. Although the hypothetical ending level of the lowest performing Index on the final calculation
day is significantly greater than its hypothetical starting level in this scenario, the maturity payment amount will not exceed the principal
amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">In addition to any contingent coupon
payments received prior to the stated maturity date, on the stated maturity date you would receive $1,000.00 per security as well as the
contingent coupon payment otherwise due because the hypothetical closing level of the lowest performing Index on each eligible trading
day during the final observation period was greater than its hypothetical coupon threshold level.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the EURO STOXX 50<SUP>&reg;</SUP> Index due March 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 2. The closing level of the lowest
performing Index on at least one eligible trading day during the final observation period is less than its coupon threshold level, and
the ending level of the lowest performing Index on the final calculation day is less than its starting level but greater than its downside
threshold level. As a result, the maturity payment amount is equal to the principal amount of your securities at maturity but you will
not receive a final contingent coupon payment.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; width: 55%; border: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="padding: 1pt 4pt; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>NDX Index</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>RTY Index</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>SX5E Index</B></FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical starting level:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.000</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.00</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical lowest closing level during final observation period:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">95.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">45.000</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">105.00</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical ending level:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">115.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">90.000</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">110.00</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical coupon threshold level:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.000</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.00</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical downside threshold level:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">60.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">60.000</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">60.00</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Lowest performance factor during final observation period (lowest closing level during final observation period <I>divided by</I> starting level):</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">95.00%</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">45.00%</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">105.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Performance factor on final calculation day (ending level <I>divided by</I> starting level): </B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">115.00%</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">90.00%</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">110.00%</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify"><U>Step 1</U>: Determine which Index
is the lowest performing Index on the final calculation day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">In this example, the RTY Index has the
lowest performance factor on the final calculation day and is, therefore, the lowest performing Index on the final calculation day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify"><U>Step 2</U>: Determine the maturity
payment amount based on the ending level of the lowest performing Index on the final calculation day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">Since the hypothetical ending level of
the lowest performing Index on the final calculation day is greater than its hypothetical downside threshold level, you would be repaid
the principal amount of your securities at maturity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12pt; text-align: justify">In addition to any contingent coupon
payments received during the term of the securities, on the stated maturity date you would receive $1,000.00 per security, but no final
contingent coupon payment since the hypothetical closing level of the lowest performing Index on at least one eligible trading day during
the final observation period was less than its hypothetical coupon threshold level. This is the case even though the closing levels of
the better performing Indices were greater than their respective hypothetical coupon threshold levels on every eligible trading day during
the relevant observation period, and even though the ending level of the RTY Index was greater than its hypothetical coupon threshold
level.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 3.&nbsp;The ending level of the lowest
performing Index on the final calculation day is less than its coupon threshold level and its downside threshold level, the maturity payment
amount is less than the principal amount of your securities at maturity and you do not receive a contingent coupon payment at maturity.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; width: 55%; border: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="padding: 1pt 4pt; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>NDX Index</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>RTY Index</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>SX5E Index</B></FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical starting level:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.000</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.00</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical lowest closing level during final observation period:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">45.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">105.000</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">85.00</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical ending level:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">45.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">120.000</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">90.00</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical coupon threshold level:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.000</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.00</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical downside threshold level:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">60.00</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">60.000</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">60.00</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Lowest performance factor during final observation period (lowest closing level during final observation period <I>divided by</I> starting level):</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">45.00%</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">105.00%</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">85.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Performance factor on final calculation day (ending level <I>divided by</I> starting level): </B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">45.00%</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">120.00%</FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">90.00%</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify"><U>Step 1</U>: Determine which Index
is the lowest performing Index on the final calculation day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">In this example, the NDX Index has the
lowest performance factor on the final calculation day and is, therefore, the lowest performing Index on the final calculation day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify"><U>Step 2</U>: Determine the maturity
payment amount based on the ending level of the lowest performing Index on the final calculation day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the EURO STOXX 50<SUP>&reg;</SUP> Index due March 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">Since the hypothetical ending level of
the lowest performing Index on the final calculation day is less than its hypothetical downside threshold level, you would lose a portion
of the principal amount of your securities and receive the maturity payment amount equal to $450.00 per security, calculated as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">$1,000 &times; performance factor of the lowest
performing Index on the final calculation day</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">= $1,000 &times; 45.00%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">= $450.00</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify">In addition to any contingent coupon
payments received prior to the stated maturity date, on the stated maturity date you would receive $450.00 per security, but no contingent
coupon payment because the hypothetical closing level of the lowest performing Index on at least one eligible trading day during the final
observation period was less than its hypothetical coupon threshold level.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These examples illustrate that you will not participate
in any appreciation of any Index, but will be fully exposed to a decrease in the lowest performing Index if the ending level of the lowest
performing Index on the final calculation day is less than its downside threshold level, even if the ending levels of the other Indices
have appreciated or have not declined below their respective downside threshold levels.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent that the starting level, coupon
threshold level, downside threshold level and ending level of the lowest performing Index on the final calculation day differ from the
values assumed above, the results indicated above would be different.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the EURO STOXX 50<SUP>&reg;</SUP> Index due March 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">The
Nasdaq-100 Index<SUP>&reg;</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The NDX Index is a modified market capitalization-weighted
index that is designed to measure the performance of 100 of the largest non-financial companies listed on The Nasdaq Stock Market. For
more information about the NDX Index, see &ldquo;Indices&mdash;The Nasdaq-100 Index<SUP>&reg;</SUP>&rdquo; in the accompanying underlying
supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Historical Information</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We obtained the closing levels of the NDX Index
displayed in the graph below from Bloomberg Professional<SUP>&reg;</SUP> service (&ldquo;<U>Bloomberg</U>&rdquo;) without independent
verification. The historical performance of the NDX Index should not be taken as an indication of the future performance of the NDX Index.
Future performance of the NDX Index may differ significantly from historical performance, and no assurance can be given as to the closing
levels of the NDX Index during the term of the securities, including on any eligible trading day during an observation period or on the
final calculation day. We cannot give you assurance that the performance of the NDX Index will not result in a loss on your initial investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following graph sets forth daily closing levels
of the NDX Index for the period from January 1, 2020 to September 19, 2025. The closing level on September 19, 2025 was 24,626.25.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="image_003.jpg" ALT="" STYLE="height: 323px; width: 613px"></B></FONT></P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">* The dotted lines indicate the coupon threshold
level and the downside threshold level of 70% and 60%, respectively, of the starting level of the NDX Index.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-align: center">PAST PERFORMANCE IS NOT
INDICATIVE OF FUTURE RESULTS.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the EURO STOXX 50<SUP>&reg;</SUP> Index due March 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">The
Russell 2000<SUP>&reg;</SUP> Index</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The RTY Index measures the capitalization-weighted
price performance of 2,000 U.S. small-capitalization stocks listed on eligible U.S. exchanges and is designed to track the performance
of the small-capitalization segment of the U.S. equity market. For more information about the RTY Index, see &ldquo;Indices&mdash;The
Russell Indices&rdquo; in the accompanying underlying supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Historical Information</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We obtained the closing levels of the RTY Index
displayed in the graph below from Bloomberg without independent verification. The historical performance of the RTY Index should not be
taken as an indication of the future performance of the RTY Index. Future performance of the RTY Index may differ significantly from historical
performance, and no assurance can be given as to the closing levels of the RTY Index during the term of the securities, including on any
eligible trading day during an observation period or on the final calculation day. We cannot give you assurance that the performance of
the RTY Index will not result in a loss on your initial investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following graph sets forth daily closing levels
of the RTY Index for the period from January 1, 2020 to September 19, 2025. The closing level on September 19, 2025 was 2,448.769.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="image_004.jpg" ALT="" STYLE="height: 323px; width: 613px"></B></FONT></P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">* The dotted lines indicate the coupon threshold
level and the downside threshold level of 70% and 60%, respectively, of the starting level of the RTY Index.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-align: center">PAST PERFORMANCE IS NOT
INDICATIVE OF FUTURE RESULTS.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the EURO STOXX 50<SUP>&reg;</SUP> Index due March 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">The
EURO STOXX 50<SUP>&reg;</SUP> Index</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The SX5E Index is a free float market capitalization-weighted
index composed of 50 of the largest stocks in terms of free float market capitalization traded on major Eurozone exchanges. For more information
about the SX5E Index, see &ldquo;Indices&mdash;The STOXX Benchmark Indices&rdquo; in the accompanying underlying supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Historical Information</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We obtained the closing levels of the SX5E Index
displayed in the graph below from Bloomberg without independent verification. The historical performance of the SX5E Index should not
be taken as an indication of the future performance of the SX5E Index. Future performance of the SX5E Index may differ significantly from
historical performance, and no assurance can be given as to the closing levels of the SX5E Index during the term of the securities, including
on any eligible trading day during an observation period or on the final calculation day. We cannot give you assurance that the performance
of the SX5E Index will not result in a loss on your initial investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following graph sets forth daily closing levels
of the SX5E Index for the period from January 1, 2020 to September 19, 2025. The closing level on September 19, 2025 was 5,458.42.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="image_005.jpg" ALT="" STYLE="height: 322px; width: 613px"></B></FONT></P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">* The dotted lines indicate the coupon threshold
level and the downside threshold level of 70% and 60%, respectively, of the starting level of the SX5E Index.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-align: center">PAST PERFORMANCE IS NOT
INDICATIVE OF FUTURE RESULTS.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the EURO STOXX 50<SUP>&reg;</SUP> Index due March 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Tax
Considerations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should review carefully the sections in the
accompanying prospectus supplement entitled &ldquo;Material U.S. Federal Income Tax Consequences&mdash;Tax Consequences to U.S. Holders&mdash;Notes
Treated as Prepaid Forward or Derivative Contracts with Associated Contingent Coupons&rdquo; and, if you are a non-U.S. holder, &ldquo;&mdash;Tax
Consequences to Non-U.S. Holders.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In determining our reporting responsibilities,
if any, we intend to treat (i) the securities for U.S. federal income tax purposes as prepaid forward contracts with associated contingent
coupons and (ii) any contingent coupon payments as ordinary income, as described in the section entitled &ldquo;Material U.S. Federal
Income Tax Consequences&mdash;Tax Consequences to U.S. Holders&mdash;Notes Treated as Prepaid Forward or Derivative Contracts with Associated
Contingent Coupons&rdquo; in the accompanying prospectus supplement. Our special tax counsel, Davis Polk &amp; Wardwell LLP, has advised
that it believes this treatment to be reasonable, but that there are other reasonable treatments that the Internal Revenue Service (the
&ldquo;IRS&rdquo;) or a court may adopt.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Sale, exchange or redemption of a security.</I>
Assuming the treatment described above is respected, if you are a U.S. holder, upon a sale or exchange of the securities (including upon
early redemption or redemption at maturity), you should recognize capital gain or loss equal to the difference between the amount realized
on the sale or exchange and your tax basis in the securities, which should equal the amount you paid to acquire the securities (assuming
contingent coupon payments are properly treated as ordinary income, consistent with the position referred to above). This gain or loss
should be short-term capital gain or loss unless you hold the securities for more than one year, in which case the gain or loss should
be long-term capital gain or loss, whether or not you are an initial purchaser of the securities at the issue price. The deductibility
of capital losses is subject to limitations. If you sell your securities between the time your right to a contingent coupon payment is
fixed and the time it is paid, it is likely that you will be treated as receiving ordinary income equal to the contingent coupon payment.
Although uncertain, it is possible that proceeds received from the sale or exchange of your securities prior to an observation period
end-date but that can be attributed to an expected contingent coupon payment could be treated as ordinary income. You should consult your
tax advisor regarding this issue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As noted above, there are other reasonable treatments
that the IRS or a court may adopt, in which case the timing and character of any income or loss on the securities could be materially
affected. In addition, in 2007 the U.S. Treasury Department and the IRS released a notice requesting comments on the U.S. federal income
tax treatment of &ldquo;prepaid forward contracts&rdquo; and similar instruments. The notice focuses in particular on whether to require
investors in these instruments to accrue income over the term of their investment. It also asks for comments on a number of related topics,
including the character of income or loss with respect to these instruments and the relevance of factors such as the nature of the underlying
property to which the instruments are linked. While the notice requests comments on appropriate transition rules and effective dates,
any Treasury regulations or other guidance promulgated after consideration of these issues could materially affect the tax consequences
of an investment in the securities, possibly with retroactive effect. You should consult your tax advisor regarding the U.S. federal income
tax consequences of an investment in the securities, including possible alternative treatments and the issues presented by this notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Non-U.S. holders.</I> Insofar as we have responsibility
as a withholding agent, we do not currently intend to treat contingent coupon payments to non-U.S. holders (as defined in the accompanying
prospectus supplement) as subject to U.S. withholding tax. However, non-U.S. holders should in any event expect to be required to provide
appropriate Forms W-8 or other documentation in order to establish an exemption from backup withholding, as described under the heading
&ldquo;&mdash;Information Reporting and Backup Withholding&rdquo; in the accompanying prospectus supplement. If any withholding is required,
we will not be required to pay any additional amounts with respect to amounts withheld.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Treasury regulations under Section 871(m) generally
impose a withholding tax on certain &ldquo;dividend equivalents&rdquo; under certain &ldquo;equity linked instruments.&rdquo; A recent
IRS notice excludes from the scope of Section 871(m) instruments issued prior to January 1, 2027 that do not have a &ldquo;delta of one&rdquo;
with respect to underlying securities that could pay U.S.-source dividends for U.S. federal income tax purposes (each an &ldquo;Underlying
Security&rdquo;). Based on our representation that the securities do not have a &ldquo;delta of one&rdquo; within the meaning of the regulations,
our special tax counsel believes that these regulations should not apply to the securities with regard to non-U.S. holders, and we have
determined to treat the securities as not being subject to Section 871(m). Our determination is not binding on the IRS, and the IRS may
disagree with this determination. Section 871(m) is complex and its application may depend on your particular circumstances, including
whether you enter into other transactions with respect to an Underlying Security. You should consult your tax advisor regarding the potential
application of Section 871(m) to the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Non-U.S. holders should also discuss with their
tax advisors the estate tax consequences of investing in the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Market Linked Securities&mdash;Callable with Contingent Coupon with Daily Observation and Contingent Downside</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>, the Russell 2000<SUP>&reg;</SUP> Index and the EURO STOXX 50<SUP>&reg;</SUP> Index due March 22, 2030</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Validity
of the Securities</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the opinion of Davis Polk &amp; Wardwell LLP,
as special United States products counsel to Barclays Bank PLC, when the securities offered by this pricing supplement have been issued
by Barclays Bank PLC pursuant to the indenture, the trustee has made, in accordance with instructions from Barclays Bank PLC, appropriate
entries or notations in its records relating to the master global note that represents such securities (the &ldquo;master note&rdquo;),
and such securities have been delivered against payment as contemplated herein, such securities will be valid and binding obligations
of Barclays Bank PLC, enforceable in accordance with their terms, subject to applicable bankruptcy, insolvency and similar laws affecting
creditors&rsquo; rights generally, concepts of reasonableness and equitable principles of general applicability (including, without limitation,
concepts of good faith, fair dealing and the lack of bad faith) and possible judicial or regulatory actions or application giving effect
to governmental actions or foreign laws affecting creditors&rsquo; rights, <I>provided </I>that such counsel expresses no opinion as to
(i) the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law on the conclusions expressed above
or (ii) the validity, legally binding effect or enforceability of any provision that permits holders to collect any portion of the stated
principal amount upon acceleration of the securities to the extent determined to constitute unearned interest. This opinion is given as
of the date hereof and is limited to the laws of the State of New York. Insofar as this opinion involves matters governed by English law,
Davis Polk &amp; Wardwell LLP has relied, with Barclays Bank PLC&rsquo;s permission, on the opinion of Davis Polk &amp; Wardwell London
LLP, dated as of May 15, 2025, filed as an exhibit to the Registration Statement on Form F-3ASR by Barclays Bank PLC on May 15, 2025,
and this opinion is subject to the same assumptions, qualifications and limitations as set forth in such opinion of Davis Polk &amp; Wardwell
London LLP. In addition, this opinion is subject to customary assumptions about the trustee&rsquo;s authorization, execution and delivery
of the indenture and its authentication of the master note and the validity, binding nature and enforceability of the indenture with respect
to the trustee, all as stated in the opinion of Davis Polk &amp; Wardwell LLP, dated May 15, 2025, which has been filed as an exhibit
to the Registration Statement referred to above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 29; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>dp234695_exfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024-2025 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FC.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.2b -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: 4c50ac9aec6e5e24c3293f98d0e477d1 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025">
<head>
  <title>Filing Fee Exhibit</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="fee_001">424B2</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="fee_002">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="fee_003">0000312070</ix:nonNumeric>
      <ix:nonNumeric name="ffd:RegnFileNb" contextRef="c_report" id="fee_004">333-287303</ix:nonNumeric>
      <ix:nonNumeric name="ffd:OfferingTableNa" contextRef="c_report" xs:nil="true" id="fee_005"></ix:nonNumeric>
      <ix:nonNumeric name="ffd:OffsetTableNa" contextRef="c_report" id="fee_006">N/A</ix:nonNumeric>
      <ix:nonNumeric name="ffd:CombinedProspectusTableNa" contextRef="c_report" id="fee_007">N/A</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_offering_1">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000312070</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-09-23</xbrli:startDate>
          <xbrli:endDate>2025-09-23</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000312070</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-09-23</xbrli:startDate>
          <xbrli:endDate>2025-09-23</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: right">Ex-Filing Fees</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center">CALCULATION OF FILING FEE TABLES</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="fee_008">F-3</ix:nonNumeric></p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="fee_009">BARCLAYS BANK PLC</ix:nonNumeric></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; border-top: Gray 3pt double; padding-top: 6pt; text-align: center; margin-top: 0pt; margin-bottom: 4pt">Table 1: Newly Registered and Carry Forward Securities</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="font-size: 2pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="width: 12%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 6.5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td></tr>
<tr style="font-size: 8pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="border-bottom: Black 1pt solid">Line Item Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Class Title</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Notes</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Calculation<br/> Rule</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount Registered</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Proposed Maximum Offering<br/> Price Per Unit</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Maximum Aggregate Offering Price</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Rate</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Amount of Registration Fee</td></tr>
<tr style="font-size: 2pt; vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="22" style="padding-top: 2pt; font-style: italic; text-align: center; padding-bottom: 2pt">Newly Registered Securities</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_1" format="ixt:booleanfalse" id="fee_010">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_1" id="fee_011">Debt</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_1" id="fee_012">Global Medium-Term Notes, Series A</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(1)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457rFlg" contextRef="c_offering_1" format="ixt:booleantrue" id="fee_013">457(r)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_014">5,598</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_015">1,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_016">5,598,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_017">0.0001531</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-223">857.05</ix:nonFraction></td></tr>
<tr style="font-size: 4pt; vertical-align: top; text-align: left">
  <td style="width: 11%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Offering Amounts:</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-224">5,598,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-225">857.05</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fees Previously Paid:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-226">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fee Offsets:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-227">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Net Fee Due:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 3pt double">$</td>
  <td style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-228">857.05</ix:nonFraction></td></tr>
</table>

<p style="font: bold 8pt Arial, Helvetica, Sans-Serif; color: rgb(50,101,255); margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: bold 8pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">__________________________________________<br/>
Offering Note(s)</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_1" id="ixv-229">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), was originally deferred in accordance with Rule 456(b) under the Securities Act.</ix:nonNumeric></td></tr>
  </table>

<p style="font: bold 11pt Times New Roman, Times, Serif; border-top: Gray 3pt double; padding-top: 6pt; text-align: center; margin-top: 0pt; margin-bottom: 4pt">Narrative Disclosure</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">
The maximum aggregate offering price of the securities to which the prospectus relates is $<ix:nonFraction name="ffd:NrrtvMaxAggtOfferingPric" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" contextRef="c_report" id="ixv-230">5,598,000</ix:nonFraction>.
<ix:nonNumeric name="ffd:FnlPrspctsFlg" contextRef="c_report" format="ixt:booleantrue" id="ixv-231">The prospectus is a final prospectus for the related offering.</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">&#160;</p>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1"  = 'D# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#V4G%4KW5H
M+.WEE :81?ZQ8L$I]>:MS$K$Y'4 D5Y9/JTVR9(VV"4;9/4BNC#X=UF[=#AQ
MN,6&2OU/2[?4[:XM[>42*@N #&KD GVQ4T]Q%:Q&6>18XUZLQP!7C-[J5Q)#
M;QM(2ML<Q>J_C7I?BIR?"4Y;[S(F?KD4ZN']G)1ON3A\=[:G*=MC4M]5L;N3
MR[>ZAD?^ZK@FI;B\M[0*;B9(@YVJ7.,GTKB;'[--K^EC[.;!H$SF1-K3G';M
M^/O5CQ:7U.>>.)_DT^+S#[N>WX*,TO8KF2&L8_9N=M3K[BZAM(O-N)%BCSC<
MYP*CMM3L[UBMM<Q2L.2$<$USOB.[%YX)CF!SYWEG\<C-5=)2&]UZ._TZ'R;6
MTA*2-M"[VQTQ4JE[K;*EBFJBBNMCJKO5;*P(%W<Q0EN@=L$THU6R(A(NHOW_
M /JOF'S]N/6N>\+6D6J176IWL:337$K %QNVJ.@&:34[.&V\1:#:P+MCC9V5
M?3O1[-7Y2O;SY>>VC.JDE2&-I)&"HHRS'H!5=]4LH[5;EKF(6['"R%AM)^M9
MWB:<M9Q6$;8DO9!%GT3JQ_+^=96@VBW_ (>U#29<%H970>W<'\Z4::<>9CGB
M&JG)%=/Q.JGO;>UA$L\R1QD@!V; .>E5Y];TZUE$<]Y#&Y_A9AFN8T%IM<^R
M6MRI\C3>9,_QR D*/P%16)M;#5+S3]=ME+74I9)W7(8'ISV^M5[%)M=C/ZU)
MI-+1G=*P=0RG((R#2TU%"HJKT P*=6!W",,BO-/%NDQZ)N=0S"X<[#CA1G)&
M?R _&O3*AN+:&[A:&XC26-A@JXR#6M*JZ<KHYL3AHUX<KW/+O"FB0^(9G657
M"P.&9P.",@XSZ\8QZ-[5W?BVUN+O0V@M(6ED=U^5?0'-:UK:064"PVL211+T
M1!@"IJ<ZSE/F)HX2-.E[/N<?<6VI:K<V<LNG/;06/[S!8%Y",?* /I5C3O#$
M%W9-<ZK;G[=.S.^YC\A).!@'' Q7444G5ETT&L)"]Y:G"MI^IMX7BT]K.4R0
MW0].4!)S5^\LY]&UU;RTADEM+OY+F.-2=I_O8'^>M=711[9B^J1[G'::NK>'
M9)K.+3WO+9W+0NC8QGU]*DU*/5!KFGWIL6N#!$=XB( #-G@$^G%=;11[76]A
M_55R\O,['+P:;-X@U.6XUFQ>&&*,)#$S]R<DY'X4[3=,ET?Q+<I;V[BPGB!5
MARJL.W\_SKIJ*7M'MT*6&CH^O<YSPS:7=I97YG@:*:6=Y$#8YR.*H:DNI^(+
M.*RFTEX)PP+SN1L3U(/O7944>T?-S \.G!0OH,B3RXD3).U0,GO3Z**S.@__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #' RH# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^D) !).
M.I-,GFCMK>2>9PD4:EW<]%4#)->2:MJUUXM<RWADCTIN8+#.U73LTP_B)Z[3
M\HXX)YJHQ<GH3*2BM3O[CQOX:MY&C.KP2NIPPM@T^T^AV XJ+_A/_#?_ #^S
M?^ 4_P#\17 HBQJ$10JC@ # %+6OLD8^U?8[W_A/_#?_ #^S?^ 4_P#\11_P
MG_AO_G]F_P# *?\ ^(K@J*/9(/:OL=[_ ,)_X;_Y_9O_  "G_P#B*/\ A/\
MPW_S^S?^ 4__ ,17!44>R0>U?8[W_A/_  W_ ,_LW_@%/_\ $4?\)_X;_P"?
MV;_P"G_^(K@J*/9(/:OL=[_PG_AO_G]F_P# *?\ ^(H_X3_PW_S^S?\ @%/_
M /$5P5%'LD'M7V.]_P"$_P##?_/[-_X!3_\ Q%'_  G_ (;_ .?V;_P"G_\
MB*X*BCV2#VK['>_\)_X;_P"?V;_P"G_^(H_X3_PW_P _LW_@%/\ _$5P5%'L
MD'M7V.]_X3_PW_S^S?\ @%/_ /$4?\)_X;_Y_9O_  "G_P#B*X*BCV2#VK['
M>_\ "?\ AO\ Y_9O_ *?_P"(H_X3_P -_P#/[-_X!3__ !%<%11[)![5]CO?
M^$_\-_\ /[-_X!3_ /Q%'_"?^&_^?V;_ , I_P#XBN"HH]D@]J^QWO\ PG_A
MO_G]F_\  *?_ .(H_P"$_P##?_/[-_X!3_\ Q%<%11[)![5]CO?^$_\ #?\
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M^A&,GKGMZSIU_;ZIIUO?VC[[>XC$D9(P<$=QV/M64HN)M&2D6J***DH****
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MT7_GK=?^ ,__ ,11_P )AHO_ #UNO_ &?_XBJM%'M7V"Q:_X3#1?^>MU_P"
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M4?\ "8:+_P ];K_P!G_^(JK11[5]@L6O^$PT7_GK=?\ @#/_ /$4?\)AHO\
MSUNO_ &?_P"(JK11[5]@L6O^$PT7_GK=?^ ,_P#\11_PF&B_\];K_P  9_\
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MN\M?,V[\#=MZ9]J32Z .HHHJ1A4?DQ>?Y_EIYNW9OVC=MSG&?2I** "BBB@
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MAT"U6V\R [DG5)?N<9#@[>G(R/6JY5W*MK8])HKSG6((L7;:KITTNI27%O\
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M73[^/R=1MOEFC(P&]'7U1NH/X=016U)]#"JNI/1116Q@%%%% !1110 4444
M%%%% !1110 4444 %:.AW'V;5$8S>4&5EW%MHY4XR?KBLZBAC3MJ=-!J$L+Z
M9#/?*<RN+G]^'!4D?>.2",5%%J$4<NEPO<?Z(L?[V-6^7.YL;A[<'FN>HJ>4
M?,SJQ>':-SQ&;#@/)J*&4 X^ZX7"^V?>H;G4/LT+?9M09I#<H6;S!NQLYR1U
M /&>]<U10HH;FVCJS<Q+<K]DN[>&W6ZD:Y4R !TSQQ_&,9&!FH#=1?946SGC
MCN?LX6)C(J%!YC$C)/!QBN;HI<H<YIZW*)=01A,LI$489U;<"P49Y^M;CWMN
M+B4VTJ[_ +26D*W21!UP,9)!W+UX%<A13Y=+"YM3HUO+86LEWYD:7-KYD4,:
M-U#'Y2.F0N6[>E37%W T#K$4^S&-!&KW280C'(C"[@V<\Y]>:Y:BCE'S&W-=
MQP7^IW<.QYC*1#('! !)R0,\\=\&L2BBFE83=PHHHIDA1110 4444 %%%% !
M1110 4444 %%%% !1110 5V_P]_Y%E_^ORX_]&&N"GG:-XH(8FGNYVV00)]Z
M1OZ =23P!R:]1\,Z.=!\.VFG.ZO,BL\SJ,!I78NY ]"S-BL:KZ&])=37HHHK
M$W"BBB@ KE?&7_'[X7_["K?^D=S755B>)],GU'2TDLT1[ZRF6ZME<X#, 05S
MVW(SKGMNI2U0%.BJMA?V^HV_FP,?E)62-AAXG'56'4,/2K5<11 ME:I%-$MM
M"L<Q9I4"#$A;J6'?/?/6ING I:* (Q#$)S,(D\XKL,FT;BH.<9],U)110 44
M44 %%%% !1110 4444 4GTC3'U)=1?3K1KY1A;EH%,H[?>QG]:NT44 %%%%
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M_P#X#/\ _%T?\('K?_04T_\ \!G_ /BZ]#HHYY=PY(]CSS_A ];_ .@II_\
MX#/_ /%T?\('K?\ T%-/_P# 9_\ XNO0Z*.>7<.2/8\\_P"$#UO_ *"FG_\
M@,__ ,75&T\+:Q=ZA>6BW]BK6Q +&W?#9_X'7J-<[HO_ ",NM?[R_P!::D[,
MEPC=:'/?\('K?_04T_\ \!G_ /BZ/^$#UO\ Z"FG_P#@,_\ \77H=<[#XSTR
M;6]7TG9<)=:6ADDWJH64!59O+.><!ESG'WA4NHUN_P"D5[./8Y[_ (0/6_\
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M2YY=PY(]C&T3PMI6@%Y+.%FN9!B2ZF;?*X]-QZ#V&![5LT45)84444 %%%%
M!1110!BZIX7L-3N3>*9K+4"NW[9:,$D(&<!L@JX&> P(%9S>'M?B=?(UNQEC
M'5;BP;>?^!+( /\ OG\JZNBI<4]P.5_L7Q%_S^Z7_P" \G_Q=']B^(O^?W2_
M_ >3_P"+KJJ*7)'L!RO]B^(O^?W2_P#P'D_^+H_L7Q%_S^Z7_P" \G_Q==51
M1R1[ <K_ &+XB_Y_=+_\!Y/_ (NC^Q?$7_/[I?\ X#R?_%UU5%')'L!RO]B^
M(O\ G]TO_P !Y/\ XNC^Q?$7_/[I?_@/)_\ %UU5%')'L!RO]B^(O^?W2_\
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M <K_ &+XB_Y_=+_\!Y/_ (NC^Q?$7_/[I?\ X#R?_%UU5%')'L!RO]B^(O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "H4M8(KB2X2)5ED #N!RV.E344 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !6?JVMZ=H<"2ZA<K%YA*Q1@%Y)6 SM1%RS''8 UH5Y_I8_M"6;
M6[GY[JZ=MA/_ "RB#$)&OH, $XZL2:3=AI&K)XJU.8,=/T A?X6O[H0Y]\(K
MG\P#]*3^W?$/_/CI?_@1)_\ $445GS,=@_MWQ#_SXZ7_ .!$G_Q%']N^(?\
MGQTO_P ")/\ XBF2RQV\+S32)'%&"S.[850.I)/04TW$"O$AFC#39\M2PR_&
M>/7CFCF86)?[=\0_\^.E_P#@1)_\11_;OB'_ )\=+_\  B3_ .(HHHYF%@_M
MWQ#_ ,^.E_\ @1)_\11_;OB'_GQTO_P(D_\ B**J3:E;6\WE2M(C&1(@3$X5
MF;[H#8P?P/'?%',PLBW_ &[XA_Y\=+_\")/_ (BC^W?$/_/CI?\ X$2?_$5!
M:7D%] 9K:3?&'>,G!'S*Q5AS[@BIZ.9A8/[=\0_\^.E_^!$G_P 11_;OB'_G
MQTO_ ,")/_B*9+-%;Q^9-*D:9 W.P49)P!D^I(%/HYF%@_MWQ#_SXZ7_ .!$
MG_Q%']N^(?\ GQTO_P ")/\ XBBBCF86#^W?$/\ SXZ7_P"!$G_Q%']N^(?^
M?'2__ B3_P"(IDTJP0O*X<JBEB$0NV!Z* 23[ 9IRL'0,,X(R,@@_D>E',PL
M+_;OB'_GQTO_ ,")/_B*/[=\0_\ /CI?_@1)_P#$444<S"P?V[XA_P"?'2__
M  (D_P#B*/[=\0_\^.E_^!$G_P 1111S,+!_;OB'_GQTO_P(D_\ B*/[=\0_
M\^.E_P#@1)_\1111S,+!_;OB'_GQTO\ \")/_B*/[=\0_P#/CI?_ ($2?_$4
M57^VVYC21',J-)Y0:%3( V2"#M!Q@@@D\#O1S,+%C^W?$/\ SXZ7_P"!$G_Q
M%']N^(?^?'2__ B3_P"(HHHYF%@_MWQ#_P ^.E_^!$G_ ,11_;OB'_GQTO\
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MJ6M207?VBV6>,0LK[D \I#\O;!))XX.:T;76-,O84EM-1LYXG?RU>*=6#/\
MW00>3[47.L:99;_M6HV=OY9VOYLZIM.,X.3QP0?H:=Q' 7.M:Q8R7<WF7;Q:
M/+)9R+O)$[2EC&3UR5S#SVW-6K,)X=0CLYKF:86]UIZ@RN6.<-D\]R1D^M=5
M;ZQIEW<BVMM1LYIRGF"*.=68I_>P#G'O2)K.ER?:/+U*S?[,<3[9U/E'_:Y^
M7\:+VM_7]:BDKF;X:)7PY<$'!%U>8(_Z[R5S<4NI66C:;=6-Y?3WE[HLLSK+
M.\VZ14C*LJL2 PW'IC/?-=5>^+-#L;$7C:G:R6_VA+9GBG0A78@8)S@8ZGT
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P"^8_\ XNC[3?\ _0 U3_OF/_XNBS"Y;HJI]IO_ /H :I_WS'_\71]IO_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
80 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #/ R4# 2(  A$! Q$!_\0
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M_OF'_P".4?\ "6_]0+5O^^8?_CE144>U86)?^$M_Z@6K?]\P_P#QRC_A+?\
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M\=>>*;=G82C=7.=IPC?RS($;RP<%L< ^F:Z$:3:6ENZ70B^TP1[Y!(S[?F;
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MOM7/7NS[?<>5M\OS6V[>F,G&*:=Q.-BO78_#K_D%ZI_V$6_]%1UQU=C\.O\
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M%0>2%SDCWQ5BQU"UC%B;GSE-G(641H#O!(/))&/UJ3^U;0R1W1687$4+1*@
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MJ^I%;&_?4O,^VW,L#6/EH%A"A_ND#=N78-VXD<G@<5T]WI6G7T\,]Y86MQ-
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M"QMKN-&W*MQ"L@4^H!!P:0Z5IQODOC86OVN-=B7'DKYBKZ!L9 ]J2:7]?UZ
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MC][_ -^8O_B:/^%=?]1^]_[\Q?\ Q-=O11S/N')'L<1_PKK_ *C][_WYB_\
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M ,31_P (O>_]##=?^ \7_P 372T4<D>P'-?\(O>_]##=?^ \7_Q-'_"+WO\
MT,-U_P" \7_Q-=+11R1[ <U_PB][_P!##=?^ \7_ ,31_P (O>_]##=?^ \7
M_P 372T4<D>P'-?\(O>_]##=?^ \7_Q-'_"+WO\ T,-U_P" \7_Q-=+11R1[
M <U_PB][_P!##=?^ \7_ ,31_P (O>_]##=?^ \7_P 372T4<D>P'-?\(O>_
M]##=?^ \7_Q-'_"+WO\ T,-U_P" \7_Q-=+11R1[ <U_PB][_P!##=?^ \7_
M ,31_P (O>_]##=?^ \7_P 372T4<D>P'-?\(O>_]##=?^ \7_Q-'_"+WO\
MT,-U_P" \7_Q-=+11R1[ <U_PB][_P!##=?^ \7_ ,31_P (O>_]##=?^ \7
M_P 372T4<D>P'-?\(O>_]##=?^ \7_Q-'_"+WO\ T,-U_P" \7_Q-=+11R1[
M <U_PB][_P!##=?^ \7_ ,31_P (O>_]##=?^ \7_P 372T4<D>P'-?\(O>_
M]##=?^ \7_Q-'_"+WO\ T,-U_P" \7_Q-=+11R1[ <U_PB][_P!##=?^ \7_
M ,31_P (O>_]##=?^ \7_P 372T4<D>P'-?\(O>_]##=?^ \7_Q-'_"+WO\
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M/^$IUA>^(S^E;%\MR]E*MG(L=QCY&89&:XG3[O5KC7;A+=%ANYBHF8KD1A<
MG!JXJZ9G)V:.^KSK6?">KSQ>(;^P@5=3_M W.GYD4">-K>.-T)SP&PPYQ@@&
MO11THK*44TT:GFC^&M:ATK4M+&E&X?5;2WC2[\Z,+9LD2H0^6#?*REEV!N3V
MZUZ2@*HJDY(&,TZBK;O_ %_7<B,5&R_KI_D%%%%(H**** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P#B*MU4N[^.P#R7,<B6R)O:XX*CG&W .[//ICWHNQ:!]FU#_H/ZI_WU'_\
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MBI]FU#_H/ZI_WU'_ /$4?9M0_P"@_JG_ 'U'_P#$5;HHNPL5/LVH?]!_5/\
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M$3H"VU%.<97G.!W%:AAB:9)FB0RH"J.5&Y0<9 /;.!^5/IW'8****D84444
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M6=)71PZKM#*RD%3@8RI'ZT75Q*]FC N/%=]8YBN(K0R@SVRE<A9+E=OE@9/
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MSVI^++BT6"ZMIX)8BD3RV:V,TCIOP3NF1BD?# C<O/XYK6T A3K!/0:A*?\
MQU:=)X4T:5CNMI0I55:-+F54?: %+*&PQ  &2,\#FM*WM(+4S&!-GG2&63DG
M+'&3S]!5.VMC.STN<_9:SJ=UHPUF6\TRTL;B+?")('9H<D!-QW@/GT 7DX!-
M9@URXU(1PW0!>TU.VQ*+.6U\Q6R?]7+EAC!'4@UT!\)Z,?-!M9-DF3Y?VB38
MAR#E%W8C.0#E0#FIH/#NF6Y)2&1G,B2EY;B21BR?=)9F).,]Z-!R5UH9-OK>
MKS:&-<S8"RFC$D4'EOYD8+ #<^[#<'GA<>]1^(M0EDOGT\J@A@N-.E4@'<2]
MP0<^WR#]:UT\,:1&TV+5]DRLK1&>0QJ&Z[4+;4SZJ!1#X9TF N1!*[NT3,\M
MQ)(S&-BR$LS$G!/^13BTG<'U.?O_ !-?K=R6=O>VT\=RLZ0SQ:?-&L++&S#]
MZ7*2'Y<$*5.>:#J]YI&G:9>:BMG?SC39KA9E@,<BA4C(7<SL>2?F/?CCBN@B
M\,:3#<I.EO)NC9GC1KB1DC+ AMJ%MJ@ACP !S3H/#FEV\:1K!))&B/&JSSR2
MA4< ,H#L?EPHXZ#M25DA];F3>ZYK.E))!<_8)KEDBDB>*-T0!I5C964L2<;L
MA@1GT&.=72+V^DO;^QU!K>2:V*$2V\;1JRN,CY2S$$8/?GVHA\-:5!#)$MO(
MZR%"QEGDD;"-N4!F8D*",A0<>U:$=I!#=37,:8FG"B1LGYMN0..G>C06IR.O
MWFH7]O(Z-;1:?;ZI;P&-HF,KE9X\MNW *,]MIR!U&:F7Q)>_V]%8PW-K=Q73
MRQPR)I\T:1,J,PS*6*2?=P0I!_IM77A[3;RZ^T3Q2LV]9-@N)%CWJ00VP-MW
M9 YQGC'2FV_AO2K6\BNHH91)"YDB!N)&2-B"#M0MM4$,>  *$U:S&_(J:'XB
MEUN\CBBCC18;?-Z"#F.<MM\L'/;:^?\ @/K70UG:3I,>E+=D,KRW5R]Q*ZH$
MR6/ P/0 #WQFM&DP"J-__P ?6E?]A"#_ -"J]5&__P"/K2O^PA!_Z%0MP.ZH
MHHK8@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH Q/%_P#R*U[]$_\ 0UK.K1\7_P#(K7OT3_T-
M:SJSF4A#G!P0#VR*Y;3/$EXFG&;4XUNIY-0ELH4L(/+R4+#D/(>NPGKQD?6N
MI.<'! /;(KG-.\,W5K# EUJ,,S0ZC)? Q6QC!WA\K@NW=SSZ#'O4KS*TM_78
MU;#5%U"QEN([:>.2)FCDMY-HD5UZKPQ7/3G..>M<U;^*M4NK'0;MM,NHFNIB
MLD*"(_:!Y+M\GSG:,J/O%?RKI]/T_P"PF\_>[_M-PT_W<;<@#'OTZUEV/ARY
MM1IL4M_%)!ILQ>W5;<HQ0HZ!6.\@GYLY '3IS35KZD]!&\460$%W*][;QK%<
M-+ T:?*8B X?&3N!/&TX//7BM73K][Y',FGW5DRXPMQL.X'H049E/YYK+7PR
M\<_G17P5PUTPS &'[Y@W()Y QCWSVJ?P_H T-;@[[8-.5)BL[;[/"N,\K'N;
M!.>3GG HT'+?0=#X@6ZN)([33;ZXA1I(Q<HJ"-I$R"HRP/4$9("Y[U ?%4$*
MW"7>GWUK=0^7BVE$9>3S&*IM97*<L".6&.^*B'AJ]BM;K3[;6#!ITYE=42#]
M\C2$DXDW= S$CY0?>JMIX+>T%Z\<VEI)=0I%(D6EA87VLQ)="Y+YW8.6SQUH
MT U7\0E$C3^R=1-[)N(L@(_,"KC+9+[,<CG=SG YK1L;V'4;&*[MRQBE7*[E
M((]00>A!XKEG\!6Y@AXTR6XB+[4N=.$ML@?;D)#O&P#:,8;N>N:U])L+^PO1
M;;HDTRWME2-(84C5Y"Q+$*O*@#  ]SUZT:"U+%WKEI8RWD=P)$-K;BY8[1AT
MY'R\\G(QCW'K57_A)[87!0V=X($D2&6Y*+Y<4K8PA^;=G+ $@%03UJ/7=".K
MZUH\IC80VTC23N& #*,%8R.I!<*WI\E++X=G>ZG1-0":;/<K=26_DYDW@@D+
M)NP%)4$C:3R>10K=?Z_K]!OR_K^OU+BZY;-':.$FQ<W3VJ<#AUWY)YZ?(?TI
M=1UNUTJ8QW*R#%M+<@JH(*Q[=P'/WOF&!6?'X<NX[RV/]IH;*VO'NXH?LWSY
M;?E6?=@C+G&%'3G/6K6N:"FMR:>[7#P_9+D3,$'^M4=4//0G'Y4M- *__"2V
M=VUFL#7D?F_9Y R1ITE+!4;=G'W3G'([&JNB:Q?W>K6L$\^^-TOBR[%&?+N%
M1.@[*<>_>IK3PDEGYNR\9@^H+>*&3[B*<B(<] 2>??I5C3?#O]G7\-S]J\SR
MEN5V^7C/G2B3KGMC'OUXZ52:)U([C7#I^MZDER[M:PV]L88D0%FDD>1<#U)(
M4<G'TYIQ\4PJHB;3KY;\RB(6)\L2EBI8<[]F-H)SN[8Z\4[4/#@OKR[NA=M%
M)*MOY1"9\MX79U;K\P);D<<#KSQ7N/#5W=V\YNKRPN;FX=3,+G3_ #+<JHPJ
MB(OD8Y.=^<G\*6EBNI-/XHAMU9CIVH$0Q^;=8C7_ $5>>7!;GH3A-QQST(S?
MU+58=,L$O'CEF1Y(XT6$ LQ=@JXR1W(KFV^']L&1D_LV=R@25[_3EN6 !./+
M)8;!@XP=PX'OGH]1TO[?8V]MYWE^3/#-NV9SY;JV,<8SMQ[9HT%J9T?BV)I'
M232=2A\F98+AI%BQ;NVW;NPYSG<OW=V,\XJ>+Q+;2WBQ"VNA;-,UNEX57RGE
M!(*CYMW4$9*@$CK2OH&_^T_])Q]NN8[C_5_<V",8Z\Y\OKQU]J@A\.30SQQ?
MV@#ID5RUU';^3B0.6+8,F[!4,20-H/3FC0;\@@\5QW%M!/#I6HO]I&;9,1!I
MN"3@%^, 9); Y&"<U;_ME9M N=2M()6>%)/W#@!PZ9!4Y(&01CKCT-9USX/@
MN-$TRQ<V<\NGKB-KRT$T39&#NC+#\,-P1^%:>G:.ECHK::1;JK*P86MN((QN
MZ[4&<=?4GWI2V=MQZ<R[&+%XEU*271I6TJ\7[3;2R/:IY):4@1D,I\P@+\S=
M6!]1TK2D\1JNFPZA!I=_<VCQF21XA'F$#J&5G#$C!X4-TI-/T.[MI].EN[^&
M<V,,D$?E6YCW(P0#.7;D;.HZYZ"LN[\#?:88X7O+:>%8FC,=W9><JDLS;XP7
M 1_FQDAN@Z4Y6N[$QV5S1D\66J2R[+.]EMX6C$MRBIY<8=596.6#$88= <5J
MZA?PZ=:F:4,Q)"QQH,O(QZ*H[D_YXK'C\+>7I=_9?;/^/I8AO\K[FQ$3IGG.
MS/XUL7VFV&J0"#4+*VNX5;<$N(ED4'UP0>:3MT!7ZG.P^(M5DLH(I(+2#4KG
M49+),!I(H@H9LGD%B%4]",GTJC?>,M1LE>WD;3XKFVDFCEDDC?R[AT",D<8W
M J[A\@9;&#PU:</@NTL82=,%K9W27C7<,D=J JD@J%901N4*S#J.O&*T;#2)
M[#3KQ%O%-_=N\TESY.%$C  $)GH   ,]NM--?U\O^"/K_7G_ , BLO$%O<:B
M\$US:P!V\JVB>0"69U_UFT$\@'Y>!U5JVZYF7PBOVB#[/>"*U5;<31O%O=_)
M<NI5]PVDL3NR#GVZUK:2NH>1.^HO^\>XD:./"_NH\X097KP,\YZT.W01 =>$
M6HK9W>FWMKYA=8)9/+*3%06.-CL1P"1N JK:^+[*>))I[2\LX)+4W<4MPJ;9
M(P 6QM8D$;AP0,]LU2MO!/DZO!?O=6KR0R2.)OL>+B0.C+B24N2V-PQ@ <=/
M2XWA..73].LI;HM':6#V9(3!?<J#=UXQLSCGK0K6U'U)-.UB[OO$4MO):75G
M;K:+*L5P(\L2Y&X;68CCL2#[4Z\\3V]E=743V-Z\-HZI<W**GEQ;E#!CE@Q&
M&&< XY[5+8:7>PZJ^H7U]#/(T @"0VYB4 ,3GEV/?UK,N/#^H:AJ6LQ2W$4&
ME7LD?F)Y6Z251&H.UP_R<@@Y4GTQUI*UU_77_(.C+[>)[2.Z=#;W0M4F^SF]
MVKY(ESC9][=UXSMQGC.:C3Q7 UC]L;3K^.!PAMW98\7&\@+M(<A221P^WWQS
M3#X:G$K0)J 333<_:Q;B#]X)-^_[^[&W=\V-N??'%5HO"$L7VR07&G++<)L9
M8]-"PR@G),T>\B1CTSE>IIZ"9;N=:<E!Y5_8W)M[AUMY4BVY0+RQ!;/WAC:<
M'G-9\OBJ<>'P&AN;74&LTN(I9D3;,/E#,H!.,%APP!YZ5:L_"(M%C NHUVQW
M">7#!LB7S0H^1-QV*-F=N3U/-,/A*XN;..&_U&&5X+;[+;R16ICV(2A)8%VW
M'Y!TQWXH5KB=[?(TW\06D?FJ8YO-CNULS$%&XNV"".?NX.[/H#Z8JSJ-_/8(
MCPZ9>7P.=PMC$"@'KO=<_AFLPZ$9?&_]KO&RPPVJJGSC;)+EANV]BJDC/?=[
M4_7O#IUJXMI#+;&.)65[>\MOM$3@D'=LW*-XQP3G&3Q2Z(KJ9M]XCGECN[G3
MK@BV.FP7,&8QD,\C G!&>@ P:Z^N6A\'"'339B^&/L$5GN$.,;'+;L;N^<8]
MNM;.G+J'VF_DO7Q"T^+6+"_)&% SD==QR>3TQTINW03W*TOB2VBO9(?LMVUO
M%,MO)>!5\I)6P I^;=U8#(4@9Y-5?"^H7^J?;;R[2]B3SY(XH9?(\H!79?DV
M$OGY>=QQGIQ4DOAV=[J=$U )IL]RMU);^3F3>""0LF[ 4E02-I/)Y%:.DZ=_
M9=D;;S?,S-++NV[?OR,^,9/3=C\*%:WF-G,P^*]4N+:RF;2KJ MJ4ENRJ(3Y
MZ+YH"K^\.&&Q<D[1G.#BMA?$T+P1^587LEX\CQ_85$?FJ4QNR2^P 9'.['(Q
MG-16_ARX@FA4W\36EO?/>0QBW(<%MY96??@\R<':.G>J^H>#(+Z1IW^PS3_:
M))HQ?60GB4.%!!3<,GY!@Y%&G]?+_@@_Z_$V[?5;>ZTEM1B$GDJKEE*X92I(
M92/4$$?A64?&-I' TMQ87]NIMOM4(=$)G3(!V[6/(W+P<'GO5Z#2S8^&Y-.A
M6 N(755MX%@CW-GA4'"C)]?J3UK&A\)WEYIMNNJ7T?VB*S%M"(K?:(@=A;=\
MYWM\@&00/:C2_D2[V+UQXA2SFEFNK?48!%;-*;9EA(90X4,-K$Y.> 6''49I
MY\46T2W"W%E>V]Q"\:+;.J&27S"0FW:Q')!ZD8P<XI^KZ!_:D\LGVGRO,M?L
M^/+W8^<-GJ/3&*BU+PT;[4)[U+PPSD0-"?+W"-XF<@D9^8'?@CCZ^B5NH:B2
M>(4AG,MU;ZE:-%:3W#VDB1$%8RN3D$Y/S#&&QR<\BI8?$8FDDA72M06Y$0GA
M@;R@T\>0-R'?M&,C(8J>>E5-1T#4;JUN9Y[V.ZO3I]S;(D4'DHQDVXQECC&S
MN3UZBHI?"E[?VXDOM3C^UI"L,1BMRD:(&5BKKYA+Y*@'#*"!QBGH5T)O^$AD
MNM2TVWABGLW^W/;W=O.J;A^X>0#*EAC[IRI_J*V-1OY[!$>'3+R^!SN%L8@4
M ]=[KG\,UAZ7X-73+N*X2:UC"7?VHPVMF((\^28B H8XZ[L\_P!:N:]X=.M7
M%M(9;8QQ*RO;WEM]HB<$@[MFY1O&."<XR>*)6LK!U(Y?%]HL:2VUE?7<1M%O
M&>%$ 2)MW)#,IR-IX )] :</%EHL;M/97MO\BO LB+NN S!5V ,>22!AMIYY
MJ.Q\*"QL6MA>!@=-6PR(MN,;OFQG_;Z>W6I;[PT+Q;8B\:*2V@2.)Q'G#HZN
MK8SR,IR.X/6C2_E_P_\ P ?D36_B&"::."6UNK:Z:<0-!,%W1L49P258J00I
MY!/IZX;-XD@CF\B&RO+F8SR6ZQQ!,LR*&/+, !@]214#>';V3-V^IQ'5//29
M9A;$0KM5E"^7OSC#-_'G)Z]J?8^'9;:\BNIKX32I<S7#8AV!C(@7'4XQBEH)
MWMH5[7Q3-?:U;6UKI5U):RP%W?\ =JT3B38P;,@X4@@X!]LUJ:EK":?/#;1V
MES>74RLZ06P7=L7&YB695 &1WR<\9JA9^'+G3KR"YM;^(%6F$RRVY;>DDIDP
MN'&UAG&>1[5<U+2[FXOH+^PO([6[BC>',L)E1D8@D%0RG.5&#GUX-/30%?4R
MX]<N=5\2VMO9"^2P%LEPTD2PA6RS#;('^< ;<849SFNIK'TK05TJ[$Z7+2C[
M,L!#KRQ#NY<D>I<\8XK8I.W084444@"J-_\ \?6E?]A"#_T*KU4;_P#X^M*_
M["$'_H5-;@=U1116Q 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M..XF=U1116Q(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5BZOX:L]5F%VCR6>H*NU+RWP'QV5
M@00Z^S ^V#S6U10!QDNG^(M/SFTM]4C&<-:N(93[;'.W\=_X"JKZNL#!;O3]
M4MF_V[&5E'_ T!7]:[VBIY4.YP)\0:2N-]_#'GIO.W/YTG_"1:-_T$[7_OX*
M[^BER!<X#_A(M&_Z"=K_ -_!1_PD6C?]!.U_[^"N_HHY N<!_P )%HW_ $$[
M7_OX*/\ A(M&_P"@G:_]_!7?T4<@7. _X2+1O^@G:_\ ?P4?\)%HW_03M?\
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K %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %D BT# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$V^5YFQFSZY;8YR!C 'K0!H>/O\ DG?B3_L&7'_HMJE\%?\ (A^'O^P9;?\
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M?\*M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4O@K_D0_#W_8,MO_ $4M &[1110 4444 %%%% !1110 4444 %%%% !1110
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M (JNIHHYJ7\OX_\  #EJ?S?A_P $Y;_A/-,_Y]K[_OT/_BJ/^$\TS_GVOO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MG?B3_L&7'_HMJE\%?\B'X>_[!EM_Z*6@#=HHHH **** "BBB@ HHHH ****
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M;S!AL'!_(\'TJ;3M1BU**:2)'413R0'=CED8J2/;(H N4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% '.^(9I+34K"XE"RV)22%H%FCC=I6QL(+D
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M8QJV3R 6QG\/?-;-5U _M!VP,^4HSM'J>^<_TJQ63DY;LU22V"BBBI&%%%%
M!1110 4444 %%%% %>T7:DGR[<RN?N;<\]>IS]>]6*KV:A4DPH'[US]T#O['
M_P"O5B@#'\2Z#'XATDVPE-O=Q.)[.Z4?-;S+RKC^1'<$CO5W3&OGTNV;4XXH
M[XQCSUA8L@?'.TGMFK=% '+ZMX5FU)]8=+I8FO'M9(B-P(:$@X8CG!([=*R#
MX7U>#4MD"6K&\M;M;B:5I)%C\PQ  ,Q+,V%SS@'':KFL^+KO3_$!M8$B>VBN
MH+67<F,-( 1\Q8?-\P("JW .2.U.V\6:X8(+F=K!D:WLKETCA8$B>7RR@);M
MC(/<\8H E3P7>6VJ6MQ)<QW%G:7'G*'+EVC\DQE!&/DSSDMR6Z5)X?\ "UU'
M;V%U<2$207OFH)TQ(+9(WCA0CLP5@3[DU7/C748[6VN6^Q.+R+SDC56S; 3I
M&5<YYX<\\893Q4MWXMU1KB^CM&LE6U%Z^YD9]P@\O"\,.N\@GMZ4 ,;P'=?9
M]."7D0DL;>WC4(7C#M&SD_,O*@A^".014H\$77V2[C^TP"2YM&B8_.P#M,TI
M.6))'.,]SSQ6IX2O+R^&KRW=UYRB^(B3;CREV(0O7D<_YS7.V>N:K9M?@W]N
MTN^^NFFNE8J5@DV+$J[\*,<DCH,<'K0!U%MH4PT#5-)N)UVW<ESLECR2J2LS
M<@]QN/Y5FQ^%M1ENX+NZN;1)8GM%V0*P4QP%CGG^(ESQT '4U;T+6[_5/[1O
M)DC6VMR%CMDC/FY,22?,Q/7YB,8KF6\5ZM#<V]^;B"?[=8V[1V\"DK;F6;;E
ME+_,1G&<KDC'% &YX@T?4]3\0RQVL<"VMUI3VDUQ,"=FY^=N.IQDX.!TYXJ3
M_A%)UMS$MS'_ ,A-KW)!R5*%0#_M<]:HVWBS5+F40.UA9O!'++++=<+*$E"8
M&UCL.#SRV#@8I;OQ1J\4TP186235'T^!8X"[(%4MN.7 8G& ..N>>E $O_"'
MWD8T^6*YMS-8VUG'&K*0CO#OSGT!#\=P146K^'M6#V5Y;I9S7*-;(8HXBD:E
M;CS&;'90#UZ\9Q5.7QYJ*V\,X@@_="'[4@ *_/*8P=^_ SMR N\Y.#TJ:X\9
M:I9>;!<PQB\EE1((XX=RJC2E/,#A\2#IP=AR?R &:EX$U2]M[E!?6VZ]2?SD
M+2+'')(^[("X,@&<8; SSCG%=9H6F2:39302R)(TES+-E0< .Q8#]:HV.OW;
M^%=0U.YM@UQ9>>-BX'F>7G' +;2<<C)P<USVH:SJM\]IIIU"W&^XLI))[164
M,DI;,>0^1]S.0>0>@[@'H=%<IK.OZC8:M=16_P!F^RVD=J[*Z,7D\V4QD9SQ
M@#(.#S6%J_BO5YM(1X;JWMVO0[Q^4A+VHCG1"&.[G(;!Z8/'- 'I%%(N=HR0
M3CD@8S2T %%%% !1110 4444 %%%% !1110 4444 8T_AJSGU-[\37,4K$N!
M&X"K*4\OS0"/O[>/3VS6AI]A;Z780V5JA2"%=J@DD_4D]23SFK-% !6;/KMA
M;ZBMB[R>876-F6-F1'89568#"DCU]1ZBKMS%)-;M'%</;N>DB*I*_@P(_2N,
ME\)WZZS=2QNSO=744_\ :)D :- BK(A08&6"D<#!W<]* -M?%^CO&[K+,<!6
MC'D/F8,VU3&,?.">.*TK/4[2_P ?99?-4Q)*&4'&UON\^O'3K7)V'A>]G%G'
MJ5OY2:9IXM(7AGPTLBLI$BD?='[L=>?F/%2:3X<U72M;M#%(4L0BM($F.Q?D
M8-'L[\F/#>B?F :/C[_DG?B3_L&7'_HMJE\%?\B'X>_[!EM_Z*6LGXHV%Y>^
M =6>TU6:Q6WLYY9ECC5OM""-LQMGH#ZCFM;P5_R(GA[_ +!EM_Z*6@#=HHHH
M **** "BBB@ HHHH ***QM8\36.D'R23<79^[;Q<L3[^E5&+D[11,I**NS89
ME12SL%4#)). *Y>\\5R7=P;'P];F]N.C3$?ND]\]_P"7UJ%='UCQ(PEUN8V=
MEG*V4)P3_O'_ #^%=/96-KIUN(+2!(8QV4=?<^IK:T*>^K_#_@F=Y3VT7XF#
MI_A,/<"^UR<ZA>'D*W^K3V [_P O:NE "@   #@ 4M%93G*;U-(P4=@HHHJ"
MBNN/[1?IGRE_N^I_X%_3]:L57!']H.,C/E*<;AZGMU_I5B@ HHHH **** "B
MBB@ HHHH **** *]GC9+C'^M?IM]?]G^O/K5BJ]F<I)R#^]<<,#W]A_]?UJQ
M0 4444 8][-X;CU$O?2:4M\@&6F,?FJ!R.O(]:E$^AA[> 2:?NN$3R$!3,B*
M<KM'< \C'X5E7/AB:?7)+_=;%6U."\^8'=MCA\O'3KGD>U95GX*U*UM/L?FV
M;1SFV,LV6WP^2^["#'.1TY&"3UH Z,W7AE4NW,VDA)G\NY;='AV.?E<]SUX/
MO3K^70]"LX7N(+6W@FD6V3$:A29"!CZ'C/L/:N>F\&7ZV.FK!-#YMJMTDD:R
MM$CB9]V=P4GCH1CG)YK;N]#G_P"$>TRPMGC:6QEMG'F,P5Q$RDC/)&0.,YH
MDTG6M"O+6>]LIK6'C=< E$= N5!?!XZ8&>U+<7'AJ6UADN)=*>W=VDB:1HRI
M?/S,N>,Y/)]37.MX+U*.PM8[>>T66"W:(GD;B;A9>"5..%(W8)!.<4VT\$:@
MD=YY\EKNGAO40&5Y2IG$87+,,G[AW'OG@4 =K+):V%O<7<GEPQ*#+-(!CH.6
M/KP/TKETU[PS]@6[ATC=!>VHO+DI:("L#-C?*#C(SDXY/!..*VKO13?:-:V$
MEW+"8?+9FB"D.4'0A@05S@XQV%<U%X-U:WTC[$MW;3O<Z:-.N9)"5V ,QWJ
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MG2]/+7#&PM2;D8G)A7]Z/]KCYOQJW10 @ 50J@  8 ':EHHH **** "BBB@
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M[I<?3\:J,7)VBA.2BKL[(D*"20 .237-7_BP27!L=#MS?WG0LO\ JT]R>_\
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M%:94$RW'V96 B\T+M#XQG.,<9QP#C-)J'A>PU(DSM.':1G=T?!=6 5D/'W2
M!CVZULY'J*AMKRWN_-^SRK)Y,ABDV_PN.H^M $_2BL@>)](-T;?[2X=;C[*7
M,$@C$N<;-^W;G/'7K6O0 C(KJ5=0RGJ",@UCOX<@_MO^U8KNZ@F\M8@D?EE%
M0'.T J2H)ZX(S^%7XM2M)[^XLHI=\]N%,H"G"9&0"V,9QSC.:M4 8^G^&[+3
M;M9X9)V$:ND$3N"D"NVY@@QW('7.,8&!3?\ A%]/^W6MWF??;A<KO^65E+,K
M/QRP9V.>.3S6P\BQQLYR0HR=H+''L!R:4$'^= "T4=:KV5];:C:)=6DHE@<D
M*X!&2"0>ON#0!8K'O_#=EJ%\UU*\Z^9Y?GQ1N D_EMN3>,9X/H1GH<BM&6]M
MX;N"UDE"SW&[RD[MM&3^E3Y!Z4 96I>'[34_,:62X29G1EEC?#1[00 N00!A
MFXQ_$:T+:WBM+6&V@7;#"BQHOHH& /RJ7( R3Q4,=W;RW<UK'*K3P!3(@ZJ&
MSC/UP: )J*R3XGT8:=?Z@;^/[+83-;W4FUOW<BD J1C.<D=/6M&XNH+6UEN9
MY5CAB0R.['A5 R30!6UC2HM:TN;3YY9HH9L!S"P5B <XY!X.,$=QFJ$_A>WN
M88DDOKWS(XWA$R,B-Y3@!H_E4#;P.@R,<&MM'61%=#E6 (/J*@N;^ULRHN)1
M&&944L#@LS;0,],DGI0!!<:+8W-I%:21DVT4+0I"&(4*5V_F%R ?<T[2M*AT
MBT:"&264NYDDEF8%W8X&20 .@ Z=JO44 %%%% %/4M*L-7MFM[^UAG0@@>9&
M&*Y&"5R.#[UECP=I:"%(C/%!''#&\", DPB.8]XQV/IC/?-=!10!FZAHEKJ1
MD:9YED8)LD1L&(HVX%>.#N /?.!5JPL8--L(+.W!$,*!%R<GZGWJQ10 4444
M 9VIZ+!J<L4S2SP3QH\8E@8!BC8W*<@C!P.V>.,54B\)Z;!=12P^='#')'*+
M57_=&1%VJY&,Y  [XX!(S6Y10!DZEX>M-4\QII+A)6=766-\,F%*X7(( PS<
M8_B-:5O!':VT5O"NR*) B*.R@8 J2B@ HHHH QM0\-66HWDMQ))<1_:$2.YC
MB<!+A4)*AN,]R.",@X-+8>&[+3[Y;J)YV$8D$$+L#'!YC;GV#&>3ZDXZ# K8
MHH Q+KPMI]Y+%+*T^]'9W(?_ %H+*Y5^.1E$]/N@5MT44 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5A>*-+N]5@TV.T9
MT:'4(9I)$90R(N<L-P()YZ8-;M% 'F]UX7UL2NLL+WL:W<\LTI\IS>;T41N4
M8JH*!2F.,<,.M3:=X=U72M1BNSI[W$B3QR2RI+'OF!M/*.22,D/R<XZY&:]"
MHH \XB\'ZB^B7*7-BAOFLK*"-C*"5*']Z V>/KQFNN\/:;+I:ZE"T*PP/?/)
M;1H1M$95>@'W1G=Q6S10!YI<>$M5N=+FM&TU?/\ LD\=U*\JL+Z5I%:-NO.
M&.6P1G KK-5M[FWUW1[VTT^6XM[6&>)T@**4W!-N S*,?*>E;]% '!W7AS4-
M1U.<2V3HUU>&5[\RKE+5HMIAX.[(/&T?+_%G-9,?A3Q7<6]TUQB*>>W,YQ.#
MBXXB*9!Z&)>O3+5ZE10!YM-X8U,V;R1V$SN)I'MK61+?R5)C4?-$&P@+ G*-
MN')_B(KJ?"NF3Z6FJ+<6<=O)/?//NCV[9 P!R,<\'(YP:Z"B@#D=.\*SR-J!
MU"XN$B?5);N&V#H8F^?=&QP-W4 X)ZCI6!:>$=;-B]O=0NSLD,=SEXU6Y83H
M[/D'+?*&.YL'YL8/;TVB@#A+CPL]MK%U<PZ-#+I[WZ2O:0B-?/C%OL'RD@';
M)SM;'KZ52/@W4Y]+NEN[1)KMK.WA@)F#&/$SLR!B>,(5&>^*](HH \ZNO!]_
M']N-C8I&TLE\J;)%7]U)%B->O"[^<= >>*-0\-:E%#>7D06UN&N+MVN_,Y6%
MH"%R1SMW <#H><5Z+10!QG@?R)-0UF>RL1:63_9UC575D++'\V"I*]QG!]SS
M60G@_53II66R4W$=BZ0?O5^28W+2 J<\':0=WX5Z5THH \WO?"^LSR2BWLO+
MU$"]W:H95'FB3_5@<[NF%Y'RXXXI)/"VL2VA6WLVB7[2)A"[QPCRE0"2(+&2
M%\W[O4CC<<5Z310!S?BK3[S4+73X[:U,L"S;IT549U78P&$<A&()'7..H!Q5
M#P1H5_I$\LNHV0CN);*WC:;>CG<FX%2PY/!7G&,#VQ79T4 >;2^$];:WU&U6
MW7[/>S7=S(OFKS()',(Z]&#J3Z;!FHM5\+:[J&HWA^P B;[4C/OC$;QM$PCR
M22['=LX.%7' [UZ=10!P(T35PRV\.FO%#]L:Z#>:BJB&T\L)@-U#\8''?-0S
M^#[A(=+5-*ADBMK:T\Z+*'=*DRM)U."VT'D]?6O1** .-\)6,AU2[D:19;#3
M6DM-.D5]P9'8.Q^J_+'_ , -=E110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !14-U;K=VDUNSNBR
MH4+(<,,C&0?6N8_X0"R_Z"NK?^!'_P!:M(*#^)V^1$G);*YUM%<E_P (!9?]
M!75?_ C_ .M1_P (!9?]!75?_ C_ .M5<E/^;\/^"3S5/Y?Q.MJGJ&I0::+4
MSAS]IN$MTV#/SMTS[<5SW_" 67_05U;_ ,"/_K5>UOP]_:>F:98 I)#:W4$D
M@G))D1.HXZDU,U%?"[_(J+D]U8T+?6+.YOKJS5]DUO,("LF%WOL$GR^ORMG\
MZ?%J^F3W7V6+4;22XR5\I)E+Y'48SG(KD-2\-3Z5IVJ/I<2+=2ZA'=:8D,;,
M$D$:)\_' .'!.<8-1Z;X6NX-4N;*&UAALH+ZTN/MCY$DICC0M@8P<MD$YXRW
M%9EG5:AXDTC3+:YGN+^WVVS*LRI(I9"S!0",\<GO3[+7M-O[VXLX;F,7,$K1
MM"S@.< $L!G)7!'-<E-X*U22Q@M5>R464<BPR!F!N2TR2?/\OR\)S][).:MW
MW@V[ODND\^"$W%[<7!D3)95DMS$.W)!/Y4 ;\GB32(Y+-!J%O(;NX^S1&*16
M!DVEL9!]!^H]:LV^JV5Q)%$MS")Y5+I"94+E02,@ G(X/2N3T[PEJ5M?V=]*
MT)D@GA+H;AGW1I'(A(.P $>9P,=!@GT=H/A+4M'!A8:=,DDHG,[JS/$P0KA!
MCGJ,'(QEA@T ='+X@TR,QB.ZCN"]PEL1 X<H[$@;L'CH:MR7]G#>1VDEW ES
M(,I"T@#M]%ZGH?RKAM.\%:Q#J-E<W$UMB!;97_?N^XQ.6)4;0J+@\*!QSDFM
MS4-#OI?$T.HV)B@0O$;B0S$^8B$Y4Q%2,X) 8$$9]J -M=3L&>X1;VV+6XS.
MHE7,0_VN>/QI$U/3Y(?-2^MFCV&3>)5(V X+9STSQFN'C\!:BMJ;9[J-_(C=
M8)))F82YF63#)M&T'9@\MR<CWMZIX7UB^%W)##I<$E]:RVTD:LP6+<X8-G;\
MY/.>%YH Z6^\0:7ISNEQ>VXDC!:2/SDWHH4L25)ST';FI++6=.U#3XKZWO(&
MMY-F&\P<%@-JGGAN1Q[U@W_A2YN[J\E1[=?M&H"YW'.=GV8PX/'7)S]*IZ;X
M>NE\16"2QA;6VM89+U0K&-[J-=D95B!N^4Y.!P47- '7RZG807!MYKVVCG5"
MYC>50P4#).,YQCO54^(](^VVUJ+^!GN8I)HV612I1,;CG..,_H?2LC6?"MQJ
M<FMR1S11M?+:^4W(/[EBQ5CC@'IWZ]*I1>#]0\R:622$-=PW<4VZ9I"AE1 K
M9V@,?W?( 7KWQR =;-JFGVR%Y[^UB4;<L\RJ!N&5ZGN <>N*6WU*PNYV@M[V
MVFE49:..568#.,D ^M<K:>%M3;4;:[O19+Y4]K)Y:.S\112(3DJ.27!'I5W2
M_#5Q87]A<,UOB"2^:39G+>=('7MZ#F@#IZ*** "BBB@ HJBVEHTEP_VJ\'GC
M! N&PG/\(_A_"D&E(#;_ .EWO[CIFX;Y^<_-_>_&@"_16?\ V2FR=/ME]^^(
M)/VELKSGY3_"/I3UTU%G@E^U7A,*A0IG;:WNP[GW- %BYG2UM9KB3.R)&=L#
M)P!DUGKXBL&-AN9XTO;5KN-Y %58U"D[CG@_./UI[Z44TN]M8;B>1[B-U#7$
MK/M)4COT%<]9^"K73FTV5K>V$-OI<MI?+$K%IBRH#@ <CY6]^10!T]SJ^FV4
MHBNM1M()"H8)+,JG!Z'!/2GRZA907$=O-=V\<\HS'&\@#./89R:\\L- UF.?
M2[I[**[O)H;J)Y;M6011!4CAW<$ABHR1W+-6K_PAU_"GV2*:WEAEBLDDN9"1
M+%]G(SM&#G=CCD8)/6@#8M/&6AWIM3'>QI'=1/)%)(RJK;7"$9)^]D]*O7^N
MZ9IL5V]S>P*UI"9IHQ("ZH!G.W.?3\Q7+IX-OSIK6TC6F\:9<V*')(+22!E;
M[O P.?ZU!/X%U"9[R(W2-%*]S-%(\S<-+&RX*!>V[D[CP!QZ '8+KFG&(2O>
M011,$*R23( V\97'/I_]:I+G5K"TD>*6[A$Z1F3R!(/,*@$Y"YR> :Y27PKJ
M9UPZLL>GS,]L(&M9V8H,QA6.=O.".F.03TJ+4?!^KWFI^:LUKY(N4F4B1HU5
M1$$*^6%P6R/O,Q^7CB@#KEU>P&F6VH37,5M;W"*\;3N$^\,@<GKCM4&H>)-'
MTRUNKBXO[?;:[?.5)%9DW$ 9&>.2*J'09FLO#<+M"QTMXWESD@[863Y>/5@>
M<5SA\":F+66W^TQR>4DP@DDG8AR\JR8*A?E^[R<MS@C% '>?;K3&?M4&-VS_
M %@^]C=CZXYQZ<U677='?9LU6Q;S&VIBX0[CG&!SSS7.W/AG5)[Z7:;-;>2]
MDO"QD;<"]N8MF-N."<YSR.U,N?!ES+8^1&UHK#1X=/4X. Z/N)Z?=H ZZZOK
M2PC62\NH;=&.T--($!/IDUGKXDTYM1U&R$F6TZ(2W4F5VH",XZYSCGICWJOK
MVD7EY?VM[9I:S-%;SVYANB0N) OS @'D;<$8Y!/(J'1?#5QIEMJ%O)<1RB>U
M@@23!R2D(C)(]R,]30!;LO%>CWT\$,5Y&K7%O%<0^8P42+(2%"\\ME3D5I0W
MUG<7,MM#=023P_ZR)) 63Z@<BN17PC?O8>7(;19OL-E:@AB0#!*68YV]",8]
M_P ZG\/^%;W2M6BFN)Q+#;"<1N9V8OYK[ON;0%]\ELGD8H W8]>TUDN'EN8[
M=(+EK5FN&" NO4#)YZU9;4;)#AKRW!^;@RK_  C+=^PZ^E<M+X7U*._GO8!8
MW#22W>(IV8*$F"8;.T\C9@C'()YK+D^'5^)HUBOH#!&L"#=N#,"HCN2?=T5<
M>^<T =Y_:5B;DVPO;?SPGF&+S5W;>N[&<X]ZJ2^)='C-GC4+>47=Q]FA:*16
M!DP3C(/H/U'K7.3>#+N75;II'CGLY;J6Z"R3LH^>,IL**OOC=N^[VJ>S\.:O
M%]D>:6%DMK^.>.&28R,D8B:,@R[ 7/S9&1T&,^@!U$NHV,-VEI+>V\=R^-D+
M2J';/3"YR::=5TX/<(;^U#6PS./.7,7^]SQ^-<MJVBZAJGB75(8;6%+:YM[-
M6O9,ADV2.Q"<?,>G<8)!J@? >HM9SVCW$<BK%-'%)+.S!Q)(KG*;1MX'.2V3
MZ4 =1#XLT:XU&YM(;V%Q;1++-<"5/*0,< $[NOX8]ZNS:UI5NL33:G91K,H:
M,O.H#@]",GD5AZCX;O)]9FU&W-LV+BUGBAD) ?RE=2I(!Q]\$'GD"LT^![V2
M*<RM9%YT&4P=J$W7GE!Q]T#CW/84 ==%K.F7&X6^H6L[+&9=L4Z,=HZGKT]^
ME.BU6PFFC@6\M_M#J&$/G*7Z9Z ^ASQ7,MX0N_M,LJ/:KOFOY#C()$Z@+GCJ
M,<_UJ!O!EVNG/&TL2N;B.9GA!+[5M?).WCELYQ[4 =A:ZC8WS.MI>6]P4^^(
MI5<K]<'BJ<'B+2YH&E>[BMU$TD %PZQEF1RC8R>1D5@^#;>\.IW-U/8+:PI8
M6UHC")XS(8]^3AU4_P 0[$#IDTW_ (0Z\:.Z#O:LTMOJ,2$Y.#<2!E[= !S_
M %H Z2XUW3[;4[;36N$:[N'*+$C LORELL,Y P.OTJ:'5-/N(Q)!?6TJ&3R@
MR2J07_NY!Z^U<?/X,U*:)K'S+18&GGG^V;F,P,D+1[0,=BW7/*@"D'@K4+G2
M+ZRN)HHGO$@@:43-*8TCR=Z_*H#<X48X[D]* .YBECGB66&1)(W&5=&!!'L1
M3ZJZ;%-;Z;;0SI"DL<2HRP_<! Q\OH/:K5 !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
J1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %# F4# 2(  A$! Q$!_\0
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M^$6\/?\ 0!TO_P  X_\ "M:B@#)_X1;P]_T =+_\ X_\*/\ A%O#W_0!TO\
M\ X_\*UJ* ,G_A%O#W_0!TO_ , X_P#"C_A%O#W_ $ =+_\  ./_  K6HH R
M?^$6\/?] '2__ ./_"C_ (1;P]_T =+_ / ./_"M:B@#)_X1;P]_T =+_P#
M./\ PH_X1;P]_P! '2__  #C_P *UJ* ,G_A%O#W_0!TO_P#C_PH_P"$6\/?
M] '2_P#P#C_PK6HH R?^$6\/?] '2_\ P#C_ ,*/^$6\/?\ 0!TO_P  X_\
M"M:B@#)_X1;P]_T =+_\ X_\*/\ A%O#W_0!TO\ \ X_\*UJ* ,G_A%O#W_0
M!TO_ , X_P#"C_A%O#W_ $ =+_\  ./_  K6HH R?^$6\/?] '2__ ./_"C_
M (1;P]_T =+_ / ./_"M:B@#)_X1;P]_T =+_P# ./\ PH_X1;P]_P! '2__
M  #C_P *UJ* ,G_A%O#W_0!TO_P#C_PH_P"$6\/?] '2_P#P#C_PK6HH R?^
M$6\/?] '2_\ P#C_ ,*/^$6\/?\ 0!TO_P  X_\ "M:B@#)_X1;P]_T =+_\
M X_\*/\ A%O#W_0!TO\ \ X_\*UJ* ,G_A%O#W_0!TO_ , X_P#"C_A%O#W_
M $ =+_\  ./_  K6HH R?^$6\/?] '2__ ./_"C_ (1;P]_T =+_ / ./_"M
M:B@#)_X1;P]_T =+_P# ./\ PH_X1;P]_P! '2__  #C_P *UJ* ,G_A%O#W
M_0!TO_P#C_PH_P"$6\/?] '2_P#P#C_PK6HH R?^$6\/?] '2_\ P#C_ ,*/
M^$6\/?\ 0!TO_P  X_\ "M:B@#)_X1;P]_T =+_\ X_\*/\ A%O#W_0!TO\
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MY>=N_'\6,T <=\5;S6[3Q5X4DT*20W47VJX-N'(6X6-%9D('4E0P'UK-\/\
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M.2.[E61)6 #%7#;AD#D9J1?AWX:CTA-,BLY8K>*Z:[A,=S(LD,AZE'#;ESZ
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M4_\  8_XT?V\/^@5JG_@,?\ &@#7HK(_MX?] K5/_ 8_XT?V\/\ H%:I_P"
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M ,!C_C1_;P_Z!6J?^ Q_QH UZ*R/[>'_ $"M4_\  8_XT?V\/^@5JG_@,?\
M&@#7HK(_MX?] K5/_ 8_XT?V\/\ H%:I_P" Q_QH UZ*R/[>'_0*U3_P&/\
MC1_;P_Z!6J?^ Q_QH UZ*R/[>'_0*U3_ ,!C_C1_;P_Z!6J?^ Q_QH UZ*R/
M[>'_ $"M4_\  8_XT?V\/^@5JG_@,?\ &@#7HK(_MX?] K5/_ 8_XT?V\/\
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M]*)*Z"N?\&_\@.;_ *_[S_THDH Z"BBB@ HHHH **** "BBB@ HHHH ****
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M3.?[5U#_ +[3US_=_#Z5I44 9HTF0$?\374#C'\:>N?[OX?2@:3(,?\ $UU
MXQU=.<9_V??]*TJ* ,T:3(,?\374#C'5TYP"/[OO^E']DR8Q_:VH?]]IZ8_N
M_C]:TJ* ,TZ3(0?^)MJ Z_QIZ8_N_C]:#I,AS_Q-=0&<]'3C./\ 9]OUK2HH
M S3I,AS_ ,374!G/1TXR0?[OM^M']DR9S_:NH?\ ?:>N?[OX?2M*B@#-&DR
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M@H**** /)?C;_P P+_MX_P#:=%'QM_Y@7_;Q_P"TZ* /0_"O_(H:)_UX0?\
MHM:UZR/"O_(H:)_UX0?^BUK7H **** "BBB@ HHHH *Y_P &_P#(#F_Z_P"\
M_P#2B2N@KG_!O_(#F_Z_[S_THDH Z"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'_HUJ@LUJ*** "BBB@#R7XV_\P+_ +>/_:=%'QM_Y@7_ &\?^TZ* /0_"O\
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MF<^_M^HK3HH S!K.<?\ $MU$9QU@Z9!/K[4?VSQG^S=1_P"_'MGU_#ZUIT4
M9AUG )_LW4>,_P#+#VSZ_A]:&UC&?^);J)QGI!UQCW]_T-:=% &:=8QG_B6Z
M@<9Z0=<$#U]Z/[8YQ_9VH?\ ?CWQZ_C]*TJ* ,T:QDC_ (ENH<X_Y8>^/7\?
MI2#6,X_XENH#..L'3.??V_45IT4 9@UG./\ B6ZB,XZP=,@GU]J/[9XS_9NH
M_P#?CVSZ_A]:TZ* ,PZS@$_V;J/&?^6'MGU_#ZT'6,9_XENHG&>D'7&/?W_0
MUIT4 9IUC&?^);J!QGI!UP0/7WH_MCG']G:A_P!^/?'K^/TK2HH S1K&2/\
MB6ZASC_EA[X]?Q^E(-8SC_B6Z@,XZP=,Y]_;]16G10!F#6<X_P");J(SCK!T
MR"?7VH_MGC/]FZCT_P">'MGU_#ZUIT4 9AUG /\ Q+=1XS_RP]L^OX?6@ZQC
M/_$MU$XST@ZXQ[^_Z&M.B@#-.L8S_P 2W4#C/2#K@@>OO1_;'./[-U#_ +\>
M^/7\?I6E10!FC6,D#^S=0YQ_RP]\>OX_2D&L9Q_Q+=1&<=8.F<^_M^HK3HH
MS!K.<?\ $MU$9QU@]03Z^U']L\9_LW4?^_'MGU_#ZUIT4 9AUG /_$MU$XST
M@]L^OX?6H;CQ%#;;A)9WJL%9@&AQD#'O[BM.ZNX+.(27$@120H[DD]@*H6]M
M;ZJYOIHTDC+@P!N<;<C/XGG'TJXKJ]B6^BW*&G:Q=02W%O=VE[*_^M3;!R 6
M.1UY /3VK0_MI?,*?V??[AR1Y/.-V,]>G?Z5'JV^UO[.]AMRS?ZB248^169>
M3[<'\ZK3V\?VB;6PSI/;3E6*G[\2_*4/MU;ZU?+S:]_S)YK:#[KQ/%;_ +L6
M%\9V(1$,!P7.=H..F<9^G-9\=]K%W<P)J%A<>2HRWE6Q R5*Y.6]SQ^-=!I4
M16R6621I))_WK,WN!C\,8%7J7,HZ)!RN6K9@Z;<0Z=:)#%IFHEB 9)&@^9V(
M)RQSU_Q JR^J1RA?,TJ_;:0Z[K?."!D'KU[?6M6BLVVW=EI)*QF'6< _\2W4
M>,_\L/;/K^'UK'L]5AT&VN;7[)?&..8F%'CQM0A>!SZEOUKJZS+W1(+Z_%W(
M3O$#0KQ]TG^(>^":N#6TMB9)[K<236Q$CNVG:CM0$G$'H?K^-5;#5]R33?V=
MJ&)I2ZGR.JY"COZ#/TJ.WOA<V$.GR2L\V8DF;.&96Y)]L]*Z*B2Y59@GS.YF
MC6,D?\2W4!G'6#WQZ_C]*0:QG'_$MU$9QU@Z9S[^WZBM.BLRS,&LYQ_Q+=1&
M<=8/4$^OM47AE_,TAGV.FZYG.UQAA^];@CL:V*R?#O\ R#9?^ONX_P#1K4 :
MU%%% !1110!Y+\;?^8%_V\?^TZ*/C;_S O\ MX_]IT4 >A^%?^10T3_KP@_]
M%K6O61X5_P"10T3_ *\(/_1:UKT ><_$^2)+K1HQ=PZ?=S.T4%_]HF6:(DJ,
M)'%]_/&=Q"CCUKL?#4@F\-V$@U;^U@T0/V[8$\[_ &L#IZ8]JQ?&&B>'?$-Q
M:C4-:.G7UBX:.6WNTBE7E6P0V>,JIZ=0*L_#V:WG\!Z4]K ((?+9502%^CL,
MECU)QDGU- '34444 %%%% !7/^#?^0'+_P!?]Y_Z425T%>)6_P &K/Q3/J&L
MR:_J5J]SJ%T3##C:N)W''Y4 >VT5Q7B+X=0^(?">F:!+K>I0I8!0)TD!>;:N
MWY_7UK+\(_!^U\)>(H-7A\0:I<M$K#R9& 1\@CYL=1SGZ@4 >DT5Y=XD^"MG
MXC\07FK2^(]6A>Y?>8E8%4]AGM[5NZ?\.X=/\ 7?A-=:U)XKDL?M9D_>QY(.
M%]!QT]SZT =I17D5A\!;*PU"WNT\4:P6AD60 ,%)P<XSVKH/'/PPM_'&J6]]
M/K>HV1AB\H10,-AY)S@]#S^@H [VBN(\#_#>#P1]O\G6=1O!=H$*S. $QGE0
M._/6N3D_9]L9)6D/BK626))+,I/XF@#V.BN*\1?#J'Q#X3TS0)=;U.%+ *!.
MD@+S;5V_/Z^M9?A'X/VOA+Q#!J\/B#5+EHE8>3(P"/D$?-CJ.<_4"@#TFBO+
MO$GP5L_$?B"\U:7Q'JT+W+[S$K JGL,]O:MW3_AW#8> +OPFNM:D\5P6/VLR
M?O4R0<+Z#CI[GUH [2BO(K#X"V5AJ%O=IXHU@M!(L@ 8+G!SC/:N@\<_"^W\
M<:I!?3ZWJ-D88O*$4##9U)S@]#S^@H [VBN(\#_#>#P1]O$.LZC>"\0*5F<
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M[GI0!Z+17B.G^&/C5'J%LUWXBMGMED3S5:?J@Z]$!Z$]ZZ#QQX=^(DVI6_\
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M3J*\W\$^'O'L*WZ^,-9$^Y!]D-O<,"&P0=VT#CI[YKDY?"_QQ>1R/$EJH).
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M*/4%\8:R)RR#[(8+A@5;!!W;0..GOG-<G+X7^.+R.1XDM5!)X6<8&?3Y,]J
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M[>-\OE\'SW..7Z\X^H- '7T5G-JDRL1_9-\3S@9BYP1T^?WI?[3GS_R"+_\
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M[8_6@#1HK.&ISG'_ !*+\9QU\KC(/^W^'XT?VG/C_D$7_P#Y"],_W_P^OYT
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M_P"C6H UJ*** "BBB@#R7XV_\P+_ +>/_:=%'QM_Y@7_ &\?^TZ* /0_"O\
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MF?\ :]ZT** ,\:-:#&'O.,?\OLW88_O>]']C6F,;[S_P-F],?WO3]>>M:%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC+=;;B.TCVW%DZ$GR9MQ/RG RZX^F&!H K;KBYT;2[S3[".?59-5:\FM4G&
MXWPO("W(CW $]2 <<UWMFEREE"MY+'+<A!YKQIM5F[X&3@5G:)X:T_07N9+5
M9'FN)&=Y96W, 6+! >R@DX _G6Q0 445#/=6]J(S<3QQ"601)O8#<YZ*,]SZ
M4 35PL5Y>7&NV-[XACM[:+[%=7$,; H;0 JC+*6)# JR\\8.>QJ7Q%K$L.IV
M%[I5P,N&AAD>8&TNI-Q!MW_YYR9'ROZ@J?2KMGX;M]7MM(U#6&O+F[ME>39=
M 1Y9R&(>,<84J-HY P.O6@ \"KJR>'K6/4+06<$-O'#! _,IVC!=NP!XPO8#
MGK@=1110 445F:WK"Z583O#']JOEA>6"RC8>;-M'.U2<GWQ0!1\1ZIK%B^S2
M[: K%:RW<LURK%"$Q^[!4C#-GJ>@'0U@-HJ7!TA_#L,\-Q#! /M OL"TB+^8
M4DCSE]REAR#G/;K5S3FU3Q#-"E_>BXTN:UD>*YTY-D-QO&TI("2RLN3@=#U.
M"N*Z'0M"LO#^G+9V8=N\DTK;I)FQC<[=SQ_0<4 :=%%% !574KF>STNZN;:V
M:YGBB9XX%ZR,!POXTMSJ%G9NJ7-U#"[(\BK(X4E5&6(SV Y-<5K&JZE!KMRN
ME3S(]W"&CA)$RW$6!^_M<G!D3/S1G[PP?J 17$(N[K68M?1;F\$=G'&UF_V=
MI@79TB4.W#APW(8$C'0BNL\-6^H6NAQ1:D\C3AW*B63S)$C+$HK/_$P7 )]N
M_6F6_AC3XM9CUB3SKB^2W2%9)WW8V@C?CIO()!;\..:VJ "BBB@ KE]9UW5[
M#497AM8!IMK+;QRF96WS^:P4F-AP-N1P0<\].*G\3^(AI%A)]EDA:Y5XUF8X
M<6<;''G2("&V#_/&36=#I.H^)(]0M==NKF)=D20R6+!('4,'$T9Y.\E1D'[O
M;(.2 5O"_AC4--UV>]M[^VBT];B:-[.W8LLXRV)'YPLHR%(QT7GG&.[JO8V-
MKIME%9V<*PV\0PJ+V_Q/J>]6* "BBJEQJ=A:R/'<7EO$Z(LCJ\@4JI;:&.>Q
M/&?6@"+6KF^M=-9].MQ-=,Z1J""0FY@I<@<D*"20/2N O['5/$6K6RF[LK35
MK:XGL5U&-MCH$V2"2*,DEB59E92=O.3VJ_)=ZL==N],M;B\MXYKE6NK?(DGM
MD9N)H">#"_0]3&<X'8=58>&]-T[6;[5H8V:\O&W.\C;M@P 0@_A!P"<=3^%
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M.1@XYJ]10!P_A;PL)8OMVIQWJD7+21P7+ ><%XCFFC&1YN.IXS@$C-=Q110
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M4T8 A>$,,^8V05=!\R,.01@'DBNDTG1[?2(I5BDFGFF??-<7#[Y93C W-[
M =@*T** "BBB@ HHHH **** "BBB@#R7XV_\P+_MX_\ :=%'QM_Y@7_;Q_[3
MHH ]#\*_\BAHG_7A!_Z+6M>LCPK_ ,BAHG_7A!_Z+6M>@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P"%G^,?^@Q_Y+0__$444 '_  L_QC_T&/\ R6A_^(H_X6?XQ_Z#'_DM#_\
M$444 '_"S_&/_08_\EH?_B*/^%G^,?\ H,?^2T/_ ,1110 ?\+/\8_\ 08_\
MEH?_ (BC_A9_C'_H,?\ DM#_ /$444 <SXN\9:_K7V/^T+_SO)W[/W,:XSMS
)T4>@HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %# F4# 2(  A$! Q$!_\0
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M^$6\/?\ 0!TO_P  X_\ "M:B@#)_X1;P]_T =+_\ X_\*/\ A%O#W_0!TO\
M\ X_\*UJ* ,G_A%O#W_0!TO_ , X_P#"C_A%O#W_ $ =+_\  ./_  K6HH R
M?^$6\/?] '2__ ./_"C_ (1;P]_T =+_ / ./_"M:B@#)_X1;P]_T =+_P#
M./\ PH_X1;P]_P! '2__  #C_P *UJ* ,G_A%O#W_0!TO_P#C_PH_P"$6\/?
M] '2_P#P#C_PK6HH R?^$6\/?] '2_\ P#C_ ,*/^$6\/?\ 0!TO_P  X_\
M"M:B@#)_X1;P]_T =+_\ X_\*/\ A%O#W_0!TO\ \ X_\*UJ* ,G_A%O#W_0
M!TO_ , X_P#"C_A%O#W_ $ =+_\  ./_  K6HH R?^$6\/?] '2__ ./_"C_
M (1;P]_T =+_ / ./_"M:B@#)_X1;P]_T =+_P# ./\ PH_X1;P]_P! '2__
M  #C_P *UJ* ,G_A%O#W_0!TO_P#C_PH_P"$6\/?] '2_P#P#C_PK6HH R?^
M$6\/?] '2_\ P#C_ ,*/^$6\/?\ 0!TO_P  X_\ "M:B@#)_X1;P]_T =+_\
M X_\*/\ A%O#W_0!TO\ \ X_\*UJ* ,G_A%O#W_0!TO_ , X_P#"C_A%O#W_
M $ =+_\  ./_  K6HH R?^$6\/?] '2__ ./_"C_ (1;P]_T =+_ / ./_"M
M:B@#)_X1;P]_T =+_P# ./\ PH_X1;P]_P! '2__  #C_P *UJ* ,G_A%O#W
M_0!TO_P#C_PH_P"$6\/?] '2_P#P#C_PK6HH R?^$6\/?] '2_\ P#C_ ,*/
M^$6\/?\ 0!TO_P  X_\ "M:B@#)_X1;P]_T =+_\ X_\*/\ A%O#W_0!TO\
M\ X_\*U2R@@$@$]!GK2T 9/_  BWA[_H Z7_ . <?^%'_"+>'O\ H Z7_P"
M<?\ A6M10!D_\(MX>_Z .E_^ <?^%'_"+>'O^@#I?_@''_A6M10!D_\ "+>'
MO^@#I?\ X!Q_X4?\(MX>_P"@#I?_ (!Q_P"%:U% &3_PBWA[_H Z7_X!Q_X4
M?\(MX>_Z .E_^ <?^%:U% &3_P (MX>_Z .E_P#@''_A1_PBWA[_ * .E_\
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M?[R^;NW%2.""<8H \RT?5-1\8VVAV>KZA>)&GARXO]\-P\323I*8UD8J1G
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MI_T#-4_\!&H_M]/^@9JG_@(U &M163_;Z?\ 0,U3_P !&H_M]/\ H&:I_P"
MC4 :U%9/]OI_T#-4_P# 1J/[?3_H&:I_X"-0!K45D_V^G_0,U3_P$:C^WT_Z
M!FJ?^ C4 :U%9/\ ;Z?] S5/_ 1J/[?3_H&:I_X"-0!K45D_V^G_ $#-4_\
M 1J/[?3_ *!FJ?\ @(U &M163_;Z?] S5/\ P$:C^WT_Z!FJ?^ C4 :U%9/]
MOI_T#-4_\!&H_M]/^@9JG_@(U &M163_ &^G_0,U3_P$:C^WT_Z!FJ?^ C4
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M_P# 1J/[?3_H&:I_X"-0!K45D_V^G_0,U3_P$:C^WT_Z!FJ?^ C4 :U%9/\
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M5KV5Y;ZA90WEK()()D#QN.X- &-IW_(\Z]_UZV?\YJZ"N?T[_D>=>_Z];/\
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M;WXSGIY7&<?[';'ZUHT5!1G'3)SG_B;WXSGIY?&2/]CVQ^-']F3Y_P"0M?\
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MC1G=@J*,LQ. !3E%+8(N^Y0.F3G/_$WOQG/3R^.<_P!S\/QH_LR?/_(6O_\
MR'ZY_N?A]/SJ\DL<A8)(K%<9"G.,]*?4%&<-,G!'_$WOSC'_ #S]<_W/P^E
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M )!LO_7W<?\ HUJR;;=V:)65D:U%%%(84444 >2_&W_F!?\ ;Q_[3HH^-O\
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M$?TSZ?A]>*TJ* ,TZU$ 3]CU#_P$?TSZ?Y/%!UF(9_T/4#C/2T?MCV]ZTJ*
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MQ_Z-:@#6HHHH **** /)?C;_ ,P+_MX_]IT4?&W_ )@7_;Q_[3HH ]#\*_\
M(H:)_P!>$'_HM:UZR/"O_(H:)_UX0?\ HM:UZ ///B;/Y,^D+!>)IU[,[107
MQOY(C&25X$2 ^;GC[PP/7FNO\.222^';"2758]5=X0QOHT"+/G^(*.!6-XO\
M,:7XEGLI)]7ETZ^L7W136\J!Q\RM@A@1]Y%/X5/\/I+:3P)I36D+0P!&55:3
M>3AV!8M@9)()_&@#IJ*** "BBB@#G]._Y'G7O^O6S_G-705Y+XS\->)-?\?7
M7_"/^)+K2"MI;I(L&_;(29""Y4C&!G&>N>*N>'+'Q3I_AC4])E\13ZGJ4J,P
MO9 <V)*$;<MDLP/.#@>E4H-[$N21Z=17C4'PQ^(),<R_$^]*G# YE((^A?!K
MK_&_A/Q-XB%@-$\6SZ.($(F$:D><QQAB5(/KQTYJ2CMJ*X+P-X.\5>'-5GN=
M<\8W&LVTD.Q;>4,0K9!W98G' (X]:Y_4/AGX_NM1N9X?B5>Q122LR(/,4*I/
M P&P./2@#UVBN+O_  KXFN? %KHD'BR>'6(B#+J@0AI0">.#D<$<YS\ON:PO
M#GP]\;Z3X@L[[4/B!=WUI"^Z6V?>PE7^[\S$?C0!ZC37=8T9V.%4$D^U>;^,
M? WC#6M?GU'3/'ESI5@47;;)O58\#GE6 /.3D^M6-+\,>(]/\&7^CZAXNFU&
M]U"3R[>]*EC &7L223P">M-*[$W8Z[2;3+/J<BRI/=+N,<A^X,Y QV.-H/TK
M4KQR/X7?$-)%;_A9M[P0?^6A'Y%\&NL\<>$_$WB+[ -$\6SZ.($(F$:D><QQ
MAB5(/KQTHD[NX)65CMZ*X+P-X.\5>'-4GN-<\8W&LVTD.Q;>4,0K9!W98G'
M(X]:Y^_^&?C^ZU"YGB^)5['%)(S(@\Q0JD\# ; X]*0SUVBN+O\ PKXFNO %
MIHD'BR>'6(BIEU,(0TH!/'!R.".<Y^7W-87ASX>^-])\06=]J'Q N[ZTB?=+
M;/O82K_=^9B/QH ]1HKS;Q=X$\9:YXAFOM)\=76F63JH2TC#J(\#!^ZPSD\Y
M]ZU/#OA7Q-I7A34],U#Q;/?:A<AOLUZZ$M;97 QN))YYZT =K17CD?PO^(:2
MJ_\ PLZ]X(/)D(_(O@UUGCCPGXF\1?8/[$\6SZ.($(F$:D><QQAB5(/KQTH
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MWQC;7[4:_?0_V4SD7!CDA#*I'5=HSD8X^M 'L-%>2^+M.^+0\0W \+WT0TG
M\HR21%\D MG<OKD#VK5\/:=\0V\*:DVNWR_VZN_["(Y4$;<97?M7'WN/I^=
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MH **** "LGP[_P @V7_K[N/_ $:U:U9/AW_D&R_]?=Q_Z-:@#6HHHH ****
M/)?C;_S O^WC_P!IT4?&W_F!?]O'_M.B@#T/PK_R*&B?]>$'_HM:UZR/"O\
MR*&B?]>$'_HM:UZ "BBB@ HHK 'BVR_XF4C12K;:>76:?<A&4." H;=UX''-
M &_16#_PE5N T3V5VE\)TMQ9$)YA9UWK@AMN-H)SGC:>]:>F:C!JMA'>6X<(
MQ92KC#(RDJRD>H((_"@#*T[_ )'G7O\ KUL_YS5T%<_IW_(\Z]_UZV?\YJZ"
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+EN,X_P_G6G10!FG1E.?]/U 9STN6[D'^E']C+G/V_4/_ EO7/\ ];Z5I44
M9HT900?M^H<8_P"7EO7/_P!;Z4#1E7'^GZ@<8ZW+<XS_ (_RK2HH S!HRC'^
MGZB<8ZW+=@1_6C^Q5QC^T-1_\"6],?\ U_K6G10!F'1E((^WZCSG_EY;TQ_]
M?ZT'1E.?]/U$9STN6XSC_#^=:=% &:=&4Y_T_4!G/2Y;N0?Z4?V,N<_;]0_\
M"6]<_P#UOI6E10!FC1E!'^GZAQC_ )>6]<__ %OI0-&5<?Z?J!QCK<MSC/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K)\._\@V7_K[N/_1K
M5K5D^'?^0;+_ -?=Q_Z-:@#6HHHH **** /)?C;_ ,P+_MX_]IT4?&W_ )@7
M_;Q_[3HH ]#\*_\ (H:)_P!>$'_HM:UZR/"O_(H:)_UX0?\ HM:UZ "BBB@
MHHHH Y_Q/*XDT>V::2&UNKX17#I(4)78[!=PY&6"C@^W>I/"-Q-<^'D>:5I@
ML\\<4K-N+QK*RH2>_P H'/?K6Q/;P74+0W$,<T3?>210RGZ@U'//::98M+,\
M5M:P)R3A511P!_3% '(P:O>VWC+5YD\/:K,LUK:X""($;3*,G,@Z]OH:U?\
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M3Q;<R7,MLGA?63-"%+K^XX#9Q_RT]C70W-S!9VLMU<RK%!"A>21S@*H&23[
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MX/MQ0!1_X22__P"A4UG\X/\ X[1_PDE__P!"IK/YP?\ QVNAHH Y[_A)+_\
MZ%36?S@_^.T?\))?_P#0J:S^<'_QVNAHH Y[_A)+_P#Z%36?S@_^.U$GBVYD
MN9K=/"^LF6$*9%_<<!LX_P"6GL:WKZ^M=-LY+N]G2""/[SN< ?\ UZ;9265W
M&-0LFBE2Y16\Z/GS%'3G\30!D?\ "27_ /T*FL_G!_\ ':/^$DO_ /H5-9_.
M#_X[70T4 <]_PDE__P!"IK/YP?\ QVC_ (22_P#^A4UG\X/_ ([70T4 <S<>
M++FUB\V?POK*)N5,_N#RS!0.)/4@5+_PDE__ -"IK/YP?_':T4U#2M3N[C34
MNK:XN+<JTT <,R$$$$CV('T-:% '/?\ "27_ /T*FL_G!_\ ':/^$DO_ /H5
M-9_.#_X[70T4 <]_PDE__P!"IK/YP?\ QVC_ (22_P#^A4UG\X/_ ([70U7O
M[^UTNQFO;Z=(+:%=TDK]%'J: ,&+Q;<S3SPQ^%]9,D!"R#]Q\I(!'_+3T(J7
M_A)+_P#Z%36?S@_^.UN0QP9>X@5,SX=I$_CXP#GOQBI: .>_X22__P"A4UG\
MX/\ X[1_PDE__P!"IK/YP?\ QVNAHH Y[_A)+_\ Z%36?S@_^.U%<>+;FU1'
MF\+ZRJNZQJ?W!RS$ #_6=R17353%QI^H7,]F)89Y[.1&EBR"T38#H2.W8B@#
M*_X22_\ ^A4UG\X/_CM'_"27_P#T*FL_G!_\=KH:* .>_P"$DO\ _H5-9_.#
M_P".T?\ "27_ /T*FL_G!_\ ':Z&B@#GO^$DO_\ H5-9_.#_ ..U'%XLNII)
MDC\+ZRS0OY<@_<?*VT-C_6>C _C6WJ.HVFE63W=[,(H5(&<$DDG   Y))X '
M)J:**)#(\<81I6WN<8+' &3[X 'X4 87_"27_P#T*FL_G!_\=H_X22__ .A4
MUG\X/_CM=#10!SW_  DE_P#]"IK/YP?_ !VC_A)+_P#Z%36?S@_^.UT-% ',
MS^+;FV\KSO"^LKYL@C3_ %!RQZ#_ %GM4O\ PDE__P!"IK/YP?\ QVM.*ZT_
M59IHHV2X:RG"N=N1'*!G /3(SVZ5>H Y[_A)+_\ Z%36?S@_^.U=\/1SQZ2#
M<6[V\DDTLOE2$%E#.S '!(S@]C6I10 4444 %%%% 'DOQM_Y@7_;Q_[3HH^-
MO_,"_P"WC_VG10!Z'X5_Y%#1/^O"#_T6M:]9'A7_ )%#1/\ KP@_]%K6O0 4
M444 %%%% !7#:Y<:OJ=VMC<)'9V%Q?FUMV$9\^.2-3+'< D[67=']W'3OU%:
M'B+Q(UO);6NF7MK%YEQY%Q?.!-':/C*I(H8%2QPH)P!GUQ4$'AV7Q):2-XD-
MXDZ7@<VZ2XA 52NV,CDQL&.<X)R0>E $GAVSU"76WUB:&S@CGM@D\EG/YD5Z
MX(V2J,?+A=PR<GY@.< UUE-CC2&-8XD5(T 5548"@= !3J "BBJ4VKZ=;SO!
M->P1RQF,.CR %2YPF?J>!ZT 0ZY/J,-I"FEQ!IYYTB:5DWB!#UD*Y&<>F>_I
M7 QVVHWUM?V+QV=]/>W$[HL<H@E@N86\O[1'G)V$JA/.5)(^8'%7]/N]3GUE
MM*BGO+>W6[#W=KO#W%IR6 #G[UO(1D,.1RO'\/6Z7X>T[1[R^O+6)OM%[*99
M9)&W'DYVKGHN23@=R: -"V69+2%;AU><(HD=1@,V.2/QJ6BB@ HHKEO$7B1K
M>2WM=-O+6+S+CR+B^<":.T?&5210P*ECA03@#ZXH @U"^U*\OS9:A:PKHM[=
MR::865EF*^6S>:'S@J=I&,=#UZBM30M,739'_LV[CDT.9/,M[<?,(6)Y\MAQ
MY9Z[>QZ<' S+?P_-XCM)&\2?;$G2]$AMUEVP@(I7;'CDQL&.<X)S@]*ZV.-(
MHUCC141 %55&  .P% #J*** "LS6YM2C@MXM+11-<3K$\[)O$"$$ERN1GH!U
MZD5-+JVGPSR0/>0+.CI&T;2 $,_W ?3=V]:XK2+G4YM833(Y[V&SBN]]U;%@
M]Q9MRPC9S]ZW<\JXR?X>G0 ETZQ_M(IK%M=V]IXLD:3S&!)CN4A?R2K)G/EG
M:#ZJQR#USW@SM&[&>^*S-(\/:=HDMW-9Q,);N5I99';<W+%MH)Z*"3@#@9-:
ME !1110 5QEU=ZA?:Y91:I;0QZ:^H.D$9#)-&T(9TF+9PRML/&.A')YJQX@\
M22QW-I9Z5>6D0FG:&6_D FB@E ^6)PK JS'@$_S(J.W\.MXCL1)XC%ZMPMZ9
M7MC*!$ %*>6FWK$0<\\MW[B@!?"T6JC4M1<)##I#WDUQ'(&#F[\P@JRD'"H!
MWZD^@'/74U$6-%1%"HHPJJ, #T%.H ***I2ZM8)+)!]LM_M"R+"8FD /F,NY
M5/H2.GK0!!K4NIJEI;Z6%22XF\N2Y:/S%@3:QW%<C.2 O7'-<1;37DEKX=ET
MRSAGU;[5=SRQ>;A8R_F(TIS\PBW\XY/0"K>@W6IW&JPZ:EQ>1V5M<EKBW9@]
MQ:.!N$,K'EH6^\KC)(PIKJ]%\/:=H"7 L8F#3R-))([;F.22%R>BC)P.@H T
M8%E2WC6>19)@H#NJ[0S8Y('./I4E%% !117)Z[XDG^VV5EH]Y9Q+/(\1OI0)
MH5F7I;MM8%&;U/H0,G H KRW]]>:YIZZQ;00Z>]W,UO&0T<L#0;BLC-G#*P#
M'&  ".34WA+2)[#4+F>WA>UTJ2("*)KPW G<L6\X<D*"#T'7/3BBV\.#Q%:0
M7/B%;W[2EV\SVLD@\L<;/+&WAHL '_:ZGJ176JH50J@!0, #H* %HHHH *R=
M;EU7=9VNE!(VN)&66Z>+S%@4*6SMR,Y("]>]3S:O8!I(%N[=K@2?9Q$90I,I
M7<$/H2.:X[PY=:G=ZG;Z?]JO5L+29C+$Q#7%M(!D6\['DQ\Y1Q]X8!/<@%&&
MR.K:/I#:5%+#K?D22!X+W8EJ7FW/(RD[G1F#8!!X&/>O3ATYY-9>A^'M.\/6
MTD&GQ%?,<O([MN=CG@$GL,X Z 5J4 %%%% !7"W^HZOJ,<^GZG#:VUGJ=M>+
M"DBE'MC%]UI&)PRL/FZ#''6KNL^)+A]2L;+1;RR1)RZB]E'FP/.O2V)5OD<\
MG)]. 3Q1:>&DUVUM+S7Q?-=1W$LKVL\@V GY?+PO#1#:I _BP">I% $O@[0[
M_1K>5Y[Z&2VN562.T@W&*U)R2D1)Y3D=OTP!U%   P!@"B@ HHK/FU>P#2VZ
MW=N]RLGD>290I,I7<$/H2.: (=:EU7=9VNE;(FN)&62Z>+S%@4*3DKD9R0!U
M[UPUIIVI^(]9M]9L[ZSTV_EMHKB9XF)DD*DHT13KY+; =Q.1CCN:O^&[K4[O
M4[>P^U7HL+25C+$Q#3V\@&1;SL>2G.5<?>& 3Z]9H?A_3O#UM)!I\3+YCEY'
M=BSL2> 2>PS@#H!0!J4444 %%%<EK7B2X;4;&ST:\L4CG9U%[*/-@>=>EL2K
M?(S<G)]. 3Q0!F:I)J.M3V]MJKQZ9!.\\UI,BE)[!X#@2,S':P92V>  &[]:
MUO">D3:?>WEQ%:FQT^9$6.W^U>?YK@G,V<G&Y2H]\9-1VGAJ/7K6SO=?6^:Z
MBN)9GMIY!L!.%\O"\-&-JD>N,GJ177  # & * "BBB@ K'UR75S+9VFD^7"9
MR_FW<L1D6$*N0"N1]X\9SQS[5-<:O8LLUO%<V\MSO:!8/."EI0F[R\]CCGZ<
MURGAFZU&^U"VM#=WIT^T9]T;8,T4@&/L]R3R0H.58??&,GC+ &1IFE27MC8M
MIK2G4)UCO(!'=!$TI7;<WR9RZ,WF$9!)'R]!FO5*RM!\/:=X<LFM=/C8*[%W
MDD8N[GMECUP. .P&*U: "BBB@ HHHH **** /)?C;_S O^WC_P!IT4?&W_F!
M?]O'_M.B@#T/PK_R*&B?]>$'_HM:UZR/"O\ R*&B?]>$'_HM:UZ "BBB@ K$
M\2P:B;2*\TN^6WN;9BPAF?;#<@\&-SV)_A8=#ZC(K;J&[M+:_MGMKNWBN('X
M:.5 RM]0: /.?"7AD:E=0:MY/DZ6]OY:@N&-W"5"B*9-NT[6WL6Y+,V0<5Z6
MJA5"J  !@ =J2.-(8ECB14C0!551@*!T %.H **** "N0\<Z1_:$5L]IIDMS
MJ+$Q)(BJ8RA(W1SY(S&PSZD$ C!Q77T4 9>CZ!::+YC0O/--)@--<RF23:/N
MIN/.T=A^/)K4HHH **** ,7Q)!?FTCN]-OEM[FV8D12OMAN >#&Y[$]F'0^O
M(KC?"7AH:I=0ZOY0ATMX/+0%PQNH"H40S)MVG:V]BW)9FR#BO1KNSMK^V>VO
M+>*X@?AHY4#*WU!J2.-(8ECB14C0!551@*!T % "JH10J@!0, #M2T44 %%%
M% ''>-]'-_):/9Z7+<7\A$)E4+Y+1%ANCGR0=F,D$<A@",'KO:1H=KHRR^3)
M//-*1ON+F3S)& &%4L>< =!]>Y-:=% !1110 5@^*(+_ .QI>:=?"&:#<#;R
MRB.*Y5A@H6_A;^ZW8]<@FMZH+RRM=0MFMKVVAN8&QNCF0.IQTX- 'GOA'PNF
MH7":NT"Q:7/;[8TW!OMD!5?+26,K@%,$D\DLQ.<<5Z2  ,#H*:B+&BHBA44
M*JC  ]!3J "BBB@ KC?&6B_VA?636FF337DQ6&690ODO!N&Y)CD'@992!E6
MP1W[*B@#.TG1;;1XY!$\\\TK;I;BYD\R63 P 6/4 < ?_7K1HHH **** .=\
M60WR68OK"]\MHD=);5Y1&ERC#D!C]R08RK>O!X/'.^$_"XN[K^UIH$CTVX@
M2(,"MY"=IA\R,KA3&H'3DL6.<5WE[86FHVQM[ZUAN8"03',@=21TX-3JJHH5
M0 H&  . * %HHHH **** .,\7:&NHZQ8FVTRXEGN&2.ZF3:(7@#9(D.00RCY
MD8#(8#!Y-='I.CV^D02)"\TTLK;Y;BX??+*<8&YN^  !Z 5H44 %%%% !7,>
M,HKR*Q:_M;UEC6%XKBS:41K/&P.[8Q^[* "5/3L?4=/5>]L+/48/(OK6"YAW
M!O+FC#KD=#@T </X3\+&:[DU6YABCL;F(%8$(*7:9#0N\97"&- H&.<[B3TK
MT"@    8 Z 44 %%%% !7%^+M!74=9L6MM,N)+B=DCN9TP(7@# D2'(8,H^9
M& R& P>37:44 9^DZ-;:/#(D+S32RMOFN+A]\LIZ#<W? X'I6A110 4444 <
MQXRAO([!KZTO61$ADBN+-I1&MQ$P^;8Q^[* "5;IV/!R,?PGX7,UT^JW,,4=
MC<Q I A!CNDR&A9XBN$*(% QSG<2:[>\L+/48/(O;6&YAW!O+FC#KD=#@U8
M   & .U !1110 4444 <5XJT%=2U^Q^S:;<-).R+=W"$+"T*G^(Y#"1/O(P&
M0>,X)KIM)TBVT>W>*!I99)&+RSSMODE;U9N_''L!5^B@ HHHH **** "BBB@
M HHHH \E^-O_ # O^WC_ -IT4?&W_F!?]O'_ +3HH ]#\*_\BAHG_7A!_P"B
MUK7K(\*_\BAHG_7A!_Z+6M>@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \E^-O_ # O^WC_ -IT
M4?&W_F!?]O'_ +3HH X73?B1XLM=+M+>'5ML44*(B_9XCA0H '*U9_X6?XQ_
MZ#'_ )+0_P#Q%%% !_PL_P 8_P#08_\ ):'_ .(H_P"%G^,?^@Q_Y+0__$44
M4 '_  L_QC_T&/\ R6A_^(H_X6?XQ_Z#'_DM#_\ $444 '_"S_&/_08_\EH?
M_B*/^%G^,?\ H,?^2T/_ ,1110 ?\+/\8_\ 08_\EH?_ (BC_A9_C'_H,?\
MDM#_ /$444 '_"S_ !C_ -!C_P EH?\ XBC_ (6?XQ_Z#'_DM#_\1110 ?\
M"S_&/_08_P#):'_XBC_A9_C'_H,?^2T/_P 1110 ?\+/\8_]!C_R6A_^(H_X
M6?XQ_P"@Q_Y+0_\ Q%%% !_PL_QC_P!!C_R6A_\ B*/^%G^,?^@Q_P"2T/\
M\1110 ?\+/\ &/\ T&/_ "6A_P#B*/\ A9_C'_H,?^2T/_Q%%% !_P +/\8_
M]!C_ ,EH?_B*/^%G^,?^@Q_Y+0__ !%%% !_PL_QC_T&/_):'_XBC_A9_C'_
M *#'_DM#_P#$444 '_"S_&/_ $&/_):'_P"(H_X6?XQ_Z#'_ )+0_P#Q%%%
M!_PL_P 8_P#08_\ ):'_ .(H_P"%G^,?^@Q_Y+0__$444 '_  L_QC_T&/\
MR6A_^(H_X6?XQ_Z#'_DM#_\ $444 '_"S_&/_08_\EH?_B*/^%G^,?\ H,?^
M2T/_ ,1110 ?\+/\8_\ 08_\EH?_ (BC_A9_C'_H,?\ DM#_ /$444 '_"S_
M !C_ -!C_P EH?\ XBC_ (6?XQ_Z#'_DM#_\1110 ?\ "S_&/_08_P#):'_X
MBC_A9_C'_H,?^2T/_P 1110 ?\+/\8_]!C_R6A_^(H_X6?XQ_P"@Q_Y+0_\
MQ%%% !_PL_QC_P!!C_R6A_\ B*/^%G^,?^@Q_P"2T/\ \1110 ?\+/\ &/\
MT&/_ "6A_P#B*/\ A9_C'_H,?^2T/_Q%%% !_P +/\8_]!C_ ,EH?_B*/^%G
M^,?^@Q_Y+0__ !%%% !_PL_QC_T&/_):'_XBC_A9_C'_ *#'_DM#_P#$444
M'_"S_&/_ $&/_):'_P"(H_X6?XQ_Z#'_ )+0_P#Q%%% !_PL_P 8_P#08_\
M):'_ .(H_P"%G^,?^@Q_Y+0__$444 '_  L_QC_T&/\ R6A_^(H_X6?XQ_Z#
M'_DM#_\ $444 '_"S_&/_08_\EH?_B*/^%G^,?\ H,?^2T/_ ,1110 ?\+/\
M8_\ 08_\EH?_ (BC_A9_C'_H,?\ DM#_ /$444 '_"S_ !C_ -!C_P EH?\
MXBC_ (6?XQ_Z#'_DM#_\1110 ?\ "S_&/_08_P#):'_XBC_A9_C'_H,?^2T/
M_P 1110 ?\+/\8_]!C_R6A_^(H_X6?XQ_P"@Q_Y+0_\ Q%%% !_PL_QC_P!!
MC_R6A_\ B*/^%G^,?^@Q_P"2T/\ \1110 ?\+/\ &/\ T&/_ "6A_P#B*/\
MA9_C'_H,?^2T/_Q%%% !_P +/\8_]!C_ ,EH?_B*/^%G^,?^@Q_Y+0__ !%%
M% !_PL_QC_T&/_):'_XBC_A9_C'_ *#'_DM#_P#$444 '_"S_&/_ $&/_):'
M_P"(H_X6?XQ_Z#'_ )+0_P#Q%%% !_PL_P 8_P#08_\ ):'_ .(H_P"%G^,?
J^@Q_Y+0__$444 <SXN\9:_K7V/\ M"_\[R=^S]S&N,[<]%'H**** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %" F4# 2(  A$! Q$!_\0
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M^$6\/?\ 0!TO_P  X_\ "M:B@#)_X1;P]_T =+_\ X_\*/\ A%O#W_0!TO\
M\ X_\*UJ* ,G_A%O#W_0!TO_ , X_P#"C_A%O#W_ $ =+_\  ./_  K6HH R
M?^$6\/?] '2__ ./_"C_ (1;P]_T =+_ / ./_"M:B@#)_X1;P]_T =+_P#
M./\ PH_X1;P]_P! '2__  #C_P *UJ* ,G_A%O#W_0!TO_P#C_PH_P"$6\/?
M] '2_P#P#C_PK6HH R?^$6\/?] '2_\ P#C_ ,*/^$6\/?\ 0!TO_P  X_\
M"M:B@#)_X1;P]_T =+_\ X_\*/\ A%O#W_0!TO\ \ X_\*UJ* ,G_A%O#W_0
M!TO_ , X_P#"C_A%O#W_ $ =+_\  ./_  K6HH R?^$6\/?] '2__ ./_"C_
M (1;P]_T =+_ / ./_"M:B@#)_X1;P]_T =+_P# ./\ PH_X1;P]_P! '2__
M  #C_P *UJ* ,G_A%O#W_0!TO_P#C_PH_P"$6\/?] '2_P#P#C_PK6HH R?^
M$6\/?] '2_\ P#C_ ,*/^$6\/?\ 0!TO_P  X_\ "M:B@#)_X1;P]_T =+_\
M X_\*/\ A%O#W_0!TO\ \ X_\*UJ* ,G_A%O#W_0!TO_ , X_P#"C_A%O#W_
M $ =+_\  ./_  K6HH R?^$6\/?] '2__ ./_"C_ (1;P]_T =+_ / ./_"M
M:B@#)_X1;P]_T =+_P# ./\ PH_X1;P]_P! '2__  #C_P *UJ* ,G_A%O#W
M_0!TO_P#C_PH_P"$6\/?] '2_P#P#C_PK6HH R?^$6\/?] '2_\ P#C_ ,*/
M^$6\/?\ 0!TO_P  X_\ "M:B@#)_X1;P]_T =+_\ X_\*/\ A%O#W_0!TO\
M\ X_\*UJ* ,G_A%O#W_0!TO_ , X_P#"C_A%O#W_ $ =+_\  ./_  K5#*6*
MA@6'49Y%+0!D_P#"+>'O^@#I?_@''_A1_P (MX>_Z .E_P#@''_A6M10!D_\
M(MX>_P"@#I?_ (!Q_P"%'_"+>'O^@#I?_@''_A6M10!D_P#"+>'O^@#I?_@'
M'_A1_P (MX>_Z .E_P#@''_A6M10!D_\(MX>_P"@#I?_ (!Q_P"%'_"+>'O^
M@#I?_@''_A6M10!D_P#"+>'O^@#I?_@''_A1_P (MX>_Z .E_P#@''_A6M10
M!D_\(MX>_P"@#I?_ (!Q_P"%'_"+>'O^@#I?_@''_A6M10!D_P#"+>'O^@#I
M?_@''_A1_P (MX>_Z .E_P#@''_A6M10!D_\(MX>_P"@#I?_ (!Q_P"%'_"+
M>'O^@#I?_@''_A6M10!D_P#"+>'O^@#I?_@''_A1_P (MX>_Z .E_P#@''_A
M6M10!XQ\8M(TS3_[%^Q:;9VV_P _?Y,"INQY>,X'/4_G15WXV_\ ,"_[>/\
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M\R!%_P!892,XYZ!<'&.<&NG7X>^'AI5[IS07,D5\R&ZDDNI'EG"?=5I"VXJ
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BHI[F"VV>=*L>]MJ[CC)I+:\MKR%9K:=)8V) 9&R"1P:=G:XK
MK8FHHHI#"BBB@ K)\._\@V7_ *^[C_T:U:U9/AW_ )!LO_7W<?\ HUJ -:BB
MB@ HHHH \E^-O_,"_P"WC_VG11\;?^8%_P!O'_M.B@#T/PK_ ,BAHG_7A!_Z
M+6M>LCPK_P BAHG_ %X0?^BUK7H **** "BLW2-:BUJ$SVUM<I;_ ,$LJ@+(
M,D97DGMW JG)XOTF&683/+'#'YH%PT?[N1H_OJI[D<]N<'&<4 ;U%8'_  EM
ME_JOLM[]M\SR_L7E#SL[-^<9QC;SG/MUXK8LKVWU&Q@O+60203H'C8=P: ,;
M3O\ D>=>_P"O6S_G-705S^G?\CSKW_7K9_SFKH* "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%% &>='@.?\ 2+[G/2]E[G/][VH_L>#.?M%]_P"!DOKG^]_D<=*T** ,\:/
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M'/!%<PF*>-9(VQE6&0<'-2444 %%%% !1110 4444 %%%% !1110 5D^'?\
MD&R_]?=Q_P"C6K6K)\._\@V7_K[N/_1K4 :U%%% !1110!Y+\;?^8%_V\?\
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MV_QU$JEKS1BN1D,(\'ZX7/Y5UGCF/XA2-8CP=-IT:!#]J,X&XMQC&X$8Z^]
M'3C4+LXSH]X,X_Y:0\<?[_X?C1_:%WC_ ) ]Y_W\A],_W_7CZ^W-<GX%C^)$
M>I7'_"93Z=)9&+]UY 7>),C^Z!QC/7VKG;Z#XWM?W!M;O1UMS(WE!0F N>.J
MYZ>M 'IQU"[ /_$GO#U_Y:0^F?[_ .%0>&R6TIV*E2;J<E3U'[UN.*PM23X@
M-X!LUL)--7Q1E?M+$?N]N3G;D8S]WVZX[5=^'ZZLOA*$:ZT3:F+B?SS%C:6\
MUNF.* .GHHHH **** /)?C;_ ,P+_MX_]IT4?&W_ )@7_;Q_[3HH ]#\*_\
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MI-A!,GW9(K9%8?0@4AT.Q(((N><_\O<O<8_O>E!T.Q;.1<\YS_I<O?'^U[4
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M"Q)IEA+9+9265L]HN-L#1*4&.F%QBJ'AB"*VTAX8(HXHENK@*D:A5'[UN@'
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M<MO)-Q(,_*23@9Y.><<"N?U.:Z6UDDLI9?[<,]\-0$;'S! "V,CL OE[?TH
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MG1I1G&?W\?'!SW[<?G2?;]1Q_P @:7_O_'Z9]?7B@#3HK,-_J.#_ ,2:4_\
M;>/TSZ^O%*;_ %$9QHTIQG'[^/GICOWY_*@#2HK--_J(SC1Y3C./W\?/(QW[
M\G\*/M^HY_Y \O\ W_C]<>OIS0!I45FB_P!1R,Z/*.G_ "WC]<>OIS0+_43C
M.CRC.,_OX^.N>_;C\Z -*BLT7^HG&=&E&<9_?Q\<'/?MP/QI/M^HX_Y TO\
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M^1YU[_KUL_YS5T%<_IW_ "/.O?\ 7K9_SFKH* "BBB@ HHHH **** "BBB@
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M\9[^PK3HH S3X?TQLYMNN<_O&[D$]_84?V!IA.?LWO\ ZQO7=Z^M:5% &:-
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M?ZQNXQZ^@H;P_I;9S;=<Y_>-WQGO["M.B@#-/A_3&SFVZYS^\;N03W]0*/[
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5D^'?^0;+_ -?=Q_Z-:M:LGP[_ ,@V7_K[N/\
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MI\7_ /0+T;_P/D_^-4?:?%__ $"]&_\  ^3_ .-5T-% '/?:?%__ $"]&_\
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MF!M^=$ *'[P!..X[X9"@$Y..356QTRQTP3BRM8H/M$S3R[%QOD8Y+'U)JW0
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M?^8%_P!O'_M.B@#T/PK_ ,BAHG_7A!_Z+6M>LCPK_P BAHG_ %X0?^BUK7H
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M'_T']5_\#)/\:** #_A*_$?_ $']5_\  R3_ !H_X2OQ'_T']5_\#)/\:**
M#_A*_$?_ $']5_\  R3_ !H_X2OQ'_T']5_\#)/\:** #_A*_$?_ $']5_\
M R3_ !H_X2OQ'_T']5_\#)/\:** #_A*_$?_ $']5_\  R3_ !H_X2OQ'_T'
M]5_\#)/\:** #_A*_$?_ $']5_\  R3_ !H_X2OQ'_T']5_\#)/\:** #_A*
M_$?_ $']5_\  R3_ !H_X2OQ'_T']5_\#)/\:** #_A*_$?_ $']5_\  R3_
M !H_X2OQ'_T']5_\#)/\:** #_A*_$?_ $']5_\  R3_ !H_X2OQ'_T']5_\
M#)/\:** #_A*_$?_ $']5_\  R3_ !H_X2OQ'_T']5_\#)/\:** #_A*_$?_
M $']5_\  R3_ !H_X2OQ'_T']5_\#)/\:** #_A*_$?_ $']5_\  R3_ !H_
MX2OQ'_T']5_\#)/\:** #_A*_$?_ $']5_\  R3_ !H_X2OQ'_T']5_\#)/\
M:** #_A*_$?_ $']5_\  R3_ !H_X2OQ'_T']5_\#)/\:** #_A*_$?_ $']
M5_\  R3_ !H_X2OQ'_T']5_\#)/\:** #_A*_$?_ $']5_\  R3_ !H_X2OQ
M'_T']5_\#)/\:** #_A*_$?_ $']5_\  R3_ !H_X2OQ'_T']5_\#)/\:**
M#_A*_$?_ $']5_\  R3_ !H_X2OQ'_T']5_\#)/\:** #_A*_$?_ $']5_\
M R3_ !H_X2OQ'_T']5_\#)/\:** #_A*_$?_ $']5_\  R3_ !H_X2OQ'_T'
M]5_\#)/\:** #_A*_$?_ $']5_\  R3_ !H_X2OQ'_T']5_\#)/\:** #_A*
M_$?_ $']5_\  R3_ !H_X2OQ'_T']5_\#)/\:** #_A*_$?_ $']5_\  R3_
M !H_X2OQ'_T']5_\#)/\:** #_A*_$?_ $']5_\  R3_ !H_X2OQ'_T']5_\
M#)/\:** #_A*_$?_ $']5_\  R3_ !H_X2OQ'_T']5_\#)/\:** #_A*_$?_
M $']5_\  R3_ !H_X2OQ'_T']5_\#)/\:** #_A*_$?_ $']5_\  R3_ !H_
MX2OQ'_T']5_\#)/\:** #_A*_$?_ $']5_\  R3_ !H_X2OQ'_T']5_\#)/\
M:** #_A*_$?_ $']5_\  R3_ !H_X2OQ'_T']5_\#)/\:** #_A*_$?_ $']
M5_\  R3_ !H_X2OQ'_T']5_\#)/\:** #_A*_$?_ $']5_\  R3_ !H_X2OQ
M'_T']5_\#)/\:** #_A*_$?_ $']5_\  R3_ !H_X2OQ'_T']5_\#)/\:**
M#_A*_$?_ $']5_\  R3_ !H_X2OQ'_T']5_\#)/\:** #_A*_$?_ $']5_\
M R3_ !H_X2OQ'_T']5_\#)/\:** #_A*_$?_ $']5_\  R3_ !H_X2OQ'_T'
M]5_\#)/\:** #_A*_$?_ $']5_\  R3_ !H_X2OQ'_T']5_\#)/\:** ,+Q)
<K>K7WV;[7JE[<;-^WSKAWVYQG&3QT%%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Sep. 23, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000312070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">BARCLAYS BANK PLC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-287303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings - Offering: 1<br></strong></div></th>
<th class="th">
<div>Sep. 23, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Global Medium-Term Notes, Series A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">5,598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 5,598,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 857.05<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), was originally deferred in accordance with Rule 456(b) under the Securities Act.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457rFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection r<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457rFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Sep. 23, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 5,598,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">857.05<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">857.05<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 5,598,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>26</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="dp234695_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dp234695_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dp234695_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="dp234695_exfilingfees.htm">dp234695_exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "dp234695_exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "dp234695_exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 26,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 7,
    "http://xbrl.sec.gov/ffd/2025": 6,
    "http://xbrl.sec.gov/dei/2025": 1
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 24,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp234695_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp234695_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp234695_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp234695_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp234695_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp234695_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0000950103-25-012054-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950103-25-012054-xbrl.zip
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M/ZG\!U!+ 0(4 Q0    ( %.(-UM^OY(;LPH  (4W   9              "
M 0    !D<#(S-#8Y-5]E>&9I;&EN9V9E97,N:'1M4$L%!@     !  $ 1P
' .H*      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>dp234695_exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c_offering_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000312070</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-23</startDate>
            <endDate>2025-09-23</endDate>
        </period>
    </context>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000312070</identifier>
        </entity>
        <period>
            <startDate>2025-09-23</startDate>
            <endDate>2025-09-23</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="fee_001">424B2</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="fee_002">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="fee_003">0000312070</dei:EntityCentralIndexKey>
    <ffd:RegnFileNb contextRef="c_report" id="fee_004">333-287303</ffd:RegnFileNb>
    <ffd:OfferingTableNa contextRef="c_report" id="fee_005" xsi:nil="true"/>
    <ffd:OffsetTableNa contextRef="c_report" id="fee_006">N/A</ffd:OffsetTableNa>
    <ffd:CombinedProspectusTableNa contextRef="c_report" id="fee_007">N/A</ffd:CombinedProspectusTableNa>
    <ffd:FormTp contextRef="c_report" id="fee_008">F-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="fee_009">BARCLAYS BANK PLC</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c_offering_1" id="fee_010">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_1" id="fee_011">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_1" id="fee_012">Global Medium-Term Notes, Series A</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="c_offering_1" id="fee_013">true</ffd:Rule457rFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_1"
      decimals="0"
      id="fee_014"
      unitRef="shares">5598</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_015"
      unitRef="USD">1000</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_016"
      unitRef="USD">5598000</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_017"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-223"
      unitRef="USD">857.05</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-224"
      unitRef="USD">5598000</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-225"
      unitRef="USD">857.05</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-226"
      unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-227"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-228"
      unitRef="USD">857.05</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c_offering_1" id="ixv-229">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), was originally deferred in accordance with Rule 456(b) under the Securities Act.</ffd:OfferingNote>
    <ffd:NrrtvMaxAggtOfferingPric
      contextRef="c_report"
      decimals="INF"
      id="ixv-230"
      unitRef="USD">5598000</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="c_report" id="ixv-231">true</ffd:FnlPrspctsFlg>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
